0001206774-12-001963.txt : 20120510 0001206774-12-001963.hdr.sgml : 20120510 20120510085601 ACCESSION NUMBER: 0001206774-12-001963 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120510 DATE AS OF CHANGE: 20120510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MECHANICAL TECHNOLOGY INC CENTRAL INDEX KEY: 0000064463 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 141462255 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-06890 FILM NUMBER: 12827880 BUSINESS ADDRESS: STREET 1: 325 WASHINGTON AVENUE EXTENSION CITY: ALBANY STATE: NY ZIP: 12205 BUSINESS PHONE: 5182182550 MAIL ADDRESS: STREET 1: 325 WASHINGTON AVENUE EXTENSION CITY: ALBANY STATE: NY ZIP: 12205 10-Q 1 mti_10q.htm QUARTERLY REPORT


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________

FORM 10-Q
______________

x        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED March 31, 2012
OR

o        TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM ____ TO ______

______________

 
Mechanical Technology, Incorporated
(Exact name of registrant as specified in its charter)
______________

New York 0-6890 14-1462255
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)

325 Washington Avenue Extension, Albany, New York 12205
(Address of registrant’s principal executive office)

(518) 218-2550
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x     No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x     No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check one):

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company  x
(Do not check if a small reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12B-2 of the Act). Yes ¨     No x

The number of shares of common stock, par value of $0.01 per share, outstanding as of May 4, 2012 was 5,256,883.



MECHANICAL TECHNOLOGY, INCORPORATED AND SUBSIDIARIES
INDEX

PART I. FINANCIAL INFORMATION       2
 
       Item 1. Financial Statements 2
 
       Condensed Consolidated Balance Sheets as of March 31, 2012 (Unaudited) and December 31, 2011   2
   
       Condensed Consolidated Statements of Operations (Unaudited)
       For the Three Months Ended March 31, 2012 and 2011 3
 
       Condensed Consolidated Statements of Stockholders’ Equity
         For the Three Months Ended March 31, 2012 (Unaudited) and Twelve Months Ended December 31, 2011   4
 
       Condensed Consolidated Statements of Cash Flows (Unaudited)
       For the Three Months Ended March 31, 2012 and 2011 5
 
       Notes to Condensed Consolidated Financial Statements (Unaudited) 6
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
 
Item 4. Controls and Procedures 22
 
PART II. OTHER INFORMATION 23
 
Item 1. Legal Proceedings 23
 
Item 1A.       Risk Factors 23
 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 25
 
Item 3. Defaults Upon Senior Securities 25
 
Item 4. Mine Safety Disclosures 25
 
Item 5. Other Information 25
 
Item 6. Exhibits 25
  
SIGNATURES 26

1



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements

Mechanical Technology, Incorporated and Subsidiaries
Condensed Consolidated Balance Sheets as of March 31, 2012 (Unaudited) and December 31, 2011

(Dollars in thousands) March 31, December 31,
      2012       2011
Assets
Current Assets:
       Cash $ 1,978 $ 1,669
       Accounts receivable 661 1,881
       Inventories 1,007   957
       Deferred income taxes, net   20 20
       Prepaid expenses and other current assets 87   102  
              Total Current Assets 3,753 4,629
Deferred income taxes, net 1,515   1,515
Property, plant and equipment, net 223 258
              Total Assets $ 5,491 $ 6,402
 
Liabilities and Stockholders’ Equity
Current Liabilities:
       Accounts payable $ 177 $ 191
       Accrued liabilities 1,119 1,238
       Deferred revenue 58 58
              Total Current Liabilities 1,354 1,487
 
Commitments and Contingencies (Note 10)
Stockholders’ Equity:
       Common stock, par value $0.01 per share, authorized 75,000,000; 6,259,975 issued in
              both 2012 and 2011 63 63
       Paid-in-capital 135,447 135,389
       Accumulated deficit        (120,919 )        (120,097 )
       Common stock in treasury, at cost, 1,005,092 shares in both 2012 and 2011 (13,754 ) (13,754 )
              Total MTI stockholders’ equity 837 1,601
       Non-controlling interest 3,300 3,314
              Total Stockholders’ Equity 4,137 4,915
              Total Liabilities and Stockholders’ Equity $ 5,491 $ 6,402

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2



Mechanical Technology, Incorporated and Subsidiaries
Condensed Consolidated Statements of Operations (Unaudited)
For the Three Months Ended March 31, 2012 and 2011

(Dollars in thousands, except per share) Three Months Ended March 31,
      2012       2011
Product revenue $ 1,204 $ 2,539
Funded research and development revenue 13
       Total revenue 1,204 2,552
Operating costs and expenses:
       Cost of product revenue 578 939
       Research and product development expenses:  
              Funded research and product development   25
              Unfunded research and product development 373 385
       Total research and product development expenses 373     410  
       Selling, general and administrative expenses   1,092 1,307
Operating loss   (839 ) (104 )
Gain on derivatives 44
Other income (expense), net 3 (2 )
       Loss before non-controlling interest (836 ) (62 )
Plus: Net loss attributed to non-controlling interest 14 256
       Net (loss) income attributed to MTI (822 ) 194
Comprehensive (loss) income attributed to MTI $ (822 ) $ 194
 
Net (loss) earnings per share attributable to MTI (Basic and Diluted): $ (0.16 ) $ 0.04
Weighted average shares outstanding (Basic and Diluted)        5,254,883        4,771,658

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3



MECHANICAL TECHNOLOGY, INCORPORATED AND SUBSIDIARIES
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
For the Year Ended December 31, 2011
and the Three Months Ended March 31, 2012 (Unaudited)

Common Stock Treasury Stock
Additional Non- Total
Paid- Accumulated Controlling Stockholders'
(Dollars in thousands)      Shares      Amount      in-Capital      Deficit      Shares      Amount      Interest (NCI)      Equity
December 31, 2010 5,776,750 $ 58 $ 134,733 $ (122,483 ) 1,005,092 $ (13,754 ) $ 3,405 $ 1,959
 
Net income attributed to MTI - - - 2,386 - - - 2,386
Stock based compensation - -   656 - - -     -   656
Issuance of shares – restricted stock   483,225   5 - -   - -   -   5
Net loss attributed to NCI -   -   -     -   -   - (738 )   (738 )
Equity contribution to NCI - - - - -   - 647   647
December 31, 2011 6,259,975 $ 63 $ 135,389 $ (120,097 ) 1,005,092 $ (13,754 ) $ 3,314 $ 4,915
 
Net loss attributed to MTI - - - (822 ) - - - (822 )
Stock based compensation - - 58 - - - - 58
Net loss attributed to NCI - - - - - - (14 ) (14 )
March 31, 2012      6,259,975 $ 63 $      135,447 $      (120,919 ) 1,005,092 $      (13,754 ) $      3,300 $      4,137

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4



MECHANICAL TECHNOLOGY, INCORPORATED AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (Unaudited)
For the Three Months Ended March 31, 2012 and 2011

(Dollars in thousands) Three Months Ended March 31,
        2012       2011
Operating Activities
Net loss $ (836 ) $ (62 )
Adjustments to reconcile net loss to net cash provided by (used in) operating
              activities:
       Gain on derivatives (44 )
       Depreciation 38 99
       Gain on disposal of equipment        (5 )  
       Stock based compensation   58 102
Changes in operating assets and liabilities:  
       Accounts receivable 1,220 (572 )
       Inventories (50 ) (10 )
       Prepaid expenses and other current assets 18 8
       Accounts payable   (14 ) 177
       Deferred revenue (8 )
       Accrued liabilities (119 ) 50
Net cash provided by (used in) operating activities 310 (260 )
Investing Activities
Purchases of equipment (3 )   (13 )
Proceeds from sale of equipment 2
Net cash used in investing activities (1 ) (13 )
 
Financing Activities
Proceeds from the sale of subsidiary equity and warrants issued 203
Net cash provided by financing activities 203
Increase (decrease) in cash and cash equivalents 309 (70 )
Cash - beginning of period 1,669 1,118
Cash - end of period $            1,978 $                  1,048

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5



MECHANICAL TECHNOLOGY, INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Notes to Condensed Consolidated Financial Statements (Unaudited)

1. Nature of Operations

Description of Business

Mechanical Technology, Incorporated (MTI or the Company), a New York corporation, was incorporated in 1961. MTI operates in two segments, the Test and Measurement Instrumentation segment, which is conducted through MTI Instruments, Incorporated. (MTI Instruments), a wholly-owned subsidiary, and the New Energy segment, which is conducted through MTI MicroFuel Cells Incorporated. (MTI Micro), a variable interest entity (VIE) that is included in these condensed consolidated financial statements and described further below in Note 2.

MTI Instruments was incorporated in New York on March 8, 2000 and is a worldwide supplier of precision non-contact physical measurement solutions, portable balancing equipment and wafer inspection tools. MTI Instruments’ products use a comprehensive array of technologies to solve complex, real world applications in numerous industries including manufacturing, semiconductor, solar, commercial and military aviation, automotive and data storage. MTI Instruments’ products consist of electronic gauging instruments for position, displacement and vibration application within the design, manufacturing/production, test and research market; wafer characterization of semi-insulating and semi-conducting wafers within both the semiconductor and solar industries; tensile stage systems for materials testing at academic and industrial settings; and engine vibration analysis systems for both military and commercial aircraft.

MTI Micro was incorporated in Delaware on March 26, 2001, and has been developing Mobion®, a handheld energy-generating device to replace current lithium-ion and similar rechargeable battery systems in many handheld electronic devices for the military and consumer markets. Mobion® handheld generators are based on direct methanol fuel cell (DFMC) technology, which has been recognized as an enabling technology for advanced portable power sources by the scientific community and industry analysts. As the need for advancements in portable power increases, MTI Micro has been developing Mobion® as a solution for advancing current and future electronic device power needs of the portable electronics market. As of March 31, 2012, the Company owned approximately 47.6% of MTI Micro’s outstanding common stock. Although MTI Micro continues to believe in the potential of its Mobion® based power solutions, it has suspended its MTI Micro operations until such time as market demand and other deciding factors, including obtaining additional external financing, the successful completion of customer trials, a new development program with a government agency, and/or a customer order, come to fruition. MTI Micro will continue to seek additional capital from external sources to resume operations and fund future development, if any. If MTI Micro is unable to secure additional financing, a new development program or customer order, the MTI Micro Board of Directors will assess other options for MTI Micro, including the sale of its intellectual property portfolio and other assets.

Liquidity

The Company has historically incurred significant losses, the majority stemming from the direct methanol fuel cell product development and commercialization programs of MTI Micro, and had a consolidated accumulated deficit of $120.9 million as of March 31, 2012. During the first quarter of 2012, the Company generated a net loss attributed to MTI of $822 thousand and had working capital at March 31, 2012 of $2.4 million, a $743 thousand decrease from $3.1 million at December 31, 2011. The Company generated positive operating cash flows of $310 thousand for the three months ended March 31, 2012 and currently has no debt outstanding. While it cannot be assured, management believes that the Company will continue to generate positive cash flows in 2012 and be able to fund the Company’s operations for the foreseeable future.

As of March 31, 2012, the Company had approximately $2.0 million of cash available to fund future operations. During the three months ended March 31, 2012, the Company’s results of operations resulted in a net loss attributed to MTI of $822 thousand and cash provided by operating activities totaling $310 thousand. The Company expects to continue funding its operations from current cash, its projected 2012 cash flow pursuant to management’s current plan, and possible draw downs from its existing line of credit, if necessary. The Company may also seek to supplement its resources through the sales of assets (including its investment in MTI Micro). Besides the line of credit at MTI Instruments, the Company has no other commitments for funding future needs of the organization at this time and such additional financing during 2012 may not be available to the Company on acceptable terms, if at all.

2. Basis of Presentation

In the opinion of management, the Company’s condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the periods presented in accordance with United States of America Generally Accepted Accounting Principles (U.S. GAAP) and with the instructions to Form 10-Q in Article 10 of the Securities Exchange Commissions (SEC) Regulation S-X. The results of operations for the interim periods presented are not necessarily indicative of results for the full year.

6



Certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.

The information presented in the accompanying condensed consolidated balance sheet as of December 31, 2011 has been derived from the Company’s audited consolidated financial statements. All other information has been derived from the Company’s unaudited condensed consolidated financial statements for the three months ended March 31, 2012 and March 31, 2011.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, MTI Instruments and its VIE, MTI Micro. The Company is the primary beneficiary of the VIE. All intercompany balances and transactions are eliminated in consolidation. The Company reflects the impact of the equity securities issuances in its investment in the VIE and additional paid-in-capital accounts for the dilution or anti-dilution of its ownership interest in the VIE.

The Company has performed an analysis under the VIE accounting model and determined that MTI Micro is a VIE. One of the criteria for determining whether an entity is a VIE is determining if the entity, MTI Micro, has equity at risk. Management has concluded that MTI Micro does not have equity at risk to fund operations into its next phase of development. Further, the Company has determined that it is the primary beneficiary of MTI Micro, and therefore should include MTI Micro’s results of operations in the Company’s consolidated financial statements.

The Company's analysis to determine the primary beneficiary of MTI Micro focused primarily on determining which variable interest holder has the power to direct the activities that would have the most significant impact on the financial performance of MTI Micro. MTI Micro is governed by its own Board of Directors and significant decisions are made by a majority vote of this board. MTI does not have control of the MTI Micro Board of Directors; however, as of March 31, 2012, the Company’s Board of Directors and the MTI Micro Board of Directors consist of the same members. Under the Articles of Incorporation of MTI Micro, each share of MTI Micro stock is entitled to a vote, and further, holders of a majority of the shares of MTI Micro's common stock have the ability to reconstitute the board. As of March 31, 2012, MTI, Counter Point Ventures Fund II, LP (Counter Point), Dr. Walter L. Robb, a member of the Company’s and MTI Micro’s Board of Directors, and Peng Lim, CEO and board member own 47.6%, 45.2%, 5.1% and 0.5% of the common shares of MTI Micro, respectively. Counter Point is a venture capital fund sponsored and managed by Dr. Robb. Since no entity of the related parties has power but, as a group, the Company and its related parties have the power, then the party within the related party group that is most closely associated with the VIE, MTI Micro, is the primary beneficiary. Even though Dr. Robb and Counterpoint combined control a majority of the outstanding common stock, and they have the ability to elect the directors of MTI Micro and decide whether to continue to seek business opportunities for MTI Micro or instead seek opportunities to sell the intellectual property, they have not elected to do so. The Company continues to oversee the day to day operations, exercise management decision making, seek opportunities to sell intellectual property, and has a vested interest in the commercialization of MTI Micro’s fuel cell technology. Since inception in 2001, the Company has made the largest investment and been the principal funder of MTI Micro. The Company has also been exposed to losses and has the ability to benefit from MTI Micro. Considering the facts and circumstances, management believes the Company is most closely associated with the VIE, MTI Micro, and therefore, it is the primary beneficiary.

Should there be a change in the facts and circumstances (such as undertaking additional activities, a change in governance or a change to the related party group) in the future, management will reassess whether the Company remains the primary beneficiary and should continue to include MTI Micro in the Company’s condensed consolidated financial statements.

Non-controlling interests in subsidiaries consist of equity securities issued by a VIE of the Company. Non-controlling interests are classified as stockholders’ equity in the condensed consolidated financial statements. The condensed consolidated income statement presents condensed net income for both the Company and the non-controlling interests. The calculation of earnings per share is based on net income attributable to the Company.

Reclassifications

It is the Company’s policy to reclassify prior year consolidated financial statements to conform to current year presentation, if applicable. Prior period amounts related to prototype evaluation agreements have been reclassified.

7



3. Accounts Receivable

Receivable balances consist of the following at:

(Dollars in thousands) Test and
Measurement
      Instrumentation       New Energy       Consolidated Totals
March 31, 2012  
U.S. Government $ 67 $ $ 67
Commercial   594   594
       Total $ 661   $ $ 661
 
December 31, 2011
U.S. Government $ 990 $ $ 990
Commercial 887 4   891
       Total $              1,877 $                   4 $                   1,881

For the three months ended March 31, 2012 and 2011, the largest commercial customer represented 14.6% and 31.6%, respectively, and a U.S. governmental agency represented 11.5% and 6.8%, respectively, of the Company’s Test and Measurement Instrumentation segment product revenue. As of March 31, 2012 and December 31, 2011, the largest commercial customer represented 21.4% and 10.0%, respectively, and a U.S. governmental agency represented 10.1% and 52.7%, respectively, of the Company’s Test and Measurement Instrumentation segment accounts receivable.

As of March 31, 2012, there were no outstanding receivables for the New Energy segment. The balance as of December 31, 2011 represents minimal amounts due for service contracts.

As of March 31, 2012 and December 31, 2011, the Company had no allowance for doubtful trade accounts receivable.

4. Inventories

Inventories consist of the following at:

(Dollars in thousands)
      March 31, 2012       December 31, 2011
Finished goods $ 390   $ 310
Work in process     253   211
Raw materials 364 436
$                      1,007 $                             957

As of March 31, 2012 and December 31, 2011, the Company had an inventory reserve of $220 thousand and $243 thousand, respectively.

5. Income Taxes

During the quarter ended March 31, 2012, the Company’s effective income tax rate was 0%. The projected annual effective tax rate is less than the Federal statutory rate of 35%, primarily due to the Company’s expected level of earnings for the year ended December 31, 2012, and the permanent difference related to the stock-based compensation expense for employees of MTI Micro who transferred to MTI. For the quarter ended March 31, 2011, the Company’s effective income tax rate was also 0%. The difference between the annual effective tax rate and the Federal statutory rate was the result of the change in the valuation allowance and the gain on derivative.

The Company provides for recognition of deferred tax assets if the realization of such assets is more likely than not to occur in accordance with accounting standards that address income taxes. Significant management judgment is required in determining the period in which the reversal of a valuation allowance should occur. The Company has considered all available evidence, both positive and negative, such as historical levels of income and future forecasts of taxable income amongst other items, in determining whether a full or partial release of our valuation allowance is required. In addition, the Company’s assessment requires us to schedule future taxable income in accordance with accounting standards that address income taxes to assess the appropriateness of a valuation allowance which further requires the exercise of significant management judgment.

8



As a result of our analyses in 2011, the Company released a portion of our valuation allowance against its deferred tax assets. The partial release of the valuation allowance caused an incremental tax benefit of $1.5 million to be recognized in the fourth quarter of 2011. The release of a portion of the valuation allowance was based upon a recent cumulative income history for MTI and its subsidiary exclusive of MTI Micro (MTI Micro files separate federal and state tax returns) causing the Company to evaluate what portion of the Company's deferred tax assets it believes are more likely than not to be realized. The Company has determined that it expects to generate sufficient levels of pre-tax earnings in the future to realize the net deferred tax assets recorded on the balance sheet at March 31, 2012. The Company has projected such pre-tax earnings utilizing a combination of historical and projected results, taking into consideration existing levels of permanent differences, non-deductible expense and the reversal of significant temporary differences. The Company needs to generate approximately $225 thousand of taxable income in each year over the next twenty years to ensure the realizability of the approximately $1.5 million of deferred tax assets recorded on the condensed consolidated balance sheet at March 31, 2012.

The Company believes that the accounting estimate for the valuation of deferred tax assets is a critical accounting estimate because judgment is required in assessing the likely future tax consequences of events that have been recognized in our financial statements or tax returns. The Company based the estimate of deferred tax assets and liabilities on current tax laws and rates and, in certain cases, business plans and other expectations about future outcomes. In the event that actual results differ from these estimates or the Company adjusts these estimates in future periods, the Company may need to adjust the recorded valuation allowance, which could materially impact our financial position and results of operations. The valuation allowance at March 31, 2012 and December 31, 2011 was approximately $20 million for both periods. The Company will continue to evaluate the ability to realize its deferred tax assets and related valuation allowances on a quarterly basis.

6. Stockholders’ Equity

Common Stock

The Company has one class of common stock, par value $.01. Each share of the Company’s common stock is entitled to one vote on all matters submitted to stockholders. As of March 31, 2012 and December 31, 2011, there were 5,254,883 shares of common stock issued and outstanding.

Changes in common shares issued and treasury stock outstanding are as follows:

Three Months Ended Year Ended
      March 31, 2012       December 31, 2011
Common Shares  
Balance, beginning 6,259,975 5,776,750
Issuance of shares for restricted stock grants   483,225
Balance, ending 6,259,975 6,259,975
  
Treasury Stock
Balance, beginning 1,005,092 1,005,092
Balance, ending 1,005,092 1,005,092

Warrants Issued

On December 20, 2006, the Company issued warrants to investors to purchase 378,472 shares of the Company’s common stock at an exercise price of $18.16 per share. These warrants were fair valued by the Company until their expiration on December 19, 2011.

The Company recognized these derivatives as liabilities in the statement of financial position and measured these instruments at fair value. The fair value of the derivative was recorded in the “Derivative liability” line on the financial statements, and was valued quarterly using the Black-Scholes Option Pricing Model. As of March 31, 2012 and December 31, 2011, the fair value of the warrants was $0. Gains and losses on derivatives are included in “Gain / Loss on derivatives” in the Condensed Consolidated Statement of Operations. During the three month periods ended March 31, 2012 and 2011, the Company recognized a gain on derivatives of $0 and $44 thousand, respectively.

9



Reservation of Shares

The Company has reserved common shares for future issuance as of March 31, 2012 as follows:

Stock options outstanding       778,046
Shares available for issuance 270,616
Number of common shares reserved 1,048,662

Earnings (Loss) per Share

The Company computes basic income (loss) per common share by dividing net income (loss) by the weighted average number of common shares outstanding during the reporting period. Diluted income (loss) per share reflects the potential dilution, if any, computed by dividing income (loss) by the combination of dilutive common share equivalents, comprised of shares issuable under outstanding investment rights, warrants and the Company’s share-based compensation plans, and the weighted average number of common shares outstanding during the reporting period. Dilutive common share equivalents include the dilutive effect of in-the-money stock options, which are calculated based on the average share price for each period using the treasury stock method. Under the treasury stock method, the exercise price of a stock option, the amount of compensation cost, if any, for future service that the Company has not yet recognized, and the amount of windfall tax benefits that would be recorded in additional paid-in capital, if any, when the stock option is exercised are assumed to be used to repurchase shares in the current period.

Not included in the computation of earnings per share, assuming dilution, for the three months ended March 31, 2012, were options to purchase 778,046 shares of the Company’s common stock. These potentially dilutive items were excluded because the Company incurred a loss for this period and their inclusion would be anti-dilutive.

Not included in the computation of earnings per share, assuming dilution, for the three months ended March 31, 2011, were options to purchase 878,591 shares of the Company’s common stock and warrants to purchase 378,472 shares of the Company’s common stock. These potentially dilutive items were excluded because the average market price of the common stock exceeded the exercise prices of the options and warrants for this period.

7. Issuance of Common Stock, Warrants and Stock Options by MTI Micro

As of March 31, 2012, the Company owned approximately 47.6% of MTI Micro’s outstanding common stock, or 75,049,937 shares, and 53.3% of common stock and warrants issued, which includes 32,904,136 outstanding warrants. The number of shares of MTI Micro common stock authorized for issuance is 240,000,000 as of March 31, 2012.

Common Stock Issued – MTI Micro

On January 11, 2010, MTI Micro entered into a Purchase Agreement with Counter Point. Counter Point is a venture capital fund sponsored and managed by Dr. Walter L. Robb, a member of the Board of Directors of the Company and MTI Micro, and a current stockholder of MTI Micro. Pursuant to the Purchase Agreement, MTI Micro issued and sold to Counter Point 28,571,429 shares of common stock, par value $0.01 per share (the MTI Micro Common Stock), at a purchase price per share of $0.07, over a period of twelve months, and warrants (MTI Micro Warrants) to purchase shares of MTI Micro Common Stock equal to 20% of the shares of MTI Micro Common Stock purchased under the Purchase Agreement at an exercise price of $0.07 per share. The sale and issuance of the MTI Micro Common Stock and MTI Micro Warrants occurred over multiple closings (each, a Closing). Nine Closings occurred through December 31, 2010, with MTI Micro raising $1.9 million from the sale of 26,952,386 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 5,390,477 shares of MTI Micro Common Stock to Counter Point. The final Closing occurred on January 5, 2011, with MTI Micro raising $113 thousand from the sale of 1,619,043 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 323,809 shares of MTI Micro Common Stock to Counter Point.

On February 9, 2011, Amendment No. 1 was entered into between MTI Micro and Counter Point. Pursuant to Amendment No. 1, MTI Micro issued and sold to Counter Point 6,428,574 shares of MTI Micro Common Stock at a purchase price per share of $0.07, through December 31, 2011, and MTI Micro Warrants to purchase shares of MTI Micro Common Stock equal to 20% of the shares of MTI Micro Common Stock purchased under Amendment No. 2 at an exercise price of $0.07 per share. The sale and issuance of the MTI Micro Common Stock and MTI Micro Warrants occurred over multiple closings (each, a Closing) occurring over four one-month closing periods (each, a Closing Period). Four Closings occurred through September 30, 2011, with MTI Micro raising $450 thousand from the sale of 6,428,574 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 1,285,715 shares of MTI Micro Common Stock to Counter Point.

10



On September 23, 2011, Amendment No. 2 was entered into between MTI Micro and Counter Point. Pursuant to Amendment No. 2, MTI Micro issued and sold to Counter Point 1,200,000 shares of MTI Micro Common Stock at a purchase price per share of $0.07, through December 31, 2011, and MTI Micro Warrants to purchase shares of MTI Micro Common Stock equal to 20% of the shares of MTI Micro Common Stock purchased under Amendment No. 2 at an exercise price of $0.07 per share. The sale and issuance of the MTI Micro Common Stock and MTI Micro Warrants occurred over multiple closings (each, a Closing) occurring over three one-month closing periods (each, a Closing Period). Three Closings occurred through December 31, 2011, with MTI Micro raising $84 thousand from the sale of 1,200,000 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 240,000 shares of MTI Micro Common Stock to Counter Point.

The following table represents changes in ownership between the Company and non-controlling interests in common shares of MTI Micro:

            MTI       Non Controlling Interest
Average       Ownership       Ownership      
Price Shares % Shares % Total Shares
 
Balance at 12/31/10 75,049,937 50.6 73,325,490 49.4 148,375,427
 
      Stock issued under Purchase Agreement, 2011 $      0.07 1,619,043 1,619,043
 
Balance after Purchase Agreement 75,049,937 50.04 74,944,533 49.97 149,994,470
 
      Stock issued under Amendment No. 1 $ 0.07 6,428,574 6,428,574
 
      Stock issues under Amendment No. 2 $ 0.07 1,200,000   1,200,000
 
Balance at 12/31/11   75,049,937 47.61 82,573,107 52.39 157,623,044
 
Balance at 3/31/12 75,049,937 47.61 82,573,107 52.39 157,623,044

Reservation of Shares

MTI Micro has reserved common shares for future issuance, broken down between the Company and NCI, as follows as of March 31, 2012:

      MTI       NCI       Total
Stock options outstanding 22,566,560 22,566,560
Warrants outstanding 32,904,136 12,196,411 45,100,547
Number of shares reserved for outstanding options and warrants 32,904,136 34,762,971 67,667,107

In addition, MTI Micro has 15,375,637 stock options available for issuance.

As of March 31, 2012, the Company owned an aggregate of approximately 47.6% of the outstanding shares of MTI Micro or 53.3% of the outstanding common stock and warrants issued of MTI Micro, and Dr. Robb and Counter Point owned approximately 45.2% and 5.1%, respectively of the outstanding shares of MTI Micro or 40.3% and 4.3%, respectively of the outstanding common stock and warrants issued of MTI Micro.

Warrants Issued – MTI Micro

On December 9, 2009, MTI Micro issued warrants to the then current shareholders of MTI Micro, including the Company, without consideration, to purchase 32,779,310 shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The warrants became exercisable on December 9, 2010 and expire on December 8, 2017. The warrants have been accounted for as an equity distribution of $2.0 million, including warrants to the Company with a value of $2.0 million, which were eliminated in consolidation.

On December 9, 2009, MTI Micro issued warrants to the Bridge Investors of MTI Micro, including the Company, to purchase 5,081,237 shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on December 9, 2009 and will expire on the earlier of: (i) April 15, 2014; (ii) immediately prior to a change in control; or (iii) immediately prior to an initial public offering of MTI Micro. The MTI Micro Warrants were issued without consideration and were accounted for as equity and a loss on extinguishment of debt was recorded in the amount of $289 thousand, including warrants to the Company with a value of $57 thousand, which were eliminated in consolidation.

11



Under the Purchase Agreement entered into on January 11, 2010, MTI Micro issued 5,714,286 MTI Micro Warrants to Counter Point to purchase shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on the date of issuance and will expire on the earlier of: (a) the five (5) year anniversary of the Date of Issuance of the Warrant; (b) immediately prior to a change in control; or (c) the closing of a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act. The MTI Micro Warrants were accounted for as equity.

Under Amendment No. 1 entered into on February 9, 2011, MTI Micro issued 1,285,715 MTI Micro Warrants to Counter Point to purchase shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on the date of issuance and will expire on the earlier of: (a) the five (5) year anniversary of the Date of Issuance of the Warrant; (b) immediately prior to a change in control; or (c) the closing of a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act. The MTI Micro Warrants were accounted for as equity.

Under Amendment No. 2 entered into on September 23, 2011, MTI Micro issued 240,000 MTI Micro Warrants to Counter Point to purchase shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on the date of issuance and will expire on the earlier of: (a) the five (5) year anniversary of the Date of Issuance of the Warrant; (b) immediately prior to a change in control; or (c) the closing of a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act. The MTI Micro Warrants were accounted for as equity.

8. Fair Value Measurement

The Company performs a detailed analysis of financial assets and liabilities in determining the appropriate levels of classification. At each reporting period, all assets and liabilities for which the fair value measurements are based upon significant unobservable inputs are classified as Level 3. The derivative liability was valued using the Black-Sholes Option Pricing Model, which is based upon unobservable inputs. The derivative liability was $0 as of March 31, 2012 and December 31, 2011. The Company had no Level 1 and no Level 2 assets and liabilities as of March 31, 2012 and December 31, 2011.

The following is a rollforward of Level 3 fair value instruments for the twelve months ended December 31, 2011:

(Dollars in thousands)

      Beginning       Total (Gains) /             Ending
Balance as of Losses Purchases, Balance as of
  January 1, Realized and Issuances, Sales December 31,
Instrument 2011 Unrealized and Settlements 2011
       Derivative liability $                    73 $                  (73 ) $                        — $                        —
Total Level 3 instruments $ 73 $ (73 ) $ $

9. Segment Information

The Company operates in two business segments, Test and Measurement Instrumentation and New Energy. The Test and Measurement Instrumentation segment designs, manufactures, markets and services high performance test and measurement instruments and systems, wafer characterization tools for the semiconductor and solar industries, tensile stage systems for materials testing at academic and industrial settings, and computer-based balancing systems for aircraft engines. The New Energy segment is focused on commercializing direct methanol fuel cells. The Company’s principal operations are located in North America.

The accounting policies of the Test and Measurement Instrumentation and New Energy segments are similar to those described in the summary of significant accounting policies in the Company’s Annual Report on Form 10-K (Note 2). The Company evaluates performance based on profit or loss from operations before income taxes. Inter-segment sales and expenses are not significant.

Summarized financial information concerning the Company’s reportable segments is shown in the following table. The “Other” column includes corporate related items and items such as income taxes or unusual items, which are not allocated to reportable segments. The “Reconciling Items” column includes non-controlling interests in a consolidated entity. In addition, segments’ non-cash items include any depreciation in reported profit or loss.

12



(Dollars in thousands) Test and Condensed
Measurement Reconciling Consolidated
      Instrumentation       New Energy       Other       Items       Totals
Three months ended March 31, 2012
Product revenue $            1,204 $           — $ $             — $ 1,204
Research and product development expenses
       (income) 374 (1 ) 373
Selling, general and administrative expenses 518 37 537 1,092
Segment loss from operations before non-  
       controlling interest (478 ) (28 ) (330 ) (836 )
Segment (loss) profit (478 ) (28 ) (330 ) 14 (822 )
Total assets 1,833 85       3,573        5,491
Capital expenditures 3 3
Depreciation 25 13 38

(Dollars in thousands) Test and Condensed
Measurement Reconciling Consolidated
Instrumentation New Energy Other Items Totals
Three months ended March 31, 2011
Product revenue       $ 2,539       $       $       $       $ 2,539
Funded research and development revenue 13 13
Research and product development expenses 330 80 410
Selling, general and administrative expenses 533 393 381 1,307
Segment profit (loss) from operations before non-    
       controlling interest 622       (527 ) (157 ) (62 )
Segment profit (loss) 622 (527 ) (157 )           256 194
Total assets              2,539 420        1,061        4,020
Capital expenditures 8 5 13
Depreciation 19 77 3 99

The following table presents the details of “Other” segment loss:

(Dollars in thousands)       Three Months Ended
March 31,
2012       2011
Corporate and other (expenses) income:
       Depreciation $ $ (3 )
       Salaries and benefits         (352 )         (175 )
       Gain on derivatives 43
       Other income (expense), net 22 (22 )
Total expense $ (330 ) $ (157 )

10. Commitments and Contingencies

Commitments:

Leases

The Company and its subsidiary lease certain manufacturing, laboratory and office facilities. The leases generally provide for the Company to pay either an increase over a base year level for taxes, maintenance, insurance and other costs of the leased properties or the Company’s allocated share of insurance, taxes, maintenance and other costs of leased properties. The leases contain renewal provisions.

Future minimum rental payments required under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are (dollars in thousands): $209 thousand remaining in 2012, $285 thousand in 2013 and $266 thousand in 2014.

13



Warranties

Below is a reconciliation of changes in product warranty liabilities:

(Dollars in thousands) Three Months Ended
March 31,
      2012       2011
Balance, January 1 $ 26 $ 36
Accruals for warranties issued 3 12
Settlements made (in cash or in kind) (3 )          (3 )
Balance, end of period $          26 $ 45

Licenses

Under a 2002 NYSERDA contract, MTI Micro agreed to pay NYSERDA a royalty of 5.0% of the sales price of any product sold incorporating IP developed pursuant to the NYSERDA contract. If the product is manufactured by a New York State manufacturer, this royalty is reduced to 1.5%. Total royalties are subject to a cap equal to two times the total contract funds paid by NYSERDA to MTI Micro, and may be reduced to reflect any New York State jobs created by MTI Micro. As of March 31, 2012 and December 31, 2011, there are no amounts accrued in the condensed consolidated balance sheets related to this royalty provision.

Under the 2010 NYSERDA contract, MTI Micro agreed to pay NYSERDA a royalty of 5.0% of the sales price of any product sold incorporating IP developed pursuant to the NYSERDA contract. The obligation commences on the first date of the first sale of these products and is in place for fifteen years. Total royalties are subject to a cap equal to three times the total contract funds paid by NYSERDA to MTI Micro. However, if the product is manufactured by a New York State manufacturer, this royalty is reduced to 1.5% and total royalties are subject to a cap equal to one times the total contract funds paid by NYSERDA to MTI Micro. As of March 31, 2012 and December 31, 2011, there are no amounts accrued in the condensed consolidated balance sheets related to this royalty provision.

Employment Agreements

The Company has employment agreements with certain employees that provide severance payments, certain other payments, accelerated vesting and exercise extension periods of certain options upon termination of employment under certain circumstances, as defined in the applicable agreements. As of March 31, 2012, the Company’s potential maximum cash obligation to these employees was approximately $641 thousand.

Royalty Commitment

On January 28, 2010, MTI Instruments entered into an Asset Purchase and Sale Agreement with Ernest F. Fullam, Inc., Peter Fullam and Diane Fullam to acquire the tensile stage line of products from Ernest F. Fullam, Inc, a pioneering microscopy accessories company from Clifton Park, NY. As part of the acquisition, Mr. Peter Fullam joined MTI Instruments as a Product Sales Engineer until September 30, 2011, at which time he became a consultant for MTI Instruments, and MTI Instruments purchased machinery, inventory and the rights to use the Fullam/MTI Instruments product name. Additionally, commencing with the quarter ended March 31, 2010 and ending at the close of the quarter ending December 31, 2012, MTI Instruments will pay Ernest F. Fullam, Inc. a royalty equal to 5% of the Gross Sales achieved on specific Fullam products. Royalty expense related to this agreement was $0 and $3 thousand for the three months ended March 31, 2012 and 2011, respectively.

Contingencies:

Legal

We are subject to legal proceedings, claims and liabilities which arise in the ordinary course of business. We accrue for losses associated with legal claims when such losses are probable and can be reasonably estimated. These accruals are adjusted as additional information becomes available or circumstances change. Legal fees are charged to expense as they are incurred.

11. Line of Credit

On September 20, 2011, MTI Instruments entered into a working capital line of credit with First Niagara Bank, N.A. Pursuant to the Demand Grid Note, MTI Instruments may borrow from time to time up to $400 thousand to support its working capital needs. The note is payable upon demand, and the interest rate on the note is equal to the prime rate with a floor of 4.0% per annum. The note is secured by a lien on all of the assets of MTI Instruments and is guaranteed by the Company. The line of credit is subject to a review date of June 30, 2012. Under the line of credit, MTI Instruments is required to hold a line balance of $0 for 30 consecutive days out during each consecutive year. As of March 31, 2012 and December 31, 2011, there were no amounts outstanding under the line of credit.

14



12. New Accounting Pronouncements

In September 2011, the Financial Accounting Standards Board (FASB) issued guidance on the presentation of comprehensive income. This guidance eliminates the current option to report other comprehensive income and its components in the statement of changes in equity. The guidance allows two presentation alternatives: (1) present items of net income and other comprehensive income in one continuous statement, referred to as the statement of comprehensive income; or (2) in two separate, but consecutive, statements of net income and other comprehensive income. This guidance is effective as of the beginning of a fiscal year that begins after December 15, 2011. Early adoption is permitted, but full retrospective application is required under both sets of accounting standards. The guidance also previously required the presentation of adjustments for items that are reclassified from other comprehensive income to net income in the statement where the components of net income and the components of other comprehensive income are presented; however, this portion of the guidance has been deferred. The Company adopted the guidance during the quarter ended March 31, 2012. The adoption of this new guidance did not have a material impact on the Company’s condensed consolidated financial statements.

Other pronouncements issued by the FASB, or other authoritative accounting standard groups with future effective dates, are either not applicable, or are not expected to be significant to the financial statements of the Company.

13. Subsequent Events

The Company has evaluated subsequent events and transactions through the date of this filing for potential recognition or disclosure in the condensed consolidated financial statements and has noted no other subsequent events requiring recognition or disclosure other than as stated below.

On April 12, 2012, Kevin G. Lynch was appointed to the Board of Directors and the Audit Committee of Mechanical Technology, Incorporated.

On April 14, 2012, the Board of Directors of the Company adopted, subject to stockholder approval, the Mechanical Technology Incorporated 2012 Equity Incentive Plan (the 2012 Plan). Up to 600,000 shares of Common Stock may be issued pursuant to awards granted under the 2012 Plan. The 2012 Plan covers the Company and its majority owned subsidiaries, and references below to service providers to the Company (other than with respect to changes in control) generally refer to service providers to any of the other entities, as long as they remain majority owned. The 2012 Plan is intended to replace the Company's current option plan - the 2006 Equity Incentive Plan.

On April 14, 2012, the Board of Directors and executive officers of the Company surrendered 355,459 stock options without consideration and without any obligation on the part of the Company to grant stock options in replacement thereof or other consideration relating thereto at any time in the future in order to make more stock options available for future grants.

On April 17, 2012, in conjunction with the suspension of MTI Micro in late 2011, an auction was held to sell certain surplus equipment on hand.

15



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Unless the context requires otherwise, the terms “we,” “us,” and “our” refer to Mechanical Technology, Incorporated, a New York Corporation, “MTI Instruments” refers to MTI Instruments, Incorporated, a New York corporation and our wholly owned subsidiary, and “MTI Micro” refers to MTI MicroFuel Cells Incorporated, a Delaware corporation and variable interest entity that is included in these consolidated results. MTI Micro has a registered trademark in the United States for “Mobion.” Other trademarks, trade names, and service marks used in this Quarterly Report on Form 10-Q are the property of their respective owners.

The following discussion of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and the notes thereto included in Item 1 of Part I of this Quarterly Report on Form 10-Q and the audited consolidated financial statements and the notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations for the year ended December 31, 2011 contained in our 2011 Annual Report on Form 10-K.

In addition to historical information, the following discussion contains forward-looking statements, which involve risk and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements. Important factors that could cause actual results to differ include those set forth in Part I Item 1A-Risk Factors in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, as filed on March 27, 2012 as updated by Part II, Item 1A-Risk Factors and elsewhere in this Quarterly Report on Form 10-Q. Readers should not place undue reliance on our forward-looking statements. These forward-looking statements speak only as of the date on which the statements were made and are not guarantees of future performance. Except as may be required by applicable law, we do not undertake or intend to update any forward-looking statements after the date of this Quarterly Report on Form 10-Q.

Overview

MTI operates in two segments: the Test and Measurement Instrumentation segment, which is conducted through MTI Instruments, Incorporated (MTI Instruments), a wholly-owned subsidiary, and the New Energy segment, which is conducted through MTI MicroFuel Cells, Incorporated (MTI Micro), a variable interest entity (VIE) as of March 31, 2012. MTI and MTI Micro currently share the same Board of Directors, while MTI also continues to oversee the day to day operations, exercise management decision making, seek opportunities to sell intellectual property, and have a vested interest in the commercialization of MTI Micro’s fuel cell technology. Since inception in 2001, MTI has made the largest investment and been the principal funder of MTI Micro. MTI has also been exposed to losses and has the ability to benefit from MTI Micro. Considering the facts and circumstances, management believes MTI is most closely associated with the VIE, MTI Micro, and therefore, it is the primary beneficiary. Should there be a change in the facts and circumstances (such as undertaking additional activities, a change in governance or a change to the related party group) in the future, management will reassess whether MTI remains the primary beneficiary and should continue to include MTI Micro in MTI’s condensed consolidated financial statements.

Test and Measurement Segment – MTI Instruments is a worldwide supplier of metrology, portable balancing equipment and inspection systems. Our products use state-of-the-art technology to solve complex real world applications in numerous industries including automotive, semiconductor, solar cell manufacturing, material testing, commercial and military aviation and data storage. We are continuously working on ways to expand our sales reach, including expanded sales coverage throughout Europe and Asia, as well as a focus on internet marketing.

Our test and measurement segment has three product groups: Precision Instruments, Semiconductor and Solar Metrology Systems, and Aviation Balancing Systems. Our products consist of electronic, computerized gauging instruments for position, displacement and vibration applications for the design, manufacturing/production and test and research markets; metrology tools for wafer characterization of semiconductor and solar wafers; tensile stage systems for materials testing in research and industrial settings; and engine balancing and vibration analysis systems for both military and commercial aircraft.

In 2011, MTI Instruments was awarded a $4.1 million multi-year U.S. Air Force contract for the purchase of PBS4100+ portable aircraft engine balancing systems. As of March 31, 2012, MTI Instruments had recorded $855 thousand in orders, approximately 21% of the contract’s total potential value. MTI Instruments also has a multi-year U.S. Air Force contract to service and repair its existing fleet of PBS-4100/+ jet engine balancing systems with the latest diagnostic and balancing technology, which could potentially generate up to a total of $6.5 million in sales for the Company between 2009 and 2014. As of March 31, 2012, MTI Instruments had recorded approximately $3.0 million in orders, approximately 45.7% of the contract’s total value.

New Energy Segment - MTI Micro has been developing off-the-grid power solutions for various portable electronic devices. Our patented proprietary direct methanol fuel cell (DMFC) technology platform, called Mobion®, converts methanol fuel to usable electricity capable of providing continuous power as long as necessary fuel flows are maintained. Our proprietary fuel cell power solution consists of two primary components integrated into an easily manufactured device: the direct methanol fuel cell power engine, which we refer to as our Mobion® Chip, and methanol fuel cartridges. The methanol used by the technology is fully biodegradable.

16



Although MTI Micro continues to believe in the potential of its Mobion® based power solutions, operations have been suspended at MTI Micro until such time as market demand and other deciding factors, including obtaining additional external financing, the successful completion of customer trials, a new development program with a government agency, and/or a customer order come to fruition. MTI Micro will continue to seek additional capital from external sources to resume operations and fund future development, if any. If MTI Micro is unable to secure additional financing, a new development program or customer order, the MTI Micro Board of Directors will assess other options for MTI Micro including the sale of its intellectual property portfolio and other assets.

In the second half of 2010, MTI Micro entered into a firm fixed price contract for the development of proof of concept fuel cells for technical testing with a United States Department of Defense (DOD) agency. Additionally, during the first quarter of 2011, MTI Micro completed the work required under the United States Department of Energy (DOE) grant awarded for the period January 8, 2009 through March 30, 2011. The objective of the grant was to demonstrate and field test a commercially viable one watt DMFC charger for consumer electronic devices. As part of this objective, MTI Micro field tested 75 units to various users, including 17 OEM’s, 33 individuals, 21 military agencies and four governmental agencies. MTI Micro has achieved all technical performance targets required by the DOE under this grant; this field testing has concluded and the final report to the DOE may be found at http://www.mtimicrofuelcells.com/news/events.asp. Additional experimental testing was conducted at the DOD since the fourth quarter of 2010 that resulted in product improvements in the third quarter of 2011. Further testing by the DOD of MTI Micro’s Mobion® fuel cell charger commenced in October 2011. If approval is granted, this may result in the signing of a commercialization contract or purchase orders for final production. To date, no such approval has been granted and there is no clear indication as to when MTI Micro will be notified.

Results of Operations

Results of Operations for the Three Months Ended March 31, 2012 Compared to the Three Months Ended March 31, 2011.

Test and Measurement Instrumentation Segment

Product Revenue. Product revenue in our Test and Measurement Instrumentation segment for the three months ended March 31, 2012 decreased by $1.3 million, or 52.6%, to $1.2 million in 2012 from $2.5 million in 2011. This decrease in product revenue was due primarily to an $800 thousand decline in aviation balancing equipment sales. Last year, first quarter product revenue had included unique order activity for aviation balancing systems which began during the fourth quarter of 2010 and shipped during the first quarter of 2011. Also contributing to the first quarter decline in comparative product revenue was a slowdown in production levels at our customers in the U.S. and Asia which resulted in fewer wafer metrology tool shipments and a 31% drop in general instrumentation revenue. For the quarter ended March 31, 2012, the largest commercial customer for the segment was an Asian distributor, which accounted for $176 thousand, or 14.6%, of the first quarter revenue. In 2011, the largest commercial customer for the segment was a U.S. military aerospace equipment subcontractor which accounted for $801 thousand, or 31.6%, of the first quarter revenue. The U.S. Air Force was the largest government customer for the quarter ended March 31, 2012 and accounted for $139 thousand, or 11.5%, of the first quarter revenue. The U.S. Department of Defense was the largest government customer for the quarter ended March 31, 2011 and accounted for $172 thousand, or 6.8%, of the first quarter revenue.

Information regarding government contracts included in product revenue is as follows:

(Dollars in thousands) Revenues for the Total Contract
Three Months Ended Revenue Contract Orders Received
            March 31, to Date to Date
Contract (1) Expiration 2012       2011       March 31, 2012 March 31, 2012
$6.5 million Air Force Retrofit and Maintenance      
       of PBS-4100 Systems 9/27/2014 (2) $              63 $              83 $                  2,968 $               2,972
$4.1 million Air Force PBS-4100 Systems 08/29/2015 (3) $ $ $ 684 $ 855
____________________
 
(1)       Contract values represent maximum potential values and may not be representative of actual results.
(2) Date represents expiration of contract, including all four potential option extensions.
(3) Date represents expiration of contract, including all four potential option extensions.

17



Cost of Product Revenue. Cost of product revenue in our Test and Measurement Instrumentation segment for the three months ended March 31, 2012 decreased by $361 thousand, or 38.5%, to $578 thousand in 2012 from $939 thousand in 2011 in conjunction with the aforementioned 52.6% decrease in product revenue. Gross profit, as a percentage of product revenue, decreased to 52.0%, compared to 63.0% for the same period in 2011 due to the change in product mix and higher production overhead costs related to personnel.

Unfunded Research and Product Development Expenses. Unfunded research and product development expenses in our Test and Measurement Instrumentation segment for the three months ended March 31, 2012 increased by $44 thousand, or 13.4%, to $374 thousand in 2012 from $330 thousand in 2011. This increase was due to additional personnel costs and higher external development spending for new development projects.

Selling, General and Administrative Expenses. Selling, general and administrative expenses in our Test and Measurement Instrumentation segment for the three months ended March 31, 2012 decreased by $15 thousand, or 2.8%, to $518 thousand in 2012 from $533 thousand in 2011. This decrease is the result of reduced sales commissions and travel costs, offset by higher advertising and promotional spending.

New Energy Segment

Funded Research and Development Revenue. There was no funded research and development revenue in our New Energy segment for the three months ended March 31, 2012, compared to $13 thousand in the prior year. The final billings for both the DOE and the New York State Energy Research and Development Authority (NYSERDA) grants were done in the first quarter of 2011 for approximately $6 thousand each, as the majority of work was finished in 2010. There are no active grants at this time.

Information regarding our contracts included in funded research and development revenue is as follows:

(Dollars in thousands)
  Revenue Revenue Revenue
Three Months Three Months Contract to
Ended Ended Date
Contract       Expiration (1)       March 31, 2012       March 31, 2011       March 31, 2012
$2.99 million DOE (2) 3/31/2011 $                  — $                    7 $              2,994
$296 thousand NYSERDA 12/31/10 $ $ 6 $ 296
____________________
 
(1)       Dates represent expiration of contract, not date of final billing.
(2) The DOE contract was initially awarded for $2.4 million, effective for January 2009 through March 31, 2010. An extension to this was granted in April 2010, increasing total funding to $2.99 million and an expiration date of March 31, 2011. The DOE contract was a cost share contract.

Funded Research and Product Development Expenses. There was no funded research and product development expenses in our New Energy segment for the three months ended March 31, 2012, compared to $25 thousand in 2011. There are no active grants at this time.

Unfunded Research and Product Development Expenses. There was no unfunded research and product development expenses in our New Energy segment for the three months ended March 31, 2012, compared to $55 thousand in 2011. This decrease is attributable to the suspension of operations in late 2011, and no further research is being performed at this time.

Selling, General and Administrative Expenses. Selling, general and administrative expenses in our New Energy segment decreased by $356 thousand to $37 thousand for the three months ended March 31, 2012, compared to $393 thousand in 2011. This decrease is attributable to the suspension of operations in late 2011.

Results of Consolidated Operations

Operating Loss. Operating loss for the three months ended March 31, 2012 was $839 thousand compared to $104 thousand in 2011. This increase in operating loss was a result of the factors noted above.

Gain on Derivatives. We had no gain on derivatives for the three months ended March 31, 2012 compared to a gain on derivatives of $44 thousand in 2011. This gain was the result of derivative treatment of the freestanding warrants issued to investors in conjunction with our December 2006 capital raise. These warrants expired on December 19, 2011.

18



Income Tax Benefit (Expense). There was no income tax benefit (expense) for the three months ended March 31, 2012 and 2011. During the quarter ended March 31, 2012, our effective income tax rate was 0%. The projected annual effective tax rate is less than the Federal statutory rate of 35%, primarily due to our expected level of earnings for the year ended December 31, 2012, and the permanent difference related to the stock-based compensation expense for employees of MTI Micro who transferred to MTI. For the quarter ended March 31, 2011, our effective income tax rate was also 0%. The difference between the annual effective tax rate and the Federal statutory rate was the result of the change in the valuation allowance and the gain on derivative. The valuation allowance against our deferred tax assets at March 31, 2012 and December 31, 2011 was approximately $20 million for both periods. We will continue to evaluate the ability to realize our deferred tax assets and related valuation allowances on a quarterly basis.

Net Losses Attributed to Non-Controlling Interests (of MTI Micro). The net loss attributed to non-controlling interests for the three months ended March 31, 2012 decreased by $242 thousand, or 94.5%, to $14 thousand in 2012 from $256 thousand in 2011. This is the result of a decrease in the net loss of MTI Micro from $526 thousand in 2011 to $28 thousand in 2012 as a result of the suspension of operations in late 2011.

Net Income (Loss). Net loss for the three months ended March 31, 2012 was $822 thousand compared to net income of $194 thousand for the same period in 2011. The decrease in net income of $1.0 million is primarily attributed to a decrease of MTI Instruments net income of $1.1 million, a reduction of the net loss of MTI Micro of $500 thousand, and a reduction in the net loss attributed to non-controlling interests of $242 thousand. These are a result of the factors discussed above.

Liquidity and Capital Resources

Several key indicators of our liquidity are summarized in the following table:

Three Months Ended
(Dollars in thousands) March 31,
2012 2011
Cash $ 1,978       $          1,048
Working capital          2,399 1,863
Net (loss) income attributed to MTI (822 ) 194
Net cash provided by (used in) operating activities 310 (260 )
Purchase of property, plant and equipment (3 ) (13 )

We have historically incurred significant losses, the majority stemming from the direct methanol fuel cell product development and commercialization programs of MTI Micro, and had a consolidated accumulated deficit of $120.9 million as of March 31, 2012. During the first quarter of 2012, we generated a net loss attributed to MTI of $822 thousand and had working capital at March 31, 2012 of $2.4 million, a $743 thousand decrease from $3.1 million at December 31, 2011. We generated positive operating cash flows of $310 thousand for the three months ended March 31, 2012 and currently have no debt outstanding. While it cannot be assured, management believes that we will continue to generate positive cash flows in 2012 and be able to fund our operations for the foreseeable future.

Although MTI Micro continues to believe in the potential of its Mobion® based power solutions, operations have been suspended at MTI Micro until such time as market demand and other deciding factors, including obtaining additional external financing, the successful completion of customer trials, a new development program with a government agency, and/or a customer order, come to fruition. MTI Micro will continue to seek additional capital from external sources to resume operations and fund future development, if any. If MTI Micro is unable to secure additional financing, a new development program or customer order, the MTI Micro Board of Directors will assess other options for MTI Micro, including the sale of MTI Micro’s intellectual property portfolio and other assets.

During the three months ended March 31, 2012, cash provided by operating activities was $310 thousand, consisting of a net loss of $836 thousand, non-cash expenses of $91 thousand (primarily including $38 thousand for depreciation and $58 thousand for stock based compensation), and other changes in operating assets and liabilities of $1.1 million (primarily due to the decrease in accounts receivable from the prior year end). Cash used in investing activities for the three months ended March 31, 2012 was $1 thousand. There were outstanding commitments of $6 thousand for capital expenditures as of March 31, 2012. There was no cash provided by financing activities for the three months ended March 31, 2012.

As of March 31, 2012, we had approximately $2.0 million of cash available to fund future operations. During the three months ended March 31, 2012, our results of operations resulted in a net loss attributed to MTI of $822 thousand and cash provided by operating activities totaling $310 thousand. We expect to continue funding our operations from current cash, our projected 2012 cash flow pursuant to management’s current plan, and possible draw downs from our existing line of credit, if necessary. We may also seek to supplement our resources through the sales of assets (including our investment in MTI Micro). Besides the line of credit at MTI Instruments, we have no other commitments for funding future needs of the organization at this time and such additional financing during 2012 may not be available to us on acceptable terms, if at all.

19



Line of Credit

On September 20, 2011, MTI Instruments entered into a working capital line of credit with First Niagara Bank, N.A. Pursuant to the Demand Grid Note, MTI Instruments may borrow from time to time up to $400 thousand to support its working capital needs. The note is payable upon demand, and the interest rate on the note is equal to the prime rate with a floor of 4.0% per annum. The note is secured by a lien on all of the assets of MTI Instruments and is guaranteed by the Company. The line of credit is subject to a review date of June 30, 2012. Under the line of credit, MTI Instruments is required to hold a line balance of $0 for 30 consecutive days out during each consecutive year. As of March 31, 2012 and December 31, 2011 there were no amounts outstanding under the line of credit.

Backlog, Inventory and Accounts Receivable

At March 31, 2012, our order backlog was $710 thousand compared to $861 thousand at December 31, 2011 due to reduced quarterly order activity. Fewer orders for general instrumentation products and decreased activity under our multi-year Air Force contracts resulted in a 40% decline in orders booked during the first quarter of 2012 as compared to orders booked in the fourth quarter of 2011.

Our inventory turnover ratios and accounts receivable days outstanding for the trailing twelve month periods and their changes at March 31, 2012 and 2011 are as follows:

      2012       2011        Change
Inventory turnover   3.4 4.2   (0.8 )
Average accounts receivable days outstanding 42   42

The decrease in inventory turns is driven by a 27% increase in average inventory balances on a 7% higher sales volume. A notable drop in comparative first quarter revenue with higher inventory balances contributed to this unfavorable change in twelve-month inventory turns.

The average accounts receivable days outstanding for the last twelve months remains consistent to the previous twelve months.

Net cash provided by operating activities was $310 thousand for the three months ended March 31, 2012 compared with cash used in operating activities of $260 thousand in 2011. This cash increase of $570 thousand was driven by the timing of cash payments and receipts associated with prior quarter billings.

There were $3 thousand in capital expenditures during the three months ended March 31, 2012, compared with $13 thousand in the same period for 2011. There were outstanding commitments of $6 thousand for capital expenditures as of March 31, 2012. As production levels rise at MTI Instruments, additional capital equipment may be required in the foreseeable future. We expect to finance any such potential future expenditures with our current cash position.

Off-Balance Sheet Arrangements

There were no off balance sheet arrangements.

20



Contractual Payment Obligations

We have entered into various agreements with non-cancelable terms that result in contractual payment obligations in future years. These contracts include manufacturing, laboratory and office facility lease agreements as well as purchase commitments for general operations of the Company. The following table summarizes cash payments that we are committed to make under the existing terms of contracts to which we are a party as of March 31, 2012. This table does not include contingencies.

Less More
Contractual Payment Obligations Than 1 1-3 3-5 Than 5
(in thousands)       Year       Years       Years       Years       Total
Operating lease obligations   $ 27 $       568   $       193   $       —   $       788
Purchase obligations         326     12   338
Total Contractual Payment Obligations $ 353 $ 580 $ 193 $ $ 1,126

Market Risk

Market risk is the risk that changes in market conditions will adversely affect earnings or cashflow. We categorize our market risks as interest rate risk and credit risk. Immediately below are detailed descriptions of the market risks and explanations as to how each of these risks are managed.

Interest Rate Risk. Interest rate risk is the risk that changes in interest rates could adversely affect earnings or cashflows. The Company’s cash equivalents are sensitive to changes in interest rates. Interest rate changes would result in a change in interest income due to the difference between the current interest rates on cash. Interest rate risk sensitivity analysis is used to measure interest rate risk by computing estimated changes in cashflow as a result of assumed changes in market interest rates. A 10% decrease in 2012 interest rates would be immaterial to the Company’s consolidated financial statements.

Credit Risk. Credit risk is the risk of loss we would incur if counterparties fail to perform their contractual obligations. Financial instruments that subject the Company to concentrations of credit risk principally consist of cash equivalents, trade accounts receivable and unbilled contract costs.

Our trade accounts receivable and unbilled contract costs and fees are primarily from sales to commercial customers, the U.S. government and state agencies. We do not require collateral and have not historically experienced significant credit losses related to receivables or unbilled contract costs and fees from individual customers or groups of customers in any particular industry or geographic area.

Our deposits are primarily in cash and deposited in commercial banks and investment companies. The Company has cash deposits in excess of federally insured limits. The amount of such deposits is essentially all cash at March 31, 2012.

Critical Accounting Policies and Significant Judgments and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. Note 2, Accounting Policies, to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2011 includes a summary of our most significant accounting policies. There have been no material changes to the critical accounting policies previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2011. The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of assets and liabilities. On an ongoing basis, we evaluate our estimates and judgments, including those related to revenue recognition, inventories, income taxes, stock-based compensation and derivatives. Management bases its estimates on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Periodically, we review our critical accounting estimates with the Audit Committee of our Board of Directors.

Recent Accounting Pronouncements

A discussion of recent accounting pronouncements is included in Note 12, New Accounting Pronouncements, of the unaudited condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q.

21



Statement Concerning Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements that involve risks and uncertainties within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Any statements contained in this Form 10-Q that are not statements of historical fact may be forward-looking statements. When we use the words “anticipate,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend,” “should,” “could,” “may,” “will” and similar words or phrases, we are identifying forward-looking statements. Forward-looking statements involve risks, uncertainties, estimates and assumptions which may cause our actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements. Important factors that could cause these differences include the following:

  • sales revenue growth of our test and measurement instrumentation business may not be achieved or maintained;
  • the dependence of our test and measurement instrumentation business on a small number of customers and potential loss of government contracts;
  • our inability to build and maintain relationships with our customers;
  • our lack of long-term purchase commitments from our customers and the ability of our customers to cancel, reduce, or delay orders for our products;
  • risks related to protection and infringement of intellectual property;
  • our inability to develop and utilize new technologies that address the needs of our customers;
  • intense competition in the instrumentation business;
  • our history of recurring net losses and the risk of continued net losses;
  • the impact of future exchange rate fluctuations;
  • the uncertainty of the U.S. economy;
  • the historical volatility of our stock price;
  • the cyclical nature of the electronics industry;
  • failure of our strategic alliances to achieve their objectives or perform as contemplated and the risk of cancellation or early termination of such alliance by either party;
  • product liability or defects;
  • the loss of services of one or more of our key employees or the inability to hire, train, and retain key personnel;
  • significant periodic and seasonal quarterly fluctuations in our results of operations;
  • our dependence on sole suppliers or a limited group of suppliers for both business segments;
  • our ability to generate income to realize our net operating losses;
  • risks related to the limitation of the use of our net operating losses in the event of certain ownership changes;
  • MTI Micro’s need to raise additional financing;
  • our ownership position in MTI Micro may be reduced further as a result of our need to seek external financing for MTI Micro’s operations;
  • risks related to developing Mobion® direct methanol fuel cells and whether MTI Micro will ever successfully develop reliable and commercially viable Mobion® fuel cell solutions;
  • MTI Micro’s dependence on OEMs integrating Mobion® fuel cell systems into their devices; and
  • other factors discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011 and in Part II, Item 1A of this Quarterly Report on Form 10-Q.

Forward-looking statements speak only as of the date they are made. You should not put undue reliance on any forward-looking statements. We assume no obligation to update forward-looking statements to reflect actual results, changes in assumptions, or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. If we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

Item 4. Controls and Procedures

The certifications of our Chief Executive Officer and Chief Financial Officer attached as Exhibits 31.1 and 31.2 to this Quarterly Report on Form 10-Q include, in paragraph 4 of such certifications, information concerning our disclosure controls and procedures and internal control over financial reporting. Such certifications should be read in conjunction with the information contained in this Item 4 for a more complete understanding of the matters covered by such certifications.

(a) Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and our chief financial officer, evaluated the effectiveness of MTI’s disclosure controls and procedures as of March 31, 2012. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. We recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and we necessarily apply our judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of March 31, 2012, our chief executive officer and chief financial officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

22



(b) Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our fiscal quarter ended March 31, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

At any point in time, we may be involved in various lawsuits or other legal proceedings. Such lawsuits could arise from the sale of products or services or from other matters relating to our regular business activities, compliance with various governmental regulations and requirements, or other transactions or circumstances. We do not believe there are any such proceedings presently pending that could have a material adverse effect on our financial condition. See Note 10, Commitments and Contingencies, to our condensed consolidated financial statements for further information.

Item 1A. Risk Factors

Our Annual Report on Form 10-K for the year ended December 31, 2011 contains a detailed discussion of our risk factors. In addition, information regarding risk factors appears in “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Statement Concerning Forward Looking Statements”. These risk factors could cause our actual results to differ materially from those stated in forward-looking statements contained in this document and elsewhere. Pursuant to the instructions to this Quarterly Report on Form 10-Q, we have provided below only those risk factors that are new or that have been materially amended since the time that we filed our 2011 Annual Report on Form 10-K. Accordingly, the information presented below should be read in conjunction with the risk factors and information disclosed in our 2011 Annual Report on Form 10-K.

Historically, we have incurred net losses as a result of MTI Micro. Despite the suspension of MTI Micro’s operations in late 2011, there can be no assurance that there will be adequate resources to fund our future operations.

For the three months ended March 31, 2012, we had a net loss of $822 thousand. For the year ended December 31, 2011, we generated net income of $2.4 million primarily attributable to the reversal of a portion of the deferred tax asset’s valuation reserve of $1.5 million, representing the portion of our deferred tax asset that management has estimated is more likely than not to be realized, and MTI Instrument’s strong performance. Prior to 2011, we had incurred recurring net losses, including net losses of $1.8 million in 2010, and $3.1 million in 2009. As a result of historic operating losses, we had an accumulated deficit of approximately $120.9 million as of March 31, 2012. MTI Micro suspended its operations at the end of 2011 and, therefore, expects to incur minimal ongoing operating expenses unless additional funding becomes available to fund its operations in the future. If MTI Micro is unable to secure additional financing, MTI Micro could be forced to sell assets at unfavorable prices; or merge, consolidate, or combine with a company with greater financial resources in a transaction that may be unfavorable to us.

Since we no longer expect to fund MTI Micro, MTI Micro has sought and will continue to seek other sources of funding, but there is no assurance that such funding will be available on acceptable terms, if at all.

We have experienced an ownership change in MTI Micro that has resulted in a limitation of tax attributes relating to the use of their net operating losses, and we may experience further ownership changes in both MTI and MTI Micro which would result in a further limitation of the use of our net operating losses.

As of March 31, 2012, it is estimated that MTI has net operating loss (NOL) carryforwards of approximately $51.2 million and MTI Micro has NOL carryforwards of approximately $16.6 million. As a result of the conversion of the bridge notes in December 2009, MTI no longer maintained an 80% or greater ownership in MTI Micro. Thus, MTI Micro is no longer included in Mechanical Technology, Incorporated and Subsidiaries' consolidated federal and combined New York State tax returns, effective December 9, 2009. Pursuant to the Internal Revenue Service's consolidated tax return regulations (IRS Regulation Section 1.1502-36), upon MTI Micro leaving the Mechanical Technology, Incorporated and Subsidiaries’ consolidated group, MTI elected to reduce a portion of its stock tax basis in MTI Micro by "reattributing" a portion of MTI Micro's NOL carryforwards to MTI, for an amount equivalent to its built-in loss amount in MTI's investment in MTI Micro's stock. As the result of MTI making this election with its December 31, 2009 tax return, MTI reattributed approximately $45.2 million of MTI Micro's NOLs (reducing its tax basis in MTI Micro's stock by the same amount), leaving MTI Micro with approximately $13 million of separate company NOL carryforwards at the time of conversion of the Bridge Notes.

23



The Company and its subsidiaries have undergone a formal Section 382 study. A corporation generally undergoes an “ownership change” when the ownership of its stock, by value, changes by more than 50 percentage points over any three-year testing period. In the event of an ownership change, Section 382 of the Internal Revenue Code of 1986 imposes an annual limitation on the amount of post-ownership change taxable income a corporation may offset with pre-ownership change NOL carryforwards and certain recognized built-in losses. As a result of MTI Micro’s issuance of stock between 2009 and 2011, MTI Micro has experienced a Section 382 ownership change, which has reduced their NOLs by an estimated $14.6 million.

Our ability to utilize the MTI and remaining MTI Micro NOL carryforwards, including any future NOL carryforwards that may arise, may be limited by Section 382, if we or MTI Micro undergo any further “ownership changes” as a result of subsequent changes in the ownership of our outstanding common stock pursuant to the exercise of the MTI Micro warrants, MTI or MTI Micro options outstanding, additional financings obtained, or otherwise.

Our ownership position in MTI Micro has been reduced as a result of external financing for MTI Micro's operations, which could limit our ability to control the operations.

As of March 31, 2012, we owned approximately 47.6% of MTI Micro’s Common Stock issued. Between September 2008 and September 2011, MTI Micro entered into numerous debt and equity financings with third parties, primarily, Dr. Walter L. Robb, a member of the Company’s and MTI Micro’s boards of directors, and Counter Point Ventures Fund II, LP (Counter Point). Counter Point is a venture capital fund sponsored and managed by Dr. Robb. After these series of transactions, MTI now holds an aggregate of approximately 47.6% of the outstanding common stock of MTI Micro or 53.3% of the outstanding common stock and warrants issued of MTI Micro, and Dr. Robb and Counter Point hold approximately 5.1% and 45.2%, respectively of the outstanding common stock of MTI Micro or 4.3% and 40.3%, respectively of the outstanding common stock and warrants issued of MTI Micro. Since no entity of the related parties has power but, as a group, the Company and its related parties have the power, then the party within the related party group that is most closely associated with the VIE, MTI Micro, is the primary beneficiary. Even though Dr. Robb and Counterpoint combined control a majority of the outstanding common stock, and they have the ability to elect the directors of MTI Micro and decide whether to continue to seek business opportunities for MTI Micro or instead seek opportunities to sell the intellectual property, they have not elected to do so. The Company continues to oversee the day to day operations, exercise management decision making, seek opportunities to sell intellectual properties, and have a vested interest in the commercialization of MTI Micro’s fuel cell technology. Since inception in 2001, the Company has made the largest investment and been the principal funder of MTI Micro. The Company has also been exposed to losses and has the ability to benefit from MTI Micro. Considering the facts and circumstances, management believes the Company is most closely associated with the VIE, MTI Micro, and therefore, it is the primary beneficiary of MTI Micro. Should there be a change in the facts and circumstances (such as a change in governance or a change to the related party group) management will reassess whether they act as the primary beneficiary and should continue to include MTI Micro in the Company’s consolidated results of operations.

MTI Micro currently does not have sufficient funds to commercialize its portable power source products.

In order to resume operations and continue full commercialization of its micro fuel cell solution, MTI Micro will need to do one or more of the following to raise additional resources, or reduce its cash requirements:

  • obtain additional government grants or private funding of its direct methanol fuel cell research, development, manufacturing readiness and commercialization;
  • receive a purchase order from government agencies or OEM’s MTI Micro is currently with; or
  • secure additional debt or equity financing.

There is no guarantee that resources will be available to MTI Micro on terms acceptable to it, or at all, or that such resources will be received in a timely manner, if at all, or that MTI Micro will be able to resume operations or reduce its expenditure run-rate further. MTI Micro had cash and cash equivalents of $39 thousand as of March 31, 2012. Since 2008, MTI Micro has raised $5.4 million in external debt and equity financing. At the end of 2011, MTI Micro suspended its operations while additional necessary funding is being pursued. If MTI Micro raises additional funds by issuing equity securities, MTI Micro’s stockholders, including MTI, will experience further dilution. Additional debt financing, if available, may involve restrictive covenants. There is no assurance that funds raised in any future debt financing or additional equity financing arrangements will be sufficient, that the financing will be available on terms favorable to MTI Micro or to existing stockholders and at such times as required, or that MTI Micro will be able to obtain the additional financing required to resume the operation of its business. If MTI Micro raises additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some rights to MTI Micro’s technologies or its products, or grant licenses on terms that are not favorable to MTI Micro. If MTI Micro is unable to secure additional financing, MTI Micro could be forced to sell assets at unfavorable prices; or merge, consolidate, or combine with a company with greater financial resources in a transaction that may be unfavorable to us.

24



Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None

Item 6. Exhibits

Exhibit No.       Description  
31.1

Rule 13a-14(a)/15d-14(a) Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, of Peng K. Lim

   
31.2

Rule 13a-14(a)/15d-14(a) Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, of Frederick W. Jones

 
32.1

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Peng K. Lim

   
32.2

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Frederick W. Jones

 
101.INS

XBRL Instance Document

 
101.SCH

XBRL Taxonomy Extension Schema Document

 
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
 
101.DEF XBRL Taxonomy Definition Linkbase Document
 
101.LAB XBRL Taxonomy Extension Label Linkbase Document
 
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document

25



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Mechanical Technology, Incorporated
 
 
Date: May 10, 2012 By:  /S/ PENG K. LIM
Peng K. Lim
Chief Executive Officer
 
By: /S/ FREDERICK W. JONES
Frederick W. Jones
Chief Financial Officer

26


EX-31.1 2 exhibit31-1.htm RULE 13A-14(A)/15D-14(A) CERTIFICATION PURSUANT TO SECTION 302

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Peng K. Lim, certify that:

1.       I have reviewed this Quarterly Report on Form 10-Q of Mechanical Technology, Incorporated;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:
 
a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s Board of Directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
May 10, 2012 /S/ PENG K. LIM
Peng K. Lim
Chief Executive Officer
(Principal Executive Officer)


EX-31.2 3 exhibit31-2.htm RULE 13A-14(A)/15D-14(A) CERTIFICATION PURSUANT TO SECTION 302

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Frederick W. Jones, certify that:

1.       I have reviewed this Quarterly Report on Form 10-Q of Mechanical Technology, Incorporated;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:
 
a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s Board of Directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
May 10, 2012 /S/ FREDERICK W. JONES
Frederick W. Jones
Chief Financial Officer
(Principal Financial Officer)


EX-32.1 4 exhibit32-1.htm CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

Exhibit 32.1

Mechanical Technology, Incorporated
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(18 U.S.C. Section 1350)

In connection with the Quarterly Report on Form 10-Q of Mechanical Technology, Incorporated (the “Company”) for the three month period ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Peng K. Lim, Chief Executive Officer of the Company, certify, pursuant to the requirements of Section 906 of the Sarbanes-Oxley Act of 2002, (18 U.S.C. Sections 1350(a) and (b)), that, to my knowledge:

      (1)       The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”); and
 
(2) The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
May 10, 2012 /S/ PENG K. LIM
Peng K. Lim
Chief Executive Officer
(Principal Executive Officer)


EX-32.2 5 exhibit32-2.htm CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

Exhibit 32.2

Mechanical Technology, Incorporated
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(18 U.S.C. Section 1350)

In connection with the Quarterly Report on Form 10-Q of Mechanical Technology, Incorporated (the “Company”) for the three month period ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frederick W. Jones, Chief Financial Officer of the Company, certify, pursuant to the requirements of Section 906 of the Sarbanes-Oxley Act of 2002, (18 U.S.C. Sections 1350(a) and (b)), that, to my knowledge:

      (1)       The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”); and
 
(2) The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
May 10, 2012 /S/ FREDERICK W. JONES
Frederick W. Jones
Chief Financial Officer
(Principal Financial Officer)


EX-101.INS 6 mkty-20120331.xml XBRL INSTANCE DOCUMENT 0000064463 2011-01-01 2011-03-31 0000064463 2011-01-01 2011-12-31 0000064463 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0000064463 us-gaap:NoncontrollingInterestMember 2011-01-01 2011-12-31 0000064463 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0000064463 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0000064463 us-gaap:TreasuryStockMember 2011-01-01 2011-12-31 0000064463 2011-12-31 0000064463 2012-01-01 2012-03-31 0000064463 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-03-31 0000064463 us-gaap:NoncontrollingInterestMember 2012-01-01 2012-03-31 0000064463 us-gaap:RetainedEarningsMember 2012-01-01 2012-03-31 0000064463 us-gaap:CommonStockMember 2012-01-01 2012-03-31 0000064463 us-gaap:TreasuryStockMember 2012-01-01 2012-03-31 0000064463 2012-03-31 0000064463 2012-05-04 0000064463 2010-12-31 0000064463 2011-03-31 0000064463 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0000064463 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0000064463 us-gaap:NoncontrollingInterestMember 2010-12-31 0000064463 us-gaap:NoncontrollingInterestMember 2011-12-31 0000064463 us-gaap:RetainedEarningsMember 2010-12-31 0000064463 us-gaap:RetainedEarningsMember 2011-12-31 0000064463 us-gaap:CommonStockMember 2010-12-31 0000064463 us-gaap:CommonStockMember 2011-12-31 0000064463 us-gaap:TreasuryStockMember 2010-12-31 0000064463 us-gaap:TreasuryStockMember 2011-12-31 0000064463 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0000064463 us-gaap:NoncontrollingInterestMember 2012-03-31 0000064463 us-gaap:RetainedEarningsMember 2012-03-31 0000064463 us-gaap:CommonStockMember 2012-03-31 0000064463 us-gaap:TreasuryStockMember 2012-03-31 xbrli:shares iso4217:USD iso4217:USDxbrli:shares MECHANICAL TECHNOLOGY INC 0000064463 --12-31 Smaller Reporting Company mkty 5256883 10-Q false 2012-03-31 2012 Q1 1669000 1978000 1118000 1048000 1881000 661000 957000 1007000 20000 20000 102000 87000 4629000 3753000 1515000 1515000 258000 223000 6402000 5491000 191000 177000 1238000 1119000 58000 58000 1487000 1354000 63000 63000 135389000 135447000 -120097000 -120919000 13754000 13754000 1601000 837000 3314000 3300000 4915000 4137000 1959000 134733000 135389000 3405000 3314000 -122483000 -120097000 58000 63000 -13754000 -13754000 135447000 3300000 -120919000 63000 -13754000 6402000 5491000 0.01 0.01 75000000 75000000 6259975 6259975 1005092 1005092 2539000 1204000 13000 0 2552000 1204000 939000 578000 25000 0 385000 373000 410000 373000 1307000 1092000 -104000 -839000 44000 0 -2000 3000 -62000 -836000 -62000 -836000 -256000 0 0 0 0 -14000 0 0 0 0 194000 0 0 0 0 -822000 0 0 0 0 0.04 -0.16 4771658 5254883 5776750 6259975 1005092 1005092 6259975 1005092 656000 656000 0 0 0 0 58000 58000 0 0 0 0 5000 0 0 0 5000 0 483225 647000 0 647000 0 0 0 44000 0 99000 38000 0 5000 102000 58000 572000 -1220000 10000 50000 -8000-18000177000 -14000 -8000 0 50000 -119000 -260000 310000 13000 3000 0 2000 -13000 -1000 203000 0 203000 0 -70000 309000 <p align="justify"><b><font size="2" style="font-family:times new roman">1. Nature of Operations </font></b></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Description of Business </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">Mechanical Technology, Incorporated (MTI or the Company), a New York corporation, was incorporated in 1961. MTI operates in two segments, the Test and Measurement Instrumentation segment, which is conducted through MTI Instruments, Incorporated. (MTI Instruments), a wholly-owned subsidiary, and the New Energy segment, which is conducted through MTI MicroFuel Cells Incorporated. (MTI Micro), a variable interest entity (VIE) that is included in these condensed consolidated financial statements and described further below in Note 2. </font></p> <p align="justify"><font size="2" style="font-family:times new roman">MTI Instruments was incorporated in New York on March 8, 2000 and is a worldwide supplier of precision non-contact physical measurement solutions, portable balancing equipment and wafer inspection tools. MTI Instruments&#8217; products use a comprehensive array of technologies to solve complex, real world applications in numerous industries including manufacturing, semiconductor, solar, commercial and military aviation, automotive and data storage. MTI Instruments&#8217; products consist of electronic gauging instruments for position, displacement and vibration application within the design, manufacturing/production, test and research market; wafer characterization of semi-insulating and semi-conducting wafers within both the semiconductor and solar industries; tensile stage systems for materials testing at academic and industrial settings; and engine vibration analysis systems for both military and commercial aircraft.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">MTI Micro was incorporated in Delaware on March 26, 2001, and has been developing Mobion&#174;, a handheld energy-generating device to replace current lithium-ion and similar rechargeable battery systems in many handheld electronic devices for the military and consumer markets. Mobion&#174; handheld generators are based on direct methanol fuel cell (DFMC) technology, which has been recognized as an enabling technology for advanced portable power sources by the scientific community and industry analysts. As the need for advancements in portable power increases, MTI Micro has been developing Mobion&#174;<sup> </sup>as a solution for advancing current and future electronic device power needs of the portable electronics market. As of March 31, 2012, the Company owned approximately 47.6% of MTI Micro&#8217;s outstanding common stock. Although MTI Micro continues to believe in the potential of its Mobion<sup>&#174;</sup> based power solutions, it has suspended its MTI Micro operations until such time as market demand and other deciding factors, including obtaining additional external financing, the successful completion of customer trials, a new development program with a government agency, and/or a customer order, come to fruition. MTI Micro will continue to seek additional capital from external sources to resume operations and fund future development, if any. If MTI Micro is unable to secure additional financing, a new development program or customer order, the MTI Micro Board of Directors will assess other options for MTI Micro, including the sale of its intellectual property portfolio and other assets.</font></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Liquidity</font></i></b><font style="font-family:times new roman"> </font></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company has historically incurred significant losses, the majority stemming from the direct methanol fuel cell product development and commercialization programs of MTI Micro, and ha</font><font size="2" style="font-family:times new roman">d</font><font size="2" style="font-family:times new roman"> a consolidated accumulated deficit of $120.9 million as of March 31, 2012. During the first quarter of 2012, the Company generated a net loss attributed to MTI of $822 thousand and had working capital at March 31, 2012 of $2.4 million, a $743 thousand decrease from $3.1 million at December 31, 2011. The Company generated positive operating cash flows of $310 thousand for the three months ended March 31, 2012 and currently has no debt outstanding. While it cannot be assured, management believes that the Company will continue to generate positive cash flows in 2012 and be able to fund the Company&#8217;s operations for the foreseeable future.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">As of March 31, 2012, the Company had approximately $2.0 million of cash available to fund future operations. During the three months ended March 31, 2012, the Company&#8217;s results of operations resulted in a net loss attributed to MTI of $822 thousand and cash provided by operating activities totaling $310 thousand. The Company expects to continue funding its operations from current cash, its projected 2012 cash flow pursuant to management&#8217;s current plan, and possible draw downs from its existing line of credit, if necessary. The Company may also seek to supplement its resources through the sales of assets (including its investment in MTI Micro). Besides the line of credit at MTI Instruments, the Company has no other commitments for funding future needs of the organization at this time and such additional financing during 2012 may not be available to the Company on acceptable terms, if at all.</font></p> <p align="justify"><b><font size="2" style="font-family:times new roman">3. Accounts Receivable</font></b></p> <p align="justify"><font size="2" style="font-family:times new roman">Receivable balances consist of the following at: </font></p> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap"><font size="1" style="font-family:times new roman">(Dollars in thousands)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="6%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Test and</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="6%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Measurement</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="6%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Instrumentation</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">New Energy</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="6%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Consolidated Totals</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap"><u><font size="2" style="font-family:times new roman">March 31, 2012</font></u></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap">&#160;</td> <td align="left" width="5%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="4%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="5%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="79%" nowrap="nowrap"><font size="2" style="font-family:times new roman">U.S. Government</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">67</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="4%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">67</font></td> </tr> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Commercial</font></td> <td align="left" width="1%" nowrap="nowrap">&#160;</td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">594</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap">&#160;</td> <td align="right" style="border-bottom: #000000 1pt solid;" width="4%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">594</font></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="79%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; Total</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td style="text-align: left; padding-bottom: 1pt; background-color: #cceeff; width: 1%;" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">661</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; background-color: #cceeff; width: 1%;" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="4%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td style="text-align: left; padding-bottom: 1pt; background-color: #cceeff; width: 1%;" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">661</font></td> </tr> <tr> <td width="99%" colspan="10">&#160;</td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="79%" nowrap="nowrap"><u><font size="2" style="font-family:times new roman">December 31, 2011</font></u></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="5%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="4%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="5%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap"><font size="2" style="font-family:times new roman">U.S. Government</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">990</font></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" width="4%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">990</font></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="79%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Commercial</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">887</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="4%" nowrap="nowrap"><font size="2" style="font-family:times new roman">4</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap">&#160;</td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">891</font></td> </tr> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; Total</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: left; padding-bottom: 1.5pt; width: 1%;" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,877</font></td> <td align="right" width="1%" nowrap="nowrap"></td> <td style="text-align: left; padding-bottom: 1.5pt; width: 1%;" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="4%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 4</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: left; padding-bottom: 1.5pt; width: 1%;" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="5%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,881</font></td> </tr> </table> <div>&#160;</div> <p align="justify"><font size="2" style="font-family:times new roman">For the three months ended March 31, 2012 and 2011, the largest commercial customer represented 14.6% and 31.6%, respectively, and a U.S. governmental agency represented 11.5% and 6.8%, respectively, of the Company&#8217;s Test and Measurement Instrumentation segment product revenue. As of March 31, 2012 and December 31, 2011, the largest commercial customer represented 21.4% and 10.0%, respectively, and a U.S. governmental agency represented 10.1% and 52.7%, respectively, of the Company&#8217;s Test and Measurement Instrumentation segment accounts receivable.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">As of March 31, 2012, there were no outstanding receivables for the New Energy segment. The balance as of December 31, 2011 represents minimal amounts due for service contracts.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">As of March 31, 2012 and December 31, 2011, the Company had no allowance for doubtful trade accounts receivable. </font></p> <p align="justify"><b><font size="2" style="font-family:times new roman">4. Inventories </font></b></p> <p align="justify"><font size="2" style="font-family:times new roman">Inventories consist of the following at: </font></p> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" width="84%" nowrap="nowrap"><font size="1" style="font-family:times new roman">(Dollars in thousands)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="6%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="6%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="84%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="7%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">March 31, 2012</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="7%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">December 31, 2011</font></b></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="84%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Finished goods</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="6%" nowrap="nowrap"><font size="2" style="font-family:times new roman">390</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap">&#160;</td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="6%" nowrap="nowrap"><font size="2" style="font-family:times new roman">310</font></td> </tr> <tr valign="bottom"> <td align="left" width="84%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Work in process</font></td> <td align="left" width="1%" nowrap="nowrap">&#160;</td> <td align="left" width="1%" nowrap="nowrap">&#160;</td> <td align="right" width="6%" nowrap="nowrap"><font size="2" style="font-family:times new roman">253</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap">&#160;</td> <td align="right" width="6%" nowrap="nowrap"><font size="2" style="font-family:times new roman">211</font></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="84%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Raw materials</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="6%" nowrap="nowrap"><font size="2" style="font-family:times new roman">364</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="6%" nowrap="nowrap"><font size="2" style="font-family:times new roman">436</font></td> </tr> <tr valign="bottom"> <td align="left" width="84%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: left; padding-bottom: 1.5pt; width: 1%;" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="6%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,007</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: left; padding-bottom: 1.5pt; width: 1%;" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="6%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 957</font></td> </tr> </table> <div>&#160;</div> <p align="justify"><font size="2" style="font-family:times new roman">As of March 31, 2012 and December 31, 2011, the Company had an inventory reserve of $220 thousand and $243 thousand, respectively. </font></p> <p align="justify"><b><font size="2" style="font-family:times new roman">5. Income Taxes </font></b></p> <p align="justify"><font size="2" style="font-family:times new roman">During the quarter ended March 31, 2012, the Company&#8217;s effective income tax rate was 0%. The projected annual effective tax rate is less than the Federal statutory rate of 35%, primarily due to the</font><b><font size="2" style="font-family:times new roman"> </font></b><font size="2" style="font-family:times new roman">Company&#8217;s</font><b><font size="2" style="font-family:times new roman"> </font></b><font size="2" style="font-family:times new roman">expected level of earnings for the year ended December 31, 2012, and the permanent difference related to the stock-based compensation expense for employees of MTI Micro who transferred to MTI. For the quarter ended March 31, 2011, the Company&#8217;s effective income tax rate was also 0%. The difference between the annual effective tax rate and the Federal statutory rate was the result of the change in the valuation allowance and the gain on derivative.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company provides for recognition of deferred tax assets if the realization of such assets is more likely than not to occur in accordance with accounting standards that address income taxes. Significant management judgment is required in determining the period in which the reversal of a valuation allowance should occur. The Company has considered all available evidence, both positive and negative, such as historical levels of income and future forecasts of taxable income amongst other items, in determining whether a full or partial release of our valuation allowance is required. In addition, the Company&#8217;s assessment requires us to schedule future taxable income in accordance with accounting standards that address income taxes to assess the appropriateness of a valuation allowance which further requires the exercise of significant management judgment.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">As a result of our analyses in 2011, the Company released a portion of our valuation allowance against its deferred tax assets. The partial release of the valuation allowance caused an incremental tax benefit of $1.5 million to be recognized in the fourth quarter of 2011. The release of a portion of the valuation allowance was based upon a recent cumulative income history for MTI and its subsidiary exclusive of MTI Micro (MTI Micro files separate federal and state tax returns) causing the Company to evaluate what portion of the Company's deferred tax assets it believes are more likely than not to be realized. The Company has determined that it expects to generate sufficient levels of pre-tax earnings in the future to realize the net deferred tax assets recorded on the balance sheet at March 31, 2012. The Company has projected such pre-tax earnings utilizing a combination of historical and projected results, taking into consideration existing levels of permanent differences, non-deductible expense and the reversal of significant temporary differences. The Company needs to generate approximately $225 thousand of taxable income in each year over the next twenty years to ensure the realizability of the approximately $1.5 million of deferred tax assets recorded on the condensed consolidated balance sheet at March 31, 2012. </font></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company believes that the accounting estimate for the valuation of deferred tax assets is a critical accounting estimate because judgment is required in assessing the likely future tax consequences of events that have been recognized in our financial statements or tax returns. The Company based the estimate of deferred tax assets and liabilities on current tax laws and rates and, in certain cases, business plans and other expectations about future outcomes. In the event that actual results differ from these estimates or the Company adjusts these estimates in future periods, the Company may need to adjust the recorded valuation allowance, which could materially impact our financial position and results of operations. The valuation allowance at March 31, 2012 and December 31, 2011 was approximately $20 million for both periods. The Company will continue to evaluate the ability to realize its deferred tax assets and related valuation allowances on a quarterly basis.</font></p> <p align="justify"><b><font size="2" style="font-family:times new roman">8. Fair Value Measurement </font></b></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company performs a detailed analysis of financial assets and liabilities in determining the appropriate levels of classification. At each reporting period, all assets and liabilities for which the fair value measurements are based upon significant unobservable inputs are classified as Level 3. The derivative liability was valued using the Black-Sholes Option Pricing Model, which is based upon unobservable inputs. The derivative liability was $0 as of March 31, 2012 and December 31, 2011. The Company had no Level 1 and no Level 2 assets and liabilities as of March 31, 2012 and December 31, 2011.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">The following is a rollforward of Level 3 fair value instruments for the twelve months ended December 31, 2011: </font></p> <p align="justify"><font size="2" style="font-family:times new roman">(Dollars in thousands) </font></p> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Beginning</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Total (Gains) /</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Ending</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Balance as of</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Losses</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Purchases,</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Balance as of</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap">&#160;</td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">January 1,</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Realized and</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Issuances, Sales</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">December 31,</font></b></td> </tr> <tr valign="bottom"> <td align="left" style="border-bottom: #000000 1pt solid;" width="79%" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Instrument</font></b></td> <td align="left" style="border-bottom: #000000 1pt solid;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">2011</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Unrealized</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">and Settlements</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">2011</font></b></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="79%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; Derivative liability</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 73</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (73</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;</font></td> </tr> <tr valign="bottom"> <td align="left" width="79%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Total Level 3 instruments</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">73</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(73</font></td> <td align="left" style="padding-bottom: 2pt;" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> </tr> </table> <p align="justify"><b><font size="2" style="font-family:times new roman">6. Stockholders&#8217; Equity</font></b></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Common Stock </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company has one class of common stock, par value $.01. Each share of the Company&#8217;s common stock is entitled to one vote on all matters submitted to stockholders. As of March 31, 2012 and December 31, 2011, there were 5,254,883 shares of common stock issued and outstanding.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">Changes in common shares issued and treasury stock outstanding are as follows: </font></p> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" width="77%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="10%" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Three Months Ended</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="10%" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Year Ended</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="77%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="10%" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">March 31, 2012</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="10%" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">December 31, 2011</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="77%" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Common Shares</font></b></td> <td align="left" width="1%" nowrap="nowrap">&#160;</td> <td align="left" width="10%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="10%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="77%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Balance, beginning</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="10%" nowrap="nowrap"><font size="2" style="font-family:times new roman">6,259,975</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="10%" nowrap="nowrap"><font size="2" style="font-family:times new roman">5,776,750</font></td> </tr> <tr valign="bottom"> <td align="left" width="77%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Issuance of shares for restricted stock grants</font></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="10%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="right" width="1%" nowrap="nowrap">&#160;</td> <td align="right" style="border-bottom: #000000 1pt solid;" width="10%" nowrap="nowrap"><font size="2" style="font-family:times new roman">483,225</font></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="77%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Balance, ending</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="10%" nowrap="nowrap"><font size="2" style="font-family:times new roman">6,259,975</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="10%" nowrap="nowrap"><font size="2" style="font-family:times new roman">6,259,975</font></td> </tr> <tr> <td width="99%" colspan="5">&#160;&#160;</td> </tr> <tr valign="bottom"> <td align="left" width="77%" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Treasury Stock</font></b></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="10%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="10%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="77%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Balance, beginning</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="10%" nowrap="nowrap"><font size="2" style="font-family:times new roman">1,005,092</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="10%" nowrap="nowrap"><font size="2" style="font-family:times new roman">1,005,092</font></td> </tr> <tr valign="bottom"> <td align="left" width="77%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Balance, ending</font></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 2pt double;" width="10%" nowrap="nowrap"><font size="2" style="font-family:times new roman">1,005,092</font></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 2pt double;" width="10%" nowrap="nowrap"><font size="2" style="font-family:times new roman">1,005,092</font></td> </tr> </table> <div>&#160;</div> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Warrants Issued</font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">On December 20, 2006, the Company issued warrants to investors to purchase 378,472 shares of the Company&#8217;s common stock at an exercise price of $18.16 per share. These warrants were fair valued by the Company until their expiration on December 19, 2011.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company recognized these derivatives as liabilities in the statement of financial position and measured these instruments at fair value. The fair value of the derivative was recorded in the &#8220;Derivative liability&#8221; line on the financial statements, and was valued quarterly using the Black-Scholes Option Pricing Model. As of March 31, 2012 and December 31, 2011, the fair value of the warrants was $0. Gains and losses on derivatives are included in &#8220;Gain / Loss on derivatives&#8221; in the Condensed Consolidated Statement of Operations. During the three month periods ended March 31, 2012 and 2011, the Company recognized a gain on derivatives of $0 and $44 thousand, respectively. </font></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Reservation of Shares </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company has reserved common shares for future issuance as of March 31, 2012 as follows: </font></p> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="96%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Stock options outstanding</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">778,046</font></td> </tr> <tr valign="bottom"> <td align="left" width="96%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Shares available for issuance</font></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">270,616</font></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="96%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Number of common shares reserved</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">1,048,662</font></td> </tr> </table> <div>&#160;</div> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Earnings (Loss) per Share</font></i></b><font size="2" style="font-family:times new roman"> </font></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company computes basic income (loss) per common share by dividing net income (loss) by the weighted average number of common shares outstanding during the reporting period. Diluted income (loss) per share reflects the potential dilution, if any, computed by dividing income (loss) by the combination of dilutive common share equivalents, comprised of shares issuable under outstanding investment rights, warrants and the Company&#8217;s share-based compensation plans, and the weighted average number of common shares outstanding during the reporting period. Dilutive common share equivalents include the dilutive effect of in-the-money stock options, which are calculated based on the average share price for each period using the treasury stock method. Under the treasury stock method, the exercise price of a stock option, the amount of compensation cost, if any, for future service that the Company has not yet recognized, and the amount of windfall tax benefits that would be recorded in additional paid-in capital, if any, when the stock option is exercised are assumed to be used to repurchase shares in the current period. </font><font style="font-family:times new roman"></font></p> <p align="justify"><font size="2" style="font-family:times new roman">Not included in the computation of earnings per share, assuming dilution, for the three months ended March 31, 2012, were options to purchase 778,046 shares of the Company&#8217;s common stock. These potentially dilutive items were excluded because the Company incurred a loss for this period and their inclusion would be anti-dilutive. </font></p> <p align="justify"><font size="2" style="font-family:times new roman">Not included in the computation of earnings per share, assuming dilution, for the three months ended March 31, 2011, were options to purchase 878,591 shares of the Company&#8217;s common stock and warrants to purchase 378,472 shares of the Company&#8217;s common stock. These potentially dilutive items were excluded because the average market price of the common stock exceeded the exercise prices of the options and warrants for this period. </font></p> <p align="justify"><b><font size="2" style="font-family:times new roman">7. Issuance of Common Stock, Warrants and Stock Options by MTI Micro </font></b></p> <p align="justify"><font size="2" style="font-family:times new roman">As of March 31, 2012, the Company owned approximately 47.6% of MTI Micro&#8217;s outstanding common stock, or 75,049,937 shares, and 53.3% of common stock and warrants issued, which includes 32,904,136 outstanding warrants. The number of shares of MTI Micro common stock authorized for issuance is 240,000,000 as of March 31, 2012.</font></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Common Stock Issued &#8211; MTI Micro </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">On January 11, 2010, MTI Micro entered into a Purchase Agreement with Counter Point. Counter Point is a venture capital fund sponsored and managed by Dr. Walter L. Robb, a member of the Board of Directors of the Company and MTI Micro, and a current stockholder of MTI Micro. Pursuant to the Purchase Agreement, MTI Micro issued and sold to Counter Point 28,571,429 shares of common stock, par value $0.01 per share (the MTI Micro Common Stock), at a purchase price per share of $0.07, over a period of twelve months, and warrants (MTI Micro Warrants) to purchase shares of MTI Micro Common Stock equal to 20% of the shares of MTI Micro Common Stock purchased under the Purchase Agreement at an exercise price of $0.07 per share. The sale and issuance of the MTI Micro Common Stock and MTI Micro Warrants occurred over multiple closings (each, a Closing). Nine Closings occurred through December 31, 2010, with MTI Micro raising $1.9 million from the sale of 26,952,386 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 5,390,477 shares of MTI Micro Common Stock to Counter Point. The final Closing occurred on January 5, 2011, with MTI Micro raising $113 thousand from the sale of 1,619,043 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 323,809 shares of MTI Micro Common Stock to Counter Point. </font></p> <p align="justify"><font size="2" style="font-family:times new roman">On February 9, 2011, Amendment No. 1 was entered into between MTI Micro and Counter Point. Pursuant to Amendment No. 1, MTI Micro issued and sold to Counter Point 6,428,574 shares of MTI Micro Common Stock at a purchase price per share of $0.07, through December 31, 2011, and MTI Micro Warrants to purchase shares of MTI Micro Common Stock equal to 20% of the shares of MTI Micro Common Stock purchased under Amendment No. 2 at an exercise price of $0.07 per share. The sale and issuance of the MTI Micro Common Stock and MTI Micro Warrants occurred over multiple closings (each, a Closing) occurring over four one-month closing periods (each, a Closing Period). Four Closings occurred through September 30, 2011, with MTI Micro raising $450 thousand from the sale of 6,428,574 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 1,285,715 shares of MTI Micro Common Stock to Counter Point.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">On September 23, 2011, Amendment No. 2 was entered into between MTI Micro and Counter Point. Pursuant to Amendment No. 2, MTI Micro issued and sold to Counter Point 1,200,000 shares of MTI Micro Common Stock at a purchase price per share of $0.07, through December 31, 2011, and MTI Micro Warrants to purchase shares of MTI Micro Common Stock equal to 20% of the shares of MTI Micro Common Stock purchased under Amendment No. 2 at an exercise price of $0.07 per share. The sale and issuance of the MTI Micro Common Stock and MTI Micro Warrants occurred over multiple closings (each, a Closing) occurring over three one-month closing periods (each, a Closing Period). Three Closings occurred through December 31, 2011, with MTI Micro raising $84 thousand from the sale of 1,200,000 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 240,000 shares of MTI Micro Common Stock to Counter Point.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">The following table represents changes in ownership between the Company and non-controlling interests in common shares of MTI Micro:</font></p> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" width="75%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="7%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">MTI</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="7%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Non Controlling Interest</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="75%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Average</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="3%" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Ownership</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="3%" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Ownership</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="75%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Price</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Shares</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">%</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Shares</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">%</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Total Shares</font></b></td> </tr> <tr> <td align="left" width="75%" nowrap="nowrap">&#160;</td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="75%" nowrap="nowrap"><font size="1" style="font-family:times new roman">Balance at 12/31/10</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">75,049,937</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">50.6</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">73,325,490</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">49.4</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">148,375,427</font></td> </tr> <tr> <td align="left" width="75%" nowrap="nowrap">&#160;</td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="75%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;&#160;<font size="1" style="font-family:times new roman">Stock issued under Purchase Agreement, 2011</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="1" style="font-family:times new roman">$&#160;&#160;&#160;&#160;&#160;</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">0.07</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">1,619,043</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">1,619,043</font></td> </tr> <tr> <td align="left" width="75%" nowrap="nowrap">&#160;</td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="75%" nowrap="nowrap"><font size="1" style="font-family:times new roman">Balance after Purchase Agreement</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">75,049,937</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">50.04</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">74,944,533</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">49.97</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">149,994,470</font></td> </tr> <tr> <td align="left" width="75%" nowrap="nowrap">&#160;</td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="75%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;&#160;<font size="1" style="font-family:times new roman">Stock issued under Amendment No. 1</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="1" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">0.07</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">6,428,574</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">6,428,574</font></td> </tr> <tr> <td align="left" width="75%" nowrap="nowrap">&#160;</td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="75%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;&#160;<font size="1" style="font-family:times new roman">Stock issues under Amendment No. 2</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="1" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">0.07</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">1,200,000</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap">&#160;</td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">1,200,000</font></td> </tr> <tr> <td align="left" width="75%" nowrap="nowrap">&#160;</td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="75%" nowrap="nowrap"><font size="1" style="font-family:times new roman">Balance at 12/31/11</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap">&#160;</td> <td style="text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">75,049,937</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">47.61</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">82,573,107</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">52.39</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">157,623,044</font></td> </tr> <tr> <td align="left" width="75%" nowrap="nowrap">&#160;</td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="75%" nowrap="nowrap"><font size="1" style="font-family:times new roman">Balance at 3/31/12</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">75,049,937</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">47.61</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">82,573,107</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">52.39</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">157,623,044</font></td> </tr> </table> <div>&#160;</div> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Reservation of Shares</font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">MTI Micro has reserved common shares for future issuance, broken down between the Company and NCI, as follows as of March 31, 2012:</font></p> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" width="88%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">MTI</font></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">NCI</font></td> <td style="text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">Total</font></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="88%" nowrap="nowrap"><font size="1" style="font-family:times new roman">Stock options outstanding</font></td> <td style="text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td style="text-align: right;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">&#8212;</font></td> <td style="text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">22,566,560</font></td> <td style="text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">22,566,560</font></td> </tr> <tr valign="bottom"> <td align="left" width="88%" nowrap="nowrap"><font size="1" style="font-family:times new roman">Warrants outstanding</font></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">32,904,136</font></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">12,196,411</font></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">45,100,547</font></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="88%" nowrap="nowrap"><font size="1" style="font-family:times new roman">Number of shares reserved for outstanding options and warrants</font></td> <td style="text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 2pt double; text-align: center;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">32,904,136</font></td> <td style="border-bottom: #000000 2pt double; text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 2pt double; text-align: center;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">34,762,971</font></td> <td style="border-bottom: #000000 2pt double; text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 2pt double; text-align: center;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="1" style="font-family:times new roman">67,667,107</font></td> </tr> </table> <div>&#160;</div> <p align="justify"><font size="2" style="font-family:times new roman">In addition, MTI Micro has 15,375,637 stock options available for issuance.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">As of March 31, 2012, the Company owned an aggregate of approximately 47.6% of the outstanding shares of MTI Micro or 53.3% of the outstanding common stock and warrants issued of MTI Micro, and Dr. Robb and Counter Point owned approximately 45.2% and 5.1%, respectively of the outstanding shares of MTI Micro or 40.3% and 4.3%, respectively of the outstanding common stock and warrants issued of MTI Micro.</font></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Warrants Issued &#8211; MTI Micro</font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">On December 9, 2009, MTI Micro issued warrants to the then current shareholders of MTI Micro, including the Company, without consideration, to purchase 32,779,310 shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The warrants became exercisable on December 9, 2010 and expire on December 8, 2017. The warrants have been accounted for as an equity distribution of $2.0 million, including warrants to the Company with a value of $2.0 million, which were eliminated in consolidation.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">On December 9, 2009, MTI Micro issued warrants to the Bridge Investors of MTI Micro, including the Company, to purchase 5,081,237 shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on December 9, 2009 and will expire on the earlier of: (i) April 15, 2014; (ii) immediately prior to a change in control; or (iii) immediately prior to an initial public offering of MTI Micro. The MTI Micro Warrants were issued without consideration and were accounted for as equity and a loss on extinguishment of debt was recorded in the amount of $289 thousand, including warrants to the Company with a value of $57 thousand, which were eliminated in consolidation.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">Under the Purchase Agreement entered into on January 11, 2010, MTI Micro issued 5,714,286 MTI Micro Warrants to Counter Point to purchase shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on the date of issuance and will expire on the earlier of: (a) the five (5) year anniversary of the Date of Issuance of the Warrant; (b)</font><b><font size="2" style="font-family:times new roman"> </font></b><font size="2" style="font-family:times new roman">immediately prior to a change in control; or (c) the closing of a firm commitment underwritten public offering pursuant to a registration statement</font><b><font size="2" style="font-family:times new roman"> </font></b><font size="2" style="font-family:times new roman">under the Securities Act. The MTI Micro Warrants were accounted for as equity. </font></p> <p align="justify"><font size="2" style="font-family:times new roman">Under Amendment No. 1 entered into on February 9, 2011, MTI Micro issued 1,285,715 MTI Micro Warrants to Counter Point to purchase shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on the date of issuance and will expire on the earlier of: (a) the five (5) year anniversary of the Date of Issuance of the Warrant; (b)</font><b><font size="2" style="font-family:times new roman"> </font></b><font size="2" style="font-family:times new roman">immediately prior to a change in control; or (c) the closing of a firm commitment underwritten public offering pursuant to a registration statement</font><b><font size="2" style="font-family:times new roman"> </font></b><font size="2" style="font-family:times new roman">under the Securities Act. The MTI Micro Warrants were accounted for as equity. </font></p> <p align="justify"><font size="2" style="font-family:times new roman">Under Amendment No. 2 entered into on September 23, 2011, MTI Micro issued 240,000 MTI Micro Warrants to Counter Point to purchase shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on the date of issuance and will expire on the earlier of: (a) the five (5) year anniversary of the Date of Issuance of the Warrant; (b)</font><b><font size="2" style="font-family:times new roman"> </font></b><font size="2" style="font-family:times new roman">immediately prior to a change in control; or (c) the closing of a firm commitment underwritten public offering pursuant to a registration statement</font><b><font size="2" style="font-family:times new roman"> </font></b><font size="2" style="font-family:times new roman">under the Securities Act. The MTI Micro Warrants were accounted for as equity. </font></p> <p align="justify"><b><font size="2" style="font-family:times new roman">10. Commitments and Contingencies</font></b></p> <p align="justify"><b><font size="2" style="font-family:times new roman">Commitments: </font></b></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Leases </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company and its subsidiary lease certain manufacturing, laboratory and office facilities. The leases generally provide for the Company to pay either an increase over a base year level for taxes, maintenance, insurance and other costs of the leased properties or the Company&#8217;s allocated share of insurance, taxes, maintenance and other costs of leased properties. The leases contain renewal provisions.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">Future minimum rental payments required under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are (dollars in thousands): $209 thousand remaining in 2012, $285 thousand in 2013 and $266 thousand in 2014. </font></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Warranties </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">Below is a reconciliation of changes in product warranty liabilities: </font></p> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" width="88%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(Dollars in thousands)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="11%" colspan="7" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Three Months Ended</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="88%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="11%" colspan="7" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">March 31,</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="88%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">2012</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">2011</font></b></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="88%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Balance, January 1</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">26</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman"></font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">36</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="88%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Accruals for warranties issued</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">3</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">12</font></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="88%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Settlements made (in cash or in kind)</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(3</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (3</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> </tr> <tr valign="bottom"> <td align="left" width="88%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Balance, end of period</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 26</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman"></font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">45</font></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> </table> <div>&#160;</div> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Licenses </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">Under a 2002 NYSERDA contract, MTI Micro agreed to pay NYSERDA a royalty of 5.0% of the sales price of any product sold incorporating IP developed pursuant to the NYSERDA contract. If the product is manufactured by a New York State manufacturer, this royalty is reduced to 1.5%. Total royalties are subject to a cap equal to two times the total contract funds paid by NYSERDA to MTI Micro, and may be reduced to reflect any New York State jobs created by MTI Micro. As of March 31, 2012 and December 31, 2011, there are no amounts accrued in the condensed consolidated balance sheets related to this royalty provision.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">Under the 2010 NYSERDA contract, MTI Micro agreed to pay NYSERDA a royalty of 5.0% of the sales price of any product sold incorporating IP developed pursuant to the NYSERDA contract. The obligation commences on the first date of the first sale of these products and is in place for fifteen years. Total royalties are subject to a cap equal to three times the total contract funds paid by NYSERDA to MTI Micro. However, if the product is manufactured by a New York State manufacturer, this royalty is reduced to 1.5% and total royalties are subject to a cap equal to one times the total contract funds paid by NYSERDA to MTI Micro. As of March 31, 2012 and December 31, 2011, there are no amounts accrued in the condensed consolidated balance sheets related to this royalty provision.</font></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Employment Agreements </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company has employment agreements with certain employees that provide severance payments, certain other payments, accelerated vesting and exercise extension periods of certain options upon termination of employment under certain circumstances, as defined in the applicable agreements. As of March 31, 2012, the Company&#8217;s potential maximum cash obligation to these employees was approximately $641 thousand. </font></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Royalty Commitment </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">On January 28, 2010, MTI Instruments entered into an Asset Purchase and Sale Agreement with Ernest F. Fullam, Inc., Peter Fullam and Diane Fullam to acquire the tensile stage line of products from Ernest F. Fullam, Inc, a pioneering microscopy accessories company from Clifton Park, NY. As part of the acquisition, Mr. Peter Fullam joined MTI Instruments as a Product Sales Engineer until September 30, 2011, at which time he became a consultant for MTI Instruments, and MTI Instruments purchased machinery, inventory and the rights to use the Fullam/MTI Instruments product name. Additionally, commencing with the quarter ended March 31, 2010 and ending at the close of the quarter ending December 31, 2012, MTI Instruments will pay Ernest F. Fullam, Inc. a royalty equal to 5% of the Gross Sales achieved on specific Fullam products. Royalty expense related to this agreement was $0 and $3 thousand for the three months ended March 31, 2012 and 2011, respectively. </font></p> <p align="justify"><b><font size="2" style="font-family:times new roman">Contingencies:</font></b><font size="2" style="font-family:times new roman"> </font></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Legal </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">We are subject to legal proceedings, claims and liabilities which arise in the ordinary course of business. We accrue for losses associated with legal claims when such losses are probable and can be reasonably estimated. These accruals are adjusted as additional information becomes available or circumstances change. Legal fees are charged to expense as they are incurred. </font></p> <p align="justify"><b><font size="2" style="font-family:times new roman">9. Segment Information </font></b></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company operates in two business segments</font><b><font size="2" style="font-family:times new roman">, </font></b><font size="2" style="font-family:times new roman">Test and Measurement Instrumentation and New Energy. The Test and Measurement Instrumentation segment designs, manufactures, markets and services high performance test and measurement instruments and systems, wafer characterization tools for the semiconductor and solar industries, tensile stage systems for materials testing at academic and industrial settings, and computer-based balancing systems for aircraft engines. The New Energy segment is focused on commercializing direct methanol fuel cells. The Company&#8217;s principal operations are located in North America. </font></p> <p align="justify"><font size="2" style="font-family:times new roman">The accounting policies of the Test and Measurement Instrumentation and New Energy segments are similar to those described in the summary of significant accounting policies in the Company&#8217;s Annual Report on Form 10-K (Note 2). The Company evaluates performance based on profit or loss from operations before income taxes. Inter-segment sales and expenses are not significant. </font></p> <p align="justify"><font size="2" style="font-family:times new roman">Summarized financial information concerning the Company&#8217;s reportable segments is shown in the following table. The &#8220;Other&#8221; column includes corporate related items and items such as income taxes or unusual items, which are not allocated to reportable segments. The &#8220;Reconciling Items&#8221; column includes non-controlling interests in a consolidated entity. In addition, segments&#8217; non-cash items include any depreciation in reported profit or loss. </font></p> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="1" style="font-family:times new roman">(Dollars in thousands)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Test and</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="2%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Condensed</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Measurement</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Reconciling</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Consolidated</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Instrumentation</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">New Energy</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Other</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Items</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Totals</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><u><font size="2" style="font-family:times new roman">Three months ended March 31, 2012</font></u></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="2%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Product revenue</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 1,204</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman"></font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman"></font></td> <td align="left" bgcolor="#cceeff" width="2%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">1,204</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Research and product development expenses</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="2%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; (income)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">374</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(1</font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="2%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">373</font></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Selling, general and administrative expenses</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">518</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">37</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">537</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="2%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">1,092</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Segment loss from operations before non-</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="2%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap">&#160;</td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; controlling interest</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(478</font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(28</font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(330</font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="2%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(836</font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Segment (loss) profit</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(478</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(28</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(330</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="2%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">14</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(822</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Total assets</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">1,833</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">85</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160; 3,573</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="2%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; 5,491</font></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Capital expenditures</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">3</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="2%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">3</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Depreciation</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">25</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">13</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="2%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">38</font></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> </table> <div>&#160;</div> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="1" style="font-family:times new roman">(Dollars in thousands)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Test and</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Condensed</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Measurement</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="3%" nowrap="nowrap"></td> <td style="text-align: center;" width="6%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Reconciling</font></b></td> <td style="text-align: center;" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Consolidated</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="4%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Instrumentation</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">New Energy</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Other</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="6%" colspan="2" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Items</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="1" style="font-family:times new roman">Totals</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><u><font size="2" style="font-family:times new roman">Three months ended March 31, 2011</font></u></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Product revenue</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">2,539</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">2,539</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Funded research and development revenue</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">13</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">13</font></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Research and product development expenses</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">330</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">80</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">410</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Selling, general and administrative expenses</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">533</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">393</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">381</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">1,307</font></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Segment profit (loss) from operations before non-</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap">&#160;</td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap">&#160;</td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; controlling interest</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">622</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160; (527</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(157</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(62</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Segment profit (loss)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">622</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(527</font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(157</font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 256</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">194</font></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Total assets</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 2,539</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">420</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; 1,061</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;4,020</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Capital expenditures</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">8</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">5</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">13</font></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="68%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Depreciation</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">19</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">77</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">3</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">99</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> </tr> </table> <div>&#160;</div> <p align="justify"><font size="2" style="font-family:times new roman">The following table presents the details of &#8220;Other&#8221; segment loss: </font></p> <table style="line-height: 14pt; width: 100%; border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0"> <tr valign="bottom"> <td align="left" width="90%" nowrap="nowrap"><font size="1" style="font-family:times new roman">(Dollars in thousands)</font></td> <td align="left" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="text-align: center;" width="9%" colspan="7" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">Three Months Ended</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="90%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="text-align: center;" width="9%" colspan="7" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">March 31,</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="90%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="5%" colspan="3" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">2012</font></b></td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="1%" nowrap="nowrap">&#160;&#160;&#160;&#160;&#160;</td> <td style="border-bottom: #000000 1pt solid; text-align: center;" width="3%" colspan="3" nowrap="nowrap"><b><font size="2" style="font-family:times new roman">2011</font></b></td> </tr> <tr valign="bottom"> <td align="left" width="90%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Corporate and other (expenses) income:</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="3%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="90%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; Depreciation</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212; </font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(3</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> </tr> <tr valign="bottom"> <td align="left" width="90%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; Salaries and benefits</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160; (352</font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160; (175</font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="90%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; Gain on derivatives</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#8212;</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">43</font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> </tr> <tr valign="bottom"> <td align="left" width="90%" nowrap="nowrap"><font size="2" style="font-family:times new roman">&#160;&#160;&#160;&#160;&#160;&#160; Other income (expense), net</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">22</font></td> <td align="left" width="1%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" width="1%" nowrap="nowrap"></td> <td align="right" style="border-bottom: #000000 1pt solid;" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(22</font></td> <td align="left" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> </tr> <tr valign="bottom"> <td align="left" bgcolor="#cceeff" width="90%" nowrap="nowrap"><font size="2" style="font-family:times new roman">Total expense</font></td> <td align="right" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="3%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(330</font></td> <td align="left" style="padding-bottom: 2pt;" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">) </font></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"></td> <td align="left" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">$</font></td> <td align="right" style="border-bottom: #000000 2pt double;" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">(157</font></td> <td align="left" style="padding-bottom: 2pt;" bgcolor="#cceeff" width="1%" nowrap="nowrap"><font size="2" style="font-family:times new roman">)</font></td> </tr> </table> <p align="justify"><b><font size="2" style="font-family:times new roman">11. Line of Credit </font></b></p> <p align="justify"><font size="2" style="font-family:times new roman">On September 20, 2011, MTI Instruments entered into a working capital line of credit with First Niagara Bank, N.A. Pursuant to the Demand Grid Note, MTI Instruments may borrow from time to time up to $400 thousand to support its working capital needs. The note is payable upon demand, and the interest rate on the note is equal to the prime rate with a floor of 4.0% per annum. The note is secured by a lien on all of the assets of MTI Instruments and is guaranteed by the Company. The line of credit is subject to a review date of June 30, 2012. Under the line of credit, MTI Instruments is required to hold a line balance of $0 for 30 consecutive days out during each consecutive year. As of March 31, 2012 and December 31, 2011, there were no amounts outstanding under the line of credit.</font></p> <p align="justify"><b><font size="2" style="font-family:times new roman">13. Subsequent Events </font></b></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company has evaluated subsequent events and transactions through the date of this filing for potential recognition or disclosure in the condensed consolidated financial statements and has noted no other subsequent events requiring recognition or disclosure other than as stated below.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">On April 12, 2012, Kevin G. Lynch was appointed to the Board of Directors and the Audit Committee of Mechanical Technology, Incorporated.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">On April 14, 2012, the Board of Directors of the Company adopted, subject to stockholder approval, the Mechanical Technology Incorporated 2012 Equity Incentive Plan (the 2012 Plan). Up to 600,000 shares of Common Stock may be issued pursuant to awards granted under the 2012 Plan. The 2012 Plan covers the Company and its majority owned subsidiaries, and references below to service providers to the Company (other than with respect to changes in control) generally refer to service providers to any of the other entities, as long as they remain majority owned. The 2012 Plan is intended to replace the Company's current option plan - the 2006 Equity Incentive Plan. </font></p> <p align="justify"><font size="2" style="font-family:times new roman">On April 14, 2012, the Board of Directors and executive officers of the Company surrendered 355,459 stock options without consideration and without any obligation on the part of the Company to grant stock options in replacement thereof or other consideration relating thereto at any time in the future in order to make more stock options available for future grants.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">On April 17, 2012, in conjunction with the suspension of MTI Micro in late 2011, an auction was held to sell certain surplus equipment on hand.</font></p> 194000 -822000 <p align="justify"><b><font size="2" style="font-family:times new roman">2. Basis of Presentation </font></b></p> <p align="justify"><font size="2" style="font-family:times new roman">In the opinion of management, the Company&#8217;s condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the periods presented in accordance with United States of America Generally Accepted Accounting Principles (U.S. GAAP) and with the instructions to Form 10-Q in Article 10 of the Securities Exchange Commissions (SEC) Regulation S-X. The results of operations for the interim periods presented are not necessarily indicative of results for the full year.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">Certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2011. </font></p> <p align="justify"><font size="2" style="font-family:times new roman">The information presented in the accompanying condensed consolidated balance sheet as of December 31, 2011 has been derived from the Company&#8217;s audited consolidated financial statements. All other information has been derived from the Company&#8217;s unaudited condensed consolidated financial statements for the three months ended March 31, 2012 and March 31, 2011. </font></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Principles of Consolidation </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, MTI Instruments and its VIE, MTI Micro. The Company is the primary beneficiary of the VIE. All intercompany balances and transactions are eliminated in consolidation. The Company reflects the impact of the equity securities issuances in its investment in the VIE and additional paid-in-capital accounts for the dilution or anti-dilution of its ownership interest in the VIE.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company has performed an analysis under the VIE accounting model and determined that MTI Micro is a VIE. One of the criteria for determining whether an entity is a VIE is determining if the entity, MTI Micro, has equity at risk. Management has concluded that MTI Micro does not have equity at risk to fund operations into its next phase of development. Further, the Company has determined that it is the primary beneficiary of MTI Micro, and therefore should include MTI Micro&#8217;s results of operations in the Company&#8217;s consolidated financial statements.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">The Company's analysis to determine the primary beneficiary of MTI Micro focused primarily on determining which variable interest holder has the power to direct the activities that would have the most significant impact on the financial performance of MTI Micro. MTI Micro is governed by its own Board of Directors and significant decisions are made by a majority vote of this board. MTI does not have control of the MTI Micro Board of Directors; however, as of March 31, 2012, the Company&#8217;s Board of Directors and the MTI Micro Board of Directors consist of the same members. Under the Articles of Incorporation of MTI Micro, each share of MTI Micro stock is entitled to a vote, and further, holders of a majority of the shares of MTI Micro's common stock have the ability to reconstitute the board. As of March 31, 2012, MTI, Counter Point Ventures Fund II, LP (Counter Point), Dr. Walter L. Robb, a member of the Company&#8217;s and MTI Micro&#8217;s Board of Directors, and Peng Lim, CEO and board member own 47.6%, 45.2%, 5.1% and 0.5% of the common shares of MTI Micro, respectively. Counter Point is a venture capital fund sponsored and managed by Dr. Robb. Since no entity of the related parties has power but, as a group, the Company and its related parties have the power, then the party within the related party group that is most closely associated with the VIE, MTI Micro, is the primary beneficiary. Even though Dr. Robb and Counterpoint combined control a majority of the outstanding common stock, and they have the ability to elect the directors of MTI Micro and decide whether to continue to seek business opportunities for MTI Micro or instead seek opportunities to sell the intellectual property, they have not elected to do so. The Company continues to oversee the day to day operations, exercise management decision making, seek opportunities to sell intellectual property, and has a vested interest in the commercialization of MTI Micro&#8217;s fuel cell technology. Since inception in 2001, the Company has made the largest investment and been the principal funder of MTI Micro. The Company has also been exposed to losses and has the ability to benefit from MTI Micro. Considering the facts and circumstances, management believes the Company is most closely associated with the VIE, MTI Micro, and therefore, it is the primary beneficiary.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">Should there be a change in the facts and circumstances (such as undertaking additional activities, a change in governance or a change to the related party group) in the future, management will reassess whether the Company remains the primary beneficiary and should continue to include MTI Micro in the Company&#8217;s condensed consolidated financial statements.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">Non-controlling interests in subsidiaries consist of equity securities issued by a VIE of the Company. Non-controlling interests are classified as stockholders&#8217; equity in the condensed consolidated financial statements. The condensed consolidated income statement presents condensed net income for both the Company and the non-controlling interests. The calculation of earnings per share is based on net income attributable to the Company.</font></p> <p align="justify"><b><i><font size="2" style="font-family:times new roman">Reclassifications </font></i></b></p> <p align="justify"><font size="2" style="font-family:times new roman">It is the Company&#8217;s policy to reclassify prior year consolidated financial statements to conform to current year presentation, if applicable. Prior period amounts related to prototype evaluation agreements have been reclassified. </font></p> <p align="justify"><b><font size="2" style="font-family:times new roman">12.</font></b><b><font size="2" style="font-family:times new roman"> </font></b><b><font size="2" style="font-family:times new roman">New Accounting Pronouncements </font></b></p> <p align="justify"><font size="2" style="font-family:times new roman">In September 2011, the Financial Accounting Standards Board (FASB) issued guidance on the presentation of comprehensive income. This guidance eliminates the current option to report other comprehensive income and its components in the statement of changes in equity. The guidance allows two presentation alternatives: (1) present items of net income and other comprehensive income in one continuous statement, referred to as the statement of comprehensive income; or (2) in two separate, but consecutive, statements of net income and other comprehensive income. This guidance is effective as of the beginning of a fiscal year that begins after December 15, 2011. Early adoption is permitted, but full retrospective application is required under both sets of accounting standards. The guidance also previously required the presentation of adjustments for items that are reclassified from other comprehensive income to net income in the statement where the components of net income and the components of other comprehensive income are presented; however, this portion of the guidance has been deferred. The Company adopted the guidance during the quarter ended March 31, 2012. The adoption of this new guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements.</font></p> <p align="justify"><font size="2" style="font-family:times new roman">Other pronouncements issued by the FASB, or other authoritative accounting standard groups with future effective dates, are either not applicable, or are not expected to be significant to the financial statements of the Company.</font></p> -14000 -738000 2386000 2386000 -738000 -822000 EX-101.SCH 7 mkty-20120331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Nature of Operations link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Accounts Receivable link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Issuance of Stock, Warrants and Stock Options by MTI Micro link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Fair Value Measurement link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Line of Credit link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - New Accounting Pronouncements link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 mkty-20120331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 mkty-20120331_def.xml XBRL TAXONOMY DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 mkty-20120331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT EX-101.PRE 11 mkty-20120331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 mti_10q1x1x1.jpg GRAPHIC begin 644 mti_10q1x1x1.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_ MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`!?`.8#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BORV_;'_X+1_\`!-'] MA;3?$1^.?[5?PTE\;^'8IQ-\'?AMKVG?$WXPW6HPML31CX$\)7>H7VA7]Q+^ M[CF\8S>&M)A(:2]U.U@5Y5_C/_;U_P"#SGX__$!I_"7_``3U^#6E?`'P\5DC MF^+7QJL="^(WQ2NSYDGDSZ!X)BDOOAIX3Q'Y8FCU\?$KS\N8_L+;<`'^CS17 M\>'_``:3?MJ?M5_MP^'/V_OB5^UC\=/'OQQ\7Z5XZ^`>EZ%>^,M3C?3?#.EW M>A?%6^NM+\*>&M,M].\,^%--NKP_:;FP\.Z/IEK<3JDLT3O&C+_8?0`4444` M%%%%`!1110`4444`%%%%`'\CO[8?_!W%^SA^QW^U)\>/V6_$_P"R/\;O&'B# MX#_$OQ+\--7\4Z%XT\"66CZ]?>&KUK*?4]-L]0'VVWM+IEWQ0W7[Y%.'R:^; M?^(W3]E/_HR/]H3_`,+WX<5_&I_P7"_Y2\_\%%/^SJ_BK_Z?9:_*Z@#_`$>_ M^(W3]E/M^Q'^T'_X7WPX']#7Z5_\$IO^#DWX!_\`!57]J*Y_9;\"?L\?%/X0 M^)4^&/BWXE67B/QOXG\)ZSI.HQ>$=1\.6=YH,%IH*F\34+BTU^;4XIY"+9+? M2;J-R9980?\`)9K]3_\`@C#^W7X4_P"";_\`P4&^%/[67CW3M8USP/X"\'?& M_3_$?AS0?,_M7Q-)XF^"OCW1?"?AVU=5DAMVU?Q_<^$K1K^]BDT_2T=M4O0E MO9/+&`?ZQ_\`P43_`."I?['/_!+_`.&$7Q#_`&H_B/#I.LZ[9ZE-\.?A)X9C M@USXL_%*\TPV\=U:^#?"8N;9FL;2XO+.#5?$^MW>C^$]%>ZMH]5UNUN+FT@N M/XN_C?\`\'NGQZU+5+N']F_]B/X2>#-#CFDCLM0^-?Q`\8?$C6+VW"NL5U/I M7@:'X66.DW$AV3-9)JVN0V^&@^VW8Q.?Y'?VW_VVOC__`,%`_P!HGQS^TE^T M7XSU/Q7XP\6:C>IH6DSW"_[3O[[P[\-_`VG$1VVC>$?"L%_)::?: MP0I<7]PUWKFLSZAK^JZKJ=Y\CT`?V(>%?^#U#_@I%IE\9?%G[/G['/BG37:+ M=9V/A;XO>&KN-%9C*+?4$^+^K1(\JE55[C3[I8RN[RWR17[3_L(_\'DW[+?Q MT\<>&?AG^V1\#=:_9.OO$=Y#I,'Q=T3QG'\2_@[8:C)?#6 ML:7XA\.^(-,L=:T'7]#U"TU71=;T?5+:*]TW5M)U2PEGLM1TW4+.>&[L;ZSG MFM;NVEBG@EDBD5C^1_\`P52_X+;_`+&?_!*#PK'#\8?$%U\0/CMKNEVFK>!? MV;_A_<6LWQ#\0Z7>WLMC'XBUR\N@=%\"^$8I;:\9M=\1SQW.I"RNX/#6D>(+ MVVGM8_X*?^"*_P#P<6?$/_@FK^S#^U3\!_B?>^(OBW86/PXB\3?L1^%_%5SK M7B'PYX(^,8U6'1;WP%=.EY'=^'_A7K%AKA\?ZCIEG?Z;IUE>^"=8L=$%GKGC MF6XE_FX^,_QF^)_[0WQ4\=_&OXS>,];^('Q/^)7B34O%?C+Q;X@O)+S4M6UC M5+A[B9MTC&.TL;962STO2[1(-.TG3;>UTS3;:UL+2WMXP#^QGXP_\'M?[7.M MZE>K\!_V.?V>OAQH;B2.Q'Q1\4?$/XMZ_'B7,5S+>^&K_P"#^E!WA&)+7^Q[ MA(Y'.VZE"!F\^\#_`/!ZQ_P4(TBYB_X3_P#9H_9'\:Z?]J\RXCT+3/BUX)U- M[7;&#;6]_+\2_%=C`^5E9;B;1;LAI0&B98PK?QLT4`?ZHO\`P3+_`.#K[]C3 M]N7XBZ)\$?CQX%U#]B_XL^)_L=AX.O?&?CK2_&GP?\:^)KV_LM,LO">F_$1= M"\(7GA_Q+K%Q>"31['Q7X7TS1KORWTV#Q/<:S+I]CJ']5=?X"*LR,KHS(Z,& M1U)5E93E65@0592`00001D'-?ZE?_!IW_P`%0-:_;,_8\\1_LL_&7Q=X@\7? MM!?LASV=K!XE\4WMYJ^L>-O@5XLO+QO`.I7NO7\\]WJNK^"-3MM6\!Z@+EFF MM?#MEX&FEN+NYO[EX@#F?^"BO_!W9^R5^R/\2OB1\"/V=_@OX[_:A^*GPVUO M7/!7B7Q)J.J)\)_A#HOCC0+RZT?7='BU;5=(UOQOXGD\,:Y:7.GZL+'P=H^C MZE/:3IH?BBZM'BU(_P`:?[>7_!QI_P`%0OV\9]:T+6?C7=_L_?"'6+2?39?@ MW^SG-JOP\\/7FEW48AN[3Q/XICU*\^(7B^._B&S4++7/%21VDDD9GDD=B[N[DLSNS$L MS,Q)9B222222:;110!_3/_P0"_X+L_"+_@COX)_:7\+?$WX%?$?XPW/QT\4_ M#37](NO`GB#PQHD&A0>!M)\8:=>0:DOB`^9<2WTGB2WDMFM041+:82D,R9_H M4_XC=/V4_P#HR/\`:#_\+[X<=/R_3]:_SA**`/\`95T7_@LU\,=9_P""/=U_ MP6$B^#'CV#X:6N@:UX@;X/2:[X>;QR\&B_'B[^!$L"ZXH_L`2SZM:-K\;$;5 MTYUMG_TH&OPE_P"(W7]E3_HR/]H/_P`+[X(: MU^7^37^=Y0!_H^?\1NG[*?\`T9'^T)_X7OPXH_XC=/V4_P#HR/\`:$_\+WX< M?X5_G!T4`?[1W_!(;_@K%\._^"O/P,^)'QS^&WPF\:?"'2/AO\6+KX3WNA^. M-9T/6]1U+4;7P?X4\8-JUK<:"!;1636WBNVLUAF_?^?:S.?W;I7ZQ5_&E_P9 M/?\`*/;]J3_L\O5__5(_!RO[+:`"BBB@`HHHH`_Q8/\`@N%_REY_X**?]G5_ M%7_T^RU^5U?JC_P7"_Y2\_\`!13_`+.K^*O_`*?9:_*Z@`KZE_8D_9=\0_MK M?M;_`+/?[*7A;6;?PWJ_QV^*'AKP#_PDMW;-?6_AG2M3N_-\0>)9;!9K9]0' MA[P_;ZGK(TY+BWDOVLA9QSQ/.LB_+5?MA_P;F_\`*:S]@7_LIGB__P!5!\1J M`/[D==_X,]O^"3]Y\$[KX>Z"?C[HOQ6&ASP:?\?9_BG=ZGXF'B/[&%M-4U3P M/+I\7PSN]&&HJLUYHEAX4TJ\GT]Y[*WUZSNFAU.#_+S^)/@+7_A5\1?'WPO\ M510P^*/AOXU\5>`O$D-O)YL$6O\`@_7;_P`/:Q%!+@>;#'J.G7"1R8&]`K8& M<5_O=U_AI?\`!0__`)/_`/VYO^SP_P!IKKU_Y+5XVZT`?'E%%%`'U_\`L!?L MF:Q^W7^V;^SI^R1HFO?\(K&HH;K6_&'B.WTQ[F MS34[O0O">DZUJMGITEY:1W]U:0VDEU;I,TR?Z-?Q:_X,]_\`@E_K_P"SYK7@ M#X0'XP^`/CO;>%I8/"7QYU[XF:WXKGNO&5K9)_9^H^-_`DZV_@:^T#4M1@'] MNZ;X6\/>%[U+*\NUT:_T^>*T>'^)/_@V]_Y3:?L$_P#8_?$/_P!4;\4:_P!C M*@#_``,O&/A36O`GB[Q5X'\26WV+Q%X-\1ZYX4U^SRQ^R:UX=U.ZTC5+;+I& MY\B^LYXLM&C'9ED4Y46V_P`RYC5OY=J_H`_X-=_^4X?[&'_7/X__`/K-/Q?H M`_IW_P""LW_!L%^P;\.?V=?^"@/[?6B_%?\`:JNOB_H?@G]H#]IVT\.ZGXT^ M%DOP]D\>78\1?$*32KC2K7X.6GB!O"JZU=R6R64?B>/51IJI"VLM?';_`-0/6*_Q2*`"BBB@#^JC_@W,_P""'G[* M?_!7;P)^U/XG_:.\>_'CP9J'P0\7?"W0?"L7P<\2^!-`M+^S\;Z-XTU#59-= MC\8_#GQU+QFTZ...6Y6>*X9XWB_I._P"(+3_@E_\`]%S_`&X/ M_#B_!'_Z'RODG_@QZ_Y)#_P4+_[*1^SW_P"HQ\4Z_NPH`_F(_P""J?[&/PQ_ MX)[_`/!M#^U%^R%\&]=\;^)?AO\`"+X>:;%X;UKXC:CHFJ^,KQ?&G[5OA?XA MZG_;.H>'/#_A;1K@V^L^+-1M;$V>@V/EZ;#9Q3_:;F.:[G_RAJ_V,_\`@Y!_ MY0F?M[?]B!\/O_5X?"^O\_Y1Z_M1_]GF:Q_P"J1^#E M?V65_&G_`,&3W_*/7]J/_L\S6/\`U2/P;K^RR@`HHHH`****`/\`%@_X+A?\ MI>?^"BG_`&=7\5?_`$^RU^5U?JC_`,%PO^4O/_!13_LZOXJ_^GV6ORNH`*_; M#_@W-_Y36?L"_P#93/%__JH/B-7XGU^V'_!N;_RFL_8%_P"RF>+_`/U4'Q&H M`_V0*_PTO^"A_P#R?_\`MS=_^,P_VFN?7_B]7C:O]RVO\-/_`(*'_P#*0#]N M;_L\3]IK_P!75XVH`^.Z***`/V^_X-O?^4VG[!/_`&/WQ#_]4;\4:_V,J_QS M?^#;W_E-I^P3_P!C]\0__5&_%&O]C*@#_"J_;7_Y/+_:V_[.;^/7_JU/%=?, ME?3?[:__`">7^UM_VO\`U:GBNOF2@`K^@#_@UW_Y3A_L8?\`7/X__P#K M-/Q?K^?^OZ`/^#7?_E.'^QA_US^/_P#ZS3\7Z`/]+?\`X+3?\HD_^"C?_9GG MQV_]0/6*_P`4BO\`:W_X+3?\HD_^"C?_`&9Y\=O_`%`]8K_%(H`****`/]$# M_@QZ_P"20_\`!0O_`+*1^SW_`.HQ\4Z_NPK^$O\`X,>98C\)O^"AT`D0S1_$ M3]G>62(,ID2*;PU\64AD=`=RI*\$ZQL0%=H90I)1L?W:4`?B%_P<@_\`*$S] MO;_L0/A]_P"KP^%]?XYE?[&?_!R#_P`H3/V]O^Q`^'W_`*O#X7U_CF4`%%%% M`'^F)_P9/?\`*/7]J/\`[/,U?_U2/P M)^TU_P"KJ\;5_N6U_AI?\%#_`/D__P#;E_[/#_:9_P#5U>-J`/CRBBB@#]OO M^#;W_E-I^P3_`-C]\0__`%1OQ1K_`&,J_P`7^UM_V MO_5J>*Z^9*`"OZ`/^#7?_E.'^QA_US^/_P#ZS3\7Z_G_`*_H`_X-=_\` ME.'^QA_US^/_`/ZS3\7Z`/\`32_X+">'M5\5?\$JO^"B>AZ);->:G=?L:_M# M3VUJG^LG&F_#+Q%J=Q'$O)>5K:SF\J-06DDVQJ"S`5_B6U_OI>*O#.A^-?#' MB/P;XGT^'5O#?BW0=8\,^(=*N1NM]2T/7M/N-*U;3YU_BAO+"[N+:4=TD85_ MCB_\%K/^"0WQ7_X)._M/ZUX0N]*UO7?V9_B-K&M:U^S;\6;IX]1A\0>$H[@3 M?\(?XKU*RM+2SL?B/X.AN(=/\0:=+;6+:K;):^)]+M1I6J1+``?C/1110!^D M?_!,S_@JE^U5_P`$I?C+J_Q=_9IUCP_?6?B_1H_#_P`1_A9\0+/5]8^&/Q&T MNS:XFT9O$NC:+K?A[4X]8\-7EU=7GAOQ!H^L:9K&E->:E8I=RZ/K.M:9J/[^ MZ]_P>A?\%'?%BVGA_P`)_`']D'P'>:O=V>GMXB3PQ\6/$^IZ<+J\MXFNM-M= M5^*\6C"X2%I50:GIFJ6_F,DCP,J&-_XWZW/#'_(R^'O^PYI/_I?;T`?["/\` MP<<,TG_!$3]N]W.YW^'7PY9FP!EF^-OPM+'```R23@``=ABO\=*O]BO_`(.- MO^4(/[=O_9./AO\`^KL^%M?XZE`!1110!_IA_P#!D]_RCU_:D'_5Y>K_`/JD M?@Y_A7]EM?QI_P#!D]_RCU_:C_[/,U?_`-4C\'*_LLH`****`"BBB@#\G/B] M_P`$,?\`@D[\>OB?XZ^,_P`7OV+?AUXX^)_Q+\2:EXO\=>+]2U_XD6]_XB\2 M:O,;C4M5NX-,\;6.GQ3WI:;*\VEZG?V;+=V-Q&([EV5!(J.OZGT4`%?C]XX_X(%?\$?_`(D^-?&' MQ%\K7]W>S1VMO;VT,]2TR9 MKC1]7U&Q9;RQN8UCNFD1%F2*1/U-HHH`_';Q9_P;_P#_``1V\<^*O$WC;Q9^ MPM\,];\5>,?$&M>*O$VLW/B3XH)5EABCC"HO/_P#$.M_P17_Z,#^%G_A3?%;_`.>!7[4T4`?BM_Q#K?\` M!%?_`*,#^%G_`(4WQ6_^>!7M/[//_!%[_@E_^RC\7_"/Q\_9Y_9"\`_##XO^ M`SK;>$?'&BZ[\0;S4]$/B/P]JWA/6S;6VM^,=4TR3^T/#VN:MI`_$$'V;7?!?Q`\,:) MXQ\*:S;]1#J?A_Q#9:AI5]&I^9%N;20(V&7#`&NWHH`_EX_:`_X-%/\`@DC\ M9=3U_7O`VC?'']G+5]:N+^_BM/A#\2X+SPAIU_?SR7)-GX5^)?AWQ]%9:7;R M2E+71-&U#1]/M+98[6RCM8(XU7X$N_\`@R'_`&97\26]U8?MS_':V\(*!]JT M.[^&/P_O?$DQVSAC;^*H=4T_3+8%FMR!)X-NR%BG4EC<1M;?W!44`?R-_#?_ M`(,R_P#@EUX5B@D\??$[]K;XIWT9+[XA>`?".BW$0/ M@)\(?VG?A'XS^`_QX\#Z9\1OA'\0K*PTWQEX(U:XU.STS7;'2]8T[7["VN;C M1;[3-2BCMM7TC3KY/LE];L9+5$=FA:2-_P`M/^(=;_@BO_T8'\+/_"F^*W_S MP*_:FB@#\5O^(=;_`((K_P#1@?PL_P#"F^*W_P`\"C_B'6_X(K_]&!_"S_PI MOBM_\\"OVIHH`^5?V2OV(?V5?V$_!'B/X;_LE?!KP]\%/!'BWQ5+XW\1^'O# ME_XCU"TU3Q5-I&EZ#+K,\OB76M;NTN'TC1-+L3'!<16WEV<;"`2M)(_U5110 '`4444`?_V3\_ ` end XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Accounts Receivable
3 Months Ended
Mar. 31, 2012
Receivables [Abstract]  
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

3. Accounts Receivable

Receivable balances consist of the following at:

(Dollars in thousands) Test and
Measurement
      Instrumentation       New Energy       Consolidated Totals
March 31, 2012  
U.S. Government $ 67 $ $ 67
Commercial   594   594
       Total $ 661   $ $ 661
 
December 31, 2011
U.S. Government $ 990 $ $ 990
Commercial 887 4   891
       Total $              1,877 $                   4 $                   1,881
 

For the three months ended March 31, 2012 and 2011, the largest commercial customer represented 14.6% and 31.6%, respectively, and a U.S. governmental agency represented 11.5% and 6.8%, respectively, of the Company’s Test and Measurement Instrumentation segment product revenue. As of March 31, 2012 and December 31, 2011, the largest commercial customer represented 21.4% and 10.0%, respectively, and a U.S. governmental agency represented 10.1% and 52.7%, respectively, of the Company’s Test and Measurement Instrumentation segment accounts receivable.

As of March 31, 2012, there were no outstanding receivables for the New Energy segment. The balance as of December 31, 2011 represents minimal amounts due for service contracts.

As of March 31, 2012 and December 31, 2011, the Company had no allowance for doubtful trade accounts receivable.

EXCEL 15 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A,S`R96%C-U\U.6$T7S0R93)?83'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DQI;F5?;V9?0W)E9&ET/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O6QE#I!8W1I M=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0 M&UL/CPA M6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G M92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7V$S,#)E86,W7S4Y831?-#)E,E]A-S,R7S4Q,V)E9&1C-S!E9`T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]A,S`R96%C-U\U.6$T7S0R M93)?83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$"!+97D\+W1D/@T*("`@("`@ M("`\=&0@8VQA2!&:6QE3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^4VUA;&QE3QS M<&%N/CPO6UB;VP\+W1D/@T*("`@("`@("`\=&0@8VQA2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^9F%L'0^36%R(#,Q+`T*"0DR,#$R/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^,C`Q,CQS<&%N/CPO'0^43$\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA&5S+"!N970\+W1D/@T*("`@ M("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW M-2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@4VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!3=&]C:R!;365M8F5R73QB2!C;VYT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!F:6YA;F-I;F<@86-T:79I=&EE3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A,S`R96%C-U\U.6$T7S0R93)? M83'0O:'1M;#L@ M8VAAF%T:6]N M+"!#;VYS;VQI9&%T:6]N(&%N9"!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`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`D,BXP(&UI;&QI;VX@;V8@8V%S:"!A=F%I;&%B;&4@=&\@9G5N9"!F M=71U2!O<&5R871I;F<@86-T:79I=&EE2!E>'!E8W1S('1O(&-O;G1I;G5E(&9U;F1I;F<@ M:71S(&]P97)A=&EO;G,@9G)O;2!C=7)R96YT(&-A2!N;W0@ M8F4@879A:6QA8FQE('1O('1H92!#;VUP86YY(&]N(&%C8V5P=&%B;&4@=&5R M;7,L(&EF(&%T(&%L;"X\+V9O;G0^/"]P/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0@0FQO M8VM=/"]T9#X-"B`@("`@("`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`R96%C-U\U.6$T7S0R M93)?83'0O:'1M M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@("`@("`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`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(#0\+V9O;G0^/"]T9#X- M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG M+6)O='1O;3H@,2XU<'0[('=I9'1H.B`Q)3LG('=I9'1H/3-$,24@;F]WF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<^)#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$ M3IT:6UE2P@;V8@=&AE($-O;7!A;GDF(S@R,3<[2P@ M86YD(&$@52Y3+B!G;W9E28C M.#(Q-SMS(%1E3X\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UE2!S96=M96YT+B!4:&4@8F%L86YC92!A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A M,S`R96%C-U\U.6$T7S0R93)?83'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X\8CX\9F]N="!S:7IE/3-$,B!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^ M26YV96YT;W)I97,@8V]N6QE/3-$)VQI;F4M:&5I9VAT.B`Q-'!T.R!W M:61T:#H@,3`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`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`^#0H\<"!A;&EG;CTS1&IU"!A"!B96YE9FET(&]F("0Q+C4@;6EL;&EO;B!T M;R!B92!R96-O9VYI>F5D(&EN('1H92!F;W5R=&@@<75A2!F;W(@351)(&%N9"!I=',@2!E>&-L M=7-I=F4@;V8@351)($UI8W)O("A-5$D@36EC"!AFEN9R!A(&-O;6)I;F%T:6]N(&]F(&AI"!C;VYS97%U M96YC97,@;V8@979E;G1S('1H870@:&%V92!B965N(')E8V]G;FEZ960@:6X@ M;W5R(&9I;F%N8VEA;"!S=&%T96UE;G1S(&]R('1A>"!R971U2!B87-E9"!T:&4@97-T:6UA=&4@;V8@9&5F97)R960@=&%X(&%S M2!M87D@ M;F5E9"!T;R!A9&IU2!B87-I7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA3QB2!A;F0@4W1O8VL@3W!T M:6]N(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'`@86QI9VX],T1J=7-T:69Y/CQB/CQF;VYT('-I>F4],T0R('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^-BX@4W1O8VMH;VQD M97)S)B,X,C$W.R!%<75I='D\+V9O;G0^/"]B/CPO<#X-"CQP(&%L:6=N/3-$ M:G5S=&EF>3X\8CX\:3X\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UE3X\9F]N="!S M:7IE/3-$,B!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE6QE/3-$)VQI;F4M:&5I9VAT.B`Q-'!T.R!W:61T:#H@ M,3`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`[ M/"]D:78^#0H\<"!A;&EG;CTS1&IU3X\9F]N="!S:7IE/3-$ M,B!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE2!D:79I9&EN9R!N970@:6YC;VUE("AL;W-S*2!B>2!T:&4@ M=V5I9VAT960@879E2!D:79I9&EN9R!I;F-O M;64@*&QO28C.#(Q-SMS('-H87)E+6)A2!S=&]C:R!M971H;V0N(%5N9&5R('1H92!T M2!S=&]C:R!M971H;V0L('1H92!E>&5R8VES92!P2!H87,@;F]T('EE="!R96-O9VYI>F5D+"!A;F0@=&AE(&%M;W5N="!O9B!W M:6YD9F%L;"!T87@@8F5N969I=',@=&AA="!W;W5L9"!B92!R96-OF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<^3F]T(&EN8VQU9&5D(&EN('1H92!C;VUP=71A=&EO;B!O9B!E87)N M:6YG2!D:6QU=&EV M92!I=&5M2!D:6QU M=&EV92!I=&5M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`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`L M,#`P/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!B9V-O;&]R/3-$ M(V-C965F9B!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\+W1D/@T*/'1D M(&%L:6=N/3-$3IT:6UE6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O M3IT:6UE MF4],T0Q('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<^-S4L,#0Y+#DS-SPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N M/3-$6QE/3-$)V)O M6QE/3-$)V)O3IT:6UE3IT:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)OF4],T0Q('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<^.#(L-36QE/3-$)V)OF4],T0Q M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^-3(N,SD\ M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT(&)G8V]L;W(],T0C8V-E M969F('=I9'1H/3-$,24@;F]W3IT:6UE M6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4],T0Q('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<^5&]T86P\+V9O;G0^/"]T9#X-"CPO='(^ M#0H\='(@=F%L:6=N/3-$8F]T=&]M/@T*/'1D(&%L:6=N/3-$;&5F="!B9V-O M;&]R/3-$(V-C965F9B!W:61T:#TS1#@X)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@F4],T0Q('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^)B,X,C$R.SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3IT:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1EF4],T0Q('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<^,S(L.3`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`Q,2P@ M,C`Q,"P@351)($UI8W)O(&ES&5R8VES86)L92!O;B!T:&4@9&%T92!O9B!I'!I65A2!O9B!T:&4@1&%T92!O9B!)F4],T0R('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^(#PO9F]N=#X\ M+V(^/&9O;G0@2!P3IT M:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^ M56YD97(@06UE;F1M96YT($YO+B`Q(&5N=&5R960@:6YT;R!O;B!&96)R=6%R M>2`Y+"`R,#$Q+"!-5$D@36EC3IT M:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<^=6YD97(@=&AE(%-E8W5R:71I97,@06-T M+B!4:&4@351)($UI8W)O(%=AF4],T0R('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<^:6UM961I871E;'D@<')I;W(@=&\@82!C M:&%N9V4@:6X@8V]N=')O;#L@;W(@*&,I('1H92!C;&]S:6YG(&]F(&$@9FER M;2!C;VUM:71M96YT('5N9&5R=W)I='1E;B!P=6)L:6,@;V9F97)I;F<@<'5R MF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<^(#PO9F]N=#X\+V(^/&9O;G0@'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@86QI M9VX],T1J=7-T:69Y/CQB/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^."X@1F%I3X\9F]N M="!S:7IE/3-$,B!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE3X\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UEF4],T0R('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^*$1O;&QA6QE/3-$)VQI M;F4M:&5I9VAT.B`Q-'!T.R!W:61T:#H@,3`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`C,#`P,#`P M(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<@ M=VED=&@],T0T)2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^/&(^/&9O M;G0@'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1EF4],T0R('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^,C`Q,3PO9F]N=#X\ M+V(^/"]T9#X-"CPO='(^#0H\='(@=F%L:6=N/3-$8F]T=&]M/@T*/'1D(&%L M:6=N/3-$;&5F="!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#F4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[(#F4],T0R M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^)#PO9F]N M=#X\+W1D/@T*/'1D(&%L:6=N/3-$3IT:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<^)#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$F4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[("8C.#(Q,CL\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@ M8F=C;VQOF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^ M)#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$3IT:6UE6QE M/3-$)V)OF4],T0R('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^*#6QE/3-$)W!A9&1I;F7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`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`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`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`],T1N;W=R87`^/&9O;G0@3IT:6UE3IT:6UE3IT M:6UE3IT:6UE MF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<^,2PP.3(\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@8F=C M;VQOF4],T0R('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[(&-O;G1R;VQL:6YG(&EN=&5R97-T/"]F;VYT M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@;F]W3IT:6UE3IT:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<^*#,S,#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F M="!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S:7IE/3-$,B!S M='EL93TS1"=F;VYT+69A;6EL>3IT:6UE3IT:6UEF4],T0R('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^4V5G;65N="`H;&]S3IT:6UEF4] M,T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^*#,S M,#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!B9V-O;&]R/3-$(V-C M965F9B!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S:7IE/3-$ M,B!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^*3PO9F]N M=#X\+W1D/@T*/"]T3IT:6UE3IT:6UE3IT:6UE3IT:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<^,C4\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE M9G0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/"]T9#X-"CQT9"!A;&EG M;CTS1&QE9G0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/"]T9#X-"CQT M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/"]T M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,R4@;F]WF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<^,3,\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/"]T9#X-"CQT9"!A;&EG;CTS M1&QE9G0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/"]T9#X-"CQT9"!A M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/"]T9#X- M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,R4@;F]WF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<^)B,X,C$R.SPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F M="!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\+W1D/@T*/'1D(&%L:6=N M/3-$3IT:6UE MF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<^,S@\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`C,#`P,#`P M(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<@ M=VED=&@],T0U)2!C;VQS<&%N/3-$,R!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`^/"]T9#X-"CPO='(^#0H\='(@ M=F%L:6=N/3-$8F]T=&]M/@T*/'1D(&%L:6=N/3-$;&5F="!B9V-O;&]R/3-$ M(V-C965F9B!W:61T:#TS1#8X)2!N;W=R87`],T1N;W=R87`^/&9O;G0@'!E;G-EF4],T0R M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^.#`\+V9O M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@8F=C;VQOF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<^)B,X,C$R.SPO9F]N=#X\+W1D/@T*/'1D(&%L M:6=N/3-$;&5F="!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\+W1D/@T*/'1D(&%L:6=N/3-$3IT:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<^-#$P/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T(&)G M8V]L;W(],T0C8V-E969F('=I9'1H/3-$,24@;F]WF4] M,T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^4V5L M;&EN9RP@9V5N97)A;"!A;F0@861M:6YIF4],T0R('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^-3,S/"]F;VYT/CPO=&0^ M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@;F]W3IT:6UE3IT:6UE3IT:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<^,2PS,#<\+V9O;G0^/"]T9#X-"CQT9"!A;&EG M;CTS1&QE9G0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/"]T9#X-"CPO M='(^#0H\='(@=F%L:6=N/3-$8F]T=&]M/@T*/'1D(&%L:6=N/3-$;&5F="!B M9V-O;&]R/3-$(V-C965F9B!W:61T:#TS1#8X)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@F4],T0R('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[)B,Q-C`[)B,Q M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`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`[)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(#(U-CPO9F]N=#X\+W1D M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\+W1D/@T*/'1D(&%L:6=N/3-$F4],T0R('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q M-C`[(#(L-3,Y/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T(&)G8V]L M;W(],T0C8V-E969F('=I9'1H/3-$,24@;F]W3IT:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[-"PP,C`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE M9G0@8F=C;VQOF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<^-3PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\+W1D/@T*/'1D(&%L:6=N/3-$F4] M,T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^,3,\ M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/"]T9#X-"CPO='(^#0H\='(@=F%L:6=N/3-$8F]T=&]M M/@T*/'1D(&%L:6=N/3-$;&5F="!B9V-O;&]R/3-$(V-C965F9B!W:61T:#TS M1#8X)2!N;W=R87`],T1N;W=R87`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`Q,3PO9F]N=#X\+V(^/"]T9#X-"CPO='(^#0H\='(@=F%L:6=N/3-$8F]T M=&]M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#DP)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@'!E;G-E3IT:6UE3IT:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<^*#,\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@8F=C M;VQOF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q M-C`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`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@86QI9VX],T1J M=7-T:69Y/CQB/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<^,3`N($-O;6UI=&UE;G1S(&%N9"!#;VYT:6YG M96YC:65S/"]F;VYT/CPO8CX\+W`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`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`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`],T1N;W=R87`^/"]T9#X-"CPO M='(^#0H\+W1A8FQE/@T*/&1I=CXF(S$V,#L\+V1I=CX-"CQP(&%L:6=N/3-$ M:G5S=&EF>3X\8CX\:3X\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UE3X\9F]N="!S:7IE/3-$,B!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UE2!. M65-%4D1!(&$@2!O9B`U+C`E(&]F('1H92!S86QE2!A($YE=R!9;W)K(%-T871E(&UA M;G5F86-T=7)E2!. M65-%4D1!('1O($U422!-:6-R;RP@86YD(&UA>2!B92!R961U8V5D('1O(')E M9FQE8W0@86YY($YE=R!9;W)K(%-T871E(&IO8G,@8W)E871E9"!B>2!-5$D@ M36EC2!P3X\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UE2!P65A6%L=&EE2!.65-%4D1!('1O($U422!-:6-R;RX@2&]W979E6%L='D@:7,@6%L='D@<')O=FES:6]N+CPO9F]N=#X\ M+W`^#0H\<"!A;&EG;CTS1&IUF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<^5&AE($-O;7!A;GD@:&%S(&5M<&QO>6UE;G0@ M86=R965M96YT6UE;G0@=6YD97(@8V5R=&%I;B!C:7)C=6US=&%N8V5S+"!A&EM871E;'D@)#8T,2!T:&]U3X\8CX\:3X\9F]N="!S:7IE/3-$,B!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UE6%L='D@0V]M;6ET M;65N="`\+V9O;G0^/"]I/CPO8CX\+W`^#0H\<"!A;&EG;CTS1&IU2!F2P@:6YV96YT;W)Y(&%N9"!T:&4@2P@8V]M;65N8VEN9R!W:71H('1H92!Q=6%R=&5R M(&5N9&5D($UA6%L='D@97AP M96YS92!R96QA=&5D('1O('1H:7,@86=R965M96YT('=A2X@/"]F;VYT/CPO<#X-"CQP M(&%L:6=N/3-$:G5S=&EF>3X\8CX\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UE3IT M:6UEF4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<^3&5G86P@/"]F;VYT/CPO:3X\+V(^/"]P/@T* M/'`@86QI9VX],T1J=7-T:69Y/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<^5V4@87)E('-U8FIE8W0@=&\@ M;&5G86P@<')O8V5E9&EN9W,L(&-L86EM'!E;G-E(&%S('1H97D@87)E(&EN8W5R7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3X\8CX\9F]N="!S:7IE/3-$,B!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UE3X\9F]N="!S M:7IE/3-$,B!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE2!B;W)R;W<@9G)O M;2!T:6UE('1O('1I;64@=7`@=&\@)#0P,"!T:&]U6%B M;&4@=7!O;B!D96UA;F0L(&%N9"!T:&4@:6YT97)E2!T:&4@0V]M<&%N>2X@5&AE(&QI;F4@;V8@ M8W)E9&ET(&ES('-U8FIE8W0@=&\@82!R979I97<@9&%T92!O9B!*=6YE(#,P M+"`R,#$R+B!5;F1E'0O:F%V87-C3X- M"B`@("`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`@("`\ M=&%B;&4@8VQA'0^/'`@86QI9VX],T1J=7-T M:69Y/CQB/CQF;VYT('-I>F4],T0R('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<^,3,N(%-U8G-E<75E;G0@179E;G1S(#PO9F]N=#X\ M+V(^/"]P/@T*/'`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`S-34L-#4Y('-T M;V-K(&]P=&EO;G,@=VET:&]U="!C;VYS:61E2!O8FQI9V%T:6]N(&]N('1H92!P87)T(&]F('1H92!#;VUP86YY('1O M(&=R86YT('-T;V-K(&]P=&EO;G,@:6X@3X\9F]N="!S:7IE/3-$,B!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UE'1087)T7V$S,#)E86,W7S4Y831?-#)E,E]A-S,R7S4Q,V)E9&1C-S!E9"TM "#0H` ` end ZIP 16 0001206774-12-001963-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001206774-12-001963-xbrl.zip M4$L#!!0````(``I'JD!F)2M9QE4``*VX`P`1`!P`;6MT>2TR,#$R,#,S,2YX M;6Q55`D``_.ZJT_SNJM/=7@+``$$)0X```0Y`0``[%UY<^,VLO\[6[7?@<\O MFTJJK/NTY]CR^,AS[?C8L2='O7J5@DE(0H8BM`!I6_GTKQL@Q4.42$J4+=M* M:F9L$D#_NM'H`Q??__-Q;!OW5$C&G0][C6I]SZ".R2WF##_L?;T]J_3W_OGQ M[W][_U^5BO';IR^?#8N;WI@ZKF$*2EQJ&0_,'1FG?U746[\EHUVMP_\]XW_K MG5J]6VO6&TVCWCQLM@\[?>/ZXO^,2B5H]1.1T`K440TTJPTC?*D>G004+P#6 M@$5(_L+H`Q7&+SY10%]M5;O8UJU'I46F^\8%F1KU_KZA$?0/ZQV-P*?Q>"=L M=HA_&R`(1QZ.O[G3#WLCUYT[VC>WU6U.2>XXIIO*RD9G7( M[VO^2U3"1J7>J(1J:'I"P*A=5,]_FU+1HBR]#KQ(*4X?S5%Z>7R34H$Y]U2Z MZ57TNY1*#F&F3*^C7J54D#)RI"0R:S.@,@[U8?^ MB\55*L1U%U>#EX+=>2Z5D6JHXS*UCGJ30NO17C(L?_N,M@*,W7?OT6H<2F4/ MOM"!H:S(H3\REMN:VD3P"14N`_H1JZ8:0%0?]B0;3^S9LY$:2VA,*X'-K#Y* M:Z^F<*#9/^:.2Q]=XX::+AIO;9"_\RVRZ;]E,*;]DG^T+D[_:#4J%T1@FPW% M4E`>W`-SI^I)\(A9^!#\A3`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`$Q0W62L]AS(:V5-"RE=:*CCF&--S1$*U?(,GLC\I.)$ M$LTL(*.A%"#T[T8:F4@SBM`L*")R=.18^`^ZTWMB*T_J'A,AIJ`*OQ#;2Q?F M_$&M4`G1?T0TL-("Q>AV#\":O*\5HEPVUIF8EF,]Z/6?'^ML;]YRK(W&%F"= M[9E;CK7>7A?KD:EN)))?J$FA_)U-+ZGKNXM2U+3?;\0@+B-8$K)\2MGMK@CL MW+F'1^#)X'T9(CKH]&)`HNVO2#CGL*S7.1E-25Y2I)LQZ# ML81:.:CRB6=%5->"3@BS3A\GD&A1&(U7[H@*7:7,@55OQN#E(%LNS'Q"[/?6 M0EFZV-K=9MQMED([GRQ:O4XK)^TT9F MEH_A3ON@D4G-=^O79(H^O4P+G"2>2FEM,#D'3*^W`ACA4>LS(W?,9G@K8)G" M:;;Z24#IU,K`E%-&C<;!"I@"T_.%0G3DE:E!"4.23FAM+#G'4F$L&U*<=B)D MR.B=#:E*J],N@@)G?Y@[5MD6Y%]`%+(MZIA0?#6A/$IVZ##[PYX+&NK?N+DV ML46\9Q'SY[5*F[OHQOU4DL0:]'.F?@7H+]C8$*E3BM:W.JU^PCAE$BX59_YQ MT>ZM@S.Y3@PVV!M[-M[\##8'%Y'*D&>E@;_")D*W$3.$]G+1AY%:X@#/5XQ&V+"JD7-,N9;:W'@[UY,FNAR)E,MWI% M0%PPAPMX&.S$*4,0K58CWAU)(FL@R)E%M^KU_`CF173NF+:'JS+7N&#%G2/_ M^FX,DV]Y^AZF4F8>#A(I;3G0GIS;?+W4;F3JZHO@-N>BP4'GX#5QN];FU@Q[ MWNZU6J](5NN=WBX:%+YL6:UUR'FY4VC77X5Q+>,H<#'__;(%M>*!V:R0O-GN MOR4;M:*4YC*LERVEXL-59\3./+<$1?L+VH5EF?JV81>IY[P8DM(E@,M17R;AG8N MI5>6Q+K-SL%!K[,$E::V/J*\@EH)4L2*=^T%RP!*>KK(^29NP`;"4BH!0R9>#(6AQMUMOY<.#!J<,SS[%P M1X^D1)AX3N`$2MI<;0GT*ZTOFX:.?_(2+!M=AL2*(DL3;$DJU&DN[+IEVK-Y MQ4E2/^;2O1HH=;J!<&%]W@\2HR=!8$WB65%1\BA2"G&E(NG*X>]$BV ME%RIP'+*K3BP&ZIRPY^I0P6QH?R1-6:..LSMLGM:FNC`UR4FUG(1W@S6S,-> M!\UUL5Y-\$(`E76;?$P_#4ZH8/=*2&ETO!D&:L5 MX(2:=2;X&,DRQX,:ONIQ1WZB`RZH+G=+'JE,[G6#81MO1<_D7%#(HBT\SBGU M/O$2!-Z-2_P)P6^QT+*M2GT!!UXM`*8]@`!\6^#+W&XN*+YGN5]:\7S7#!I:P7S6OAI:DMX[:8?4QL MZMM"!MZ,#2KE([6OE^&7;8/6_VKH,W!;PD3'P1+[4I#PL\WZE;#B")^2>"C*DCH<] MPP?ZCMP[K$4<&+VJ%L^XI'2Q9%.W2K1[O4:WT_>7G58$\A24''/ M3*HO!?Y"33YT5"N+K\%(A,`9>XT34\R;1KQUXME;))JYUD=Q[[J86Z\]BEBG/GLU4=5?`+&"C!3)?J0ZE'#T18E]2]&IQQ,:#,]18=("N41:=<$+4& MGB=G[DE6@5Z;5$IQAJ]-*&LZL]=S=8_V\OIT M34>U_0RNG@=M/V_K>)+5N`N/I84'TLX=,++JNYUX%\*U`(UZW.#YO.6$-X5V ME9-[!9">T(F`!E7F!S_;5%W*Y%A'8[R?Z2_UO(1;`>+G+_,0W03*K'-^R<_D M%$29/#H9^T87CB-UJ'E]:2XYK9E.A%JIN'(,SD*XU/Z\^6+IW_STOZ*UY&.`Q8YA]L,[-E:"\'&S M\#.U='W\V?KM?PRP!)7M)3\:ON:F6#J^_#'C MNMCFO[)8@O/)8=(31#>!,E,+$S?E%L:)WY@F<@21T#VSJ/5I^A4<_[DSNYSD MR(0(OB295IK=>O((2T[BF\.<%8XW2H$,1B!8!C,ASA1TX:=S2[L@KSCIS2$N M=+?)JH`%-RFUU(T5*>%]N3*.WQ21E^X&\>;XU/SZD!_%K@BL1^Z/6P'!IN'G MO$%P5>09_77&'.*8)6MW(/+BM#<'.7_`MB):K(/?$X9_L#_NH8\P/E8K5LG` MI00#TDOC4)OC3W_^6#Q5;"]X)E:9@$S6K!@`_>9(Y M5*;!8RL"70G6!35'Q&$FL8U;^-'A-A].]PT\4RLF7.!M\,:/%[?G!A<&9.T& M3ML19_K3OD&,2VCI=R[PT\RZ+/"V;SP0:;!H=>88C8,N=(]J1G4,Q2*&^\`- M28,<(9?STGZ58#2B)DC@RG5LSQ& M(T4JLC(09ZBJ.8J\5^P\C+AM3RO\P8&&Y,RZ[RM`B`[Y/76H&$YS8[A@IN!G M'K6-8VK;,@V&*J(`W!/!U`0"\Q>.#""!GU/X\9?STY^@7>(B):8^,*$%"["T M7;!P:D7Y.\EM9BG!#[3)A*Z5P5J75,Q82A?OL(@G<"[&N*,V?\`&+[E+C68U M12TWIX+QODA5H)FJ0?]?X#6J1G_?P+A3\0-"@>[CPK8>P&5`WTTF-@.N8)RI M!0Z):N-PIX(VBIBN,1E-I=+Y<43/0'">,AG[!E!6MY48=\367L>@LW@9*3Z0 M`;3/'#FAIE)*EW-;5I-Z]P,93][]=[_9Z+T#)!P51!H>]!B!GAH#MA%T&[N' MWR%PF")>-QB$Z%9=CJ#NJ2ILT\=]`RRQK3DU"#)I^D8.1.0`25`\_-GR<&\& M#50%X8.PO0&PKO9Q[(/^CIFOL5SL(Q4"_P`9:$-I##(YQIP>1H!![ID_N(GG M\C%W%614).(2Z&:.9YGS,8\*RD"S@55J@^P$!^-C#(DW1)0LH@8#L#@3+IDF M;#$YL8E)9SUPS^ZTQ8D*PGA@[D@/"U1RT-']..*J0,3IB`#M_K$=D$9QU2+<$)M\H"?1IE9 MA&97F82&-M@CJ'-'J0-ZH&Y;1HE=\#M@7^MEH]=^AT87O)\UHC9*"2U[9:AN M%%8"AIK,I#@*!57*9YAZSMJPL6N]<44+$SJ2`1?0E0*]J1A2WW:XT&73F9`! M-+`VC5`,!X`FI3L"=271#Z!OT!.^>J*923`2MNG#YZ!_*!RU]QE%9#'`YH*] M`R\"]@4,/_@D$WR2\>/)V<7Q3Z'AF09.;29!H7=&XX=4"#H0$!4PB!(**RGD MQ+K';0U6:#\G_`%P2^X)Y.YNJ@>"R="Q#8!O5#$,6*=1#9[Z"HJ<'DE5Q:'H MK$(2VD2`1!.4F!^T@@T/U2>/*J"6@M]`O=.^S_\%&9YYA@@"=3N$KPT(?>"I MT'.N2WU:PM/3[5C$,Q;1&MQJHT8WF?C3T,G2``E9/\$>&9L&> M&NU>M?L/53'@.F)]H<78G1:X:P>MMOD-R-GN*!ZMJ$">.9[V/Q`8,)":'VL` M=!>[#BP"T&+0!;X<0^G%11J(T5?$0!UFCI:YJG>D!XY4W5>OVIQ!X6$8[P%9 M,&P>B`6-!6JB%AD(>HP]@'^X"F8PYU&LHMF'D;`?\8/\#C=E*?,YVW)G0*I" M!?XP")),+7&@!FHK!Y[M>^#`"YB@IAQ'I#*W$NT(VBXKO-@=/=Y0D+'R`O!Z MR.^!A/9>,$9-'5;64)_"UKBPJ';#RNH,A*<05B,2>6"V/>LA%2!0^BW*BZEW M#D)E/@X9"T:@LF5H3**BU?H;*G&$#1#=`-Y/J\9Y1+ M&R@LQM8VCCL/@$[\F4DU)`<0./.(&A&U,KFBQRLI:_S,(.P$N4YSI8F:1+Z6 MGS+"OXU8+QSN(X8Q(P;@8+J@J]".HA,%)S/`&W#`P7*IC+CRA>1/M9W.0#`N]FA_GQ30O'M,$09VOCS)F/8,88DY(*_%OE=.,RAHB^1TQ36^, M@2C%E`XDQU1<_7VC6:\>8`AAJ_@DQ:%4#;VA6PEQP`3$P?_QB'!USC3O4ZN0?B_6;30)D@UB,<@IZ>@B=!!(VEH3Y5@0"F7#@ALK>4.!]!W;M3Y5HU? M1QC>0T>!FCO"'+L9&1V>O["X6(7M9V%?"(//53G<`4'TF*AXD_+X[!=*C#))R+ M=SF,,'P6T^3X>*"/.&^APH&9*J$\5`[NQE4`AUL0Z2*"?54"8/Q)U727TJ^9 MRAD33^#F9A?;#A4Z)IN@-TY[? M^#&,(G3D$'R=`+LOG+JK&I^HA"[1F4HG162&I=5;]1J**3!"T:$1RS8<]#-T MHC,6\!!CJ8-"X,VV%YF!R'+.W$I!_%.RG#@2)QWEK2#6;'-8N)=1GC!IPBB! M1FXAG/UD0]KR[&L-+4B<_!U81@AUW96&E:!$=IOJR4H:FV33UMN&D:FGC`Z7 MQWVZEWW2J,J5D;JQ\-!HM"T5$YHG$TD/C>"G=WO^ M.SQ6IN(Q.2&H?;/?)ZB;^O<(<6'\?WO?VMPVDB3X>1WA_X#SVK=R!$3S*4KV MS$2H;;G/N]VVSW+/W'Z:`,&BA#8(\$+^^F)X\>H%D/!]8,W^^H+_GP?.SMK@ M//F`>PCX?$+*SO#U(LRB\:-KZRQ?VOSK3U/F\I;?&OW-+=*,SH_-39XQ'6'OFQKE\@>(< MN=T>ZX^%01582),E&@3LA0W>ZZ'"[Q@4"-?%Q"X%6;S=F7`F_+*XG[@,>5F: MN%USH'7U2[7;6//U`F9`_1:_<\T^N@$^]\$/_G?;%F(R*>JXKL\9?[2N6\:O MR2EC,8]UZ3(WA>\F`VZT[9?K;C3`,,:*A:T@A8T6=C8L:V5/!PN:JCM#^>"B7RKH*H#\IJ"K MC>3:EUEU,#1W`*;M5KNYPP&@[^SI`G/0DM=&:4#6C_N`G\V!N? MTM1`(CQU>L+T:JUH7B4ZM;9M7VY3ARDP?=3,&4; M9->,N>>46&9[:<;LXX$*^WR*\U@L%UL+3VVS` M3<.&![SE38.-![SE.AP^5A^0W+D;4XENV9%ZN+AH;[:0XP!G;4RKHX)JY41Z M`([XIB'`.JN;PH&:RJS>\_.UCTR>$IC+%G<%8[+EA@WJ#^[2J?JBF"^W?\.M MZO#C+N,1K8&>M7Z888<=$>8V:-Z*1#KF^;#HX7A#(VO1R&Y,X^II9`.JVOE1 MXY,DJ&,1.IN)J?,BJOL-W9U*/X^=NQQ[2'[+CY1[$^QCH;O*EJX@N5JP) M([W<3U*8(<`.(2&FKXZ-3A]KC."[O0[\A<6HN/S5G7!EE33+H*A/6NP"[WI3 MN8OL2,`B/-)9ZWQA('EK+>]6;9'Z<$D)@(#K?.>75J'1%J+)Q0#3[;3ZO)U. MN]7>"C#M5H='&G1;PYU!QE)W%X/D\F`M[G,'PKC'_^"%6*UB3;K*]$;Z8BT^ MO@$L[T#*J@<+B$VA'1I3Q\/2F(8U96",8[KH#N-15UBZ9(KUOS8M`5(:;%;1 MJ'X#'L!FX4U/`@#N!*5YA-5K(KQ;FXOV9==!TPN\&]W0G2M7SYTV'NIXE;?? M,O2^(XO@&.T>Z7.-3Y[(W=WS]:S5([B[6_Z5QKJN;3\[W3:$LHH2C^/BW7#S M&T?E7CM4@0^K.)5JJ)5VS:+` MK8$=(;8[Z.W:ACTP@.0IM0-39=^L^[2D]P%JLIV?PY8N'L]V??#=@!G#*;VS M_6FA&IWX'-8Q3]E4L/_CF](.@=KM@EE)#9TU=+8G:KT8%+EDO?<#RVW..BR/ MZK'2L0+U;PGN!!>1[K:S57-?=K4RTMD3M35./U:=7LS8('[.N70"BNK8N/%:BJ#W<*8HV8PV"/!^FE0Z6ML$--^Q2>`:65BR_.P MR'_Z6O*\$X*$#:FZ-O>U^"A`A,E&63'3%#X'!-4;O#)A3&=J!;`Q.B3D"KD+ M,-P.1:MPLFGR\CP$Z[YD+DL-F'.Q:C_UB+(";-:1GOL^P#>2;.:E1#?MU#83 M`8R)1]UC![`?"#P1#027RI<%CJD!RBGW)<'N'L(+^91<<)]ZFE),9Z[_($2V M.P"VBL,S52_D3N*R:G?+4"D8*^B[LRE]4SUK1>3:MD8BNL?F-CCJ@Z$E1+,*6<>VDO2^T M-@!_QF/.V'#PT)[Z55/M^+'`0MSY@-"@BXHR*9R^G%6Y!PVA1KZ)??VHTKQ]*\9QTB=A M?B];TPK.(3O@$,=CUP-03\#$U$YT*;*9,%2_QV31.(;XB=E-#*)P-2%6G`IC M:0()D<=]P83J:S%G%TI,8[85]O.1K+P,Z1;*K)#[`>0(!FE,+!+1,E%H6S'- M[7$3,IGDA0..`#43U9NE-4C:4E![+;V[FA2T$Q^Q-->1178TT1:2V>6R5:%@ M9QT7S_`'ROW!3@[<.493-LRH#TDG)6K(%H5:)U0@%-N-J5]E1ANF;4R-B8-) M6J$`N*%:F4AM0RT)L`HEROV7(WTAAE)OY4PGF#/'>H'F$BV62!. M<3V)X:)P*J6!K^:5;>VBW&T@301C[MP7:5EMX:T0T6+WG,4MI$8PR>&%5<61 M`XN@M"(T?D:.EZ@^36!3:XYD)-G2!'C.^L'-.KE]"&D)93JI5ATI0'),,1@# MN['"!K%C)ND4:7,I>T)77KI(`MF//2"!%K71LMOG+ADZHN8[PW0'J8>XJ&T` M8<("F)&EB?F:$E,_8?9[V,<#_4(SP)()J:G],,*^C0^*5N M.Z'6U(X%F6K\-_+C*.F!%$=(_R%90+30.YJ3#!%NEZ>:&C'O)6W8PG13X5R? M<#!AD,C"A<=@J7)>MEWGVN)09QK!GA4/(;E,LD>.JE-M2VTR:M79&C:8@R'M M:`YMJK.PZO^[V*R)\9=K.2QT+\L-6K'7-B=[TJ942<]="8`LO2RT^4J4(G&5 ME#.:.EEBQLC]L>>;LQFB+TO9&BX1JK,TXUF/BRT/=V7B8A\M)_@[S"O2!\/Z M!,;.P6>'!1JTPDSN_%Y"9!E'5@1`(E,4@6"0@/-%QJ5LW`R4FM+R$L&1XR=J MWH*FHFT71B`-R]U&+R/6@($@VPO>91(UV1',GPW).74^)PC4.P*JUF)=[TE, MYJBNVF//'V$85^KB62P?5ZOC[L._462H)Z,@2;0A6?J&>H<97,'*X%?!8N$IZ.!ES.6=-C\S\LIW;<#%?0LS;;93"SSOL ML#NM/G:7@;W`9!7;!&GF.JGQ`#X"C=S+GJX2CSJAS#=_I[M,]\*]F[O,M+"S M1_+BR]U:?I+Y<67F'T(CDL=:T^P\T?87<>-X*%E7:8KR,NBK@EVF.4AO1["C M*@'&R:\8@7EMO#DN")9[!Z)7R?V,H^+,*[HVN"Y1U;5K4XT!_(M^R;(:YJVQ M,/N->I77&0R5$,77&&Q0BCX\>5!LQ!\[DT.EI<+7&.+_:7DQ1H4[M2:^2L31 M-WFN4?<^KI70Q:<0FY'3B<,U=O=^\@#1G>>=2Z;U\]/7L*6V)(0DN%"`!+;; M3''JV.YZ:27T4^1&Z:YO]NYJODK$]!^>.H`^=G!60I<8\KP64>1RH+F!:<6\ M?@#5?+=*K?^0$_!?A$WM[Y/5X%[(6M?25D2]GLQ%$6-8\-YO0V$-A2VGII,J MR&DCT!4LT=20^1ID_OS94R7TK9@D2?)N.L8VLK<6?ZU/DK4K),^GO"K30TOO M*,9:Q]%FI?AEZ;*YI*C^;^!>SHH+&UYRW/G;_[#6W942WWF9S(8VFMY3AXR` M):43THSHE8G.E!(]_1$]O+W&:\>WO@L;#J_^%3O1`]963M^YPCM6R/?JZ.K+ MA%[YAQ4$EA=]]_]N!0[._@DC@B*,KKP(!KGTQO08Y[;6)\'ZK&7H.T[`/7QG M\.Y7!1C72>),GG:V6B>V^O(]7FM.,J>SX>JVS@+'RUR^)[.@*5F;%TJWUTV\ MGRBS9U^VVIV6<85YV^$MYDVO*!:OCX'9N0))R.7;%CC9G8_74^B6`%ZD`#JC M:X!3)Y+WYT,-I87KZJLJ[P.S.^B;Y^<]7O#"[F!E8SBL<>7H3GM7!\G?J;O&[SXE MI%]A0OHJ"7:\Y]0;[Z\MQK<,]V M6U*F$VG&`K2TVW*^*S!8A6.U[O0[.#=?@>AMLEE-8[3\QLMF);`W+GRZ?,05 M<-_,?P$C]<*\&`Z>T)X'YG!X9@X'.ZXG7CJA*H^9BD:PGN%CDUVA=8-8TWI[7TV>T^PLZ'))7%DMM.%8NG M`J&\IRB]#QD\<]R0V:5"P`_RR<][JG&'E)AZ1:@V%(ET(G<&EY7?&QN@ALW`L MM>?B-PY5C7-DB4=?VW'G8C^EA=*"KTE=/JXOEY9EHLI(<]6PN.JW+->7+:&5 M*0ZM$O5SYYV! MQX"J%&1>R4&N>*Y5O$KKN"W4OK*7%[\JWAI]<=,I75$5K)9!Q5VX7A452,B6 M!^?:7HZ'R0X,&@TL^*KQQL#""G-OZ<"1X'RO2F0^?X9_IT4RKW54?]'J^FF- M""(ZS:/R4JH.7VY3`MI'7L7AA`"MG!KH!%2L"(9M*/K]HETHJA&HWZAY1E*' MD\/X=4N!D!T^QG/'\!C>DV4D'17\RZ^(=G2G\$N-W8NRF^QP3HP_XYJA6G[# MKEV#4LX#UUQ#Z= M7:&P.O[]'),"U[*K&,M*IM;G5\=+RL0$Y<;#6#S"3_" MS$RP^,?X&C4D<29@33Z8:K?CS$9R-S%7WI^'NA-9<&#)=!!=[%/@V(#3 M@U12`J@18K".@\R&V9WE7B@(+Q@A<094/?\\-Y9&SFO`1#7+TV9..\+"*A@H MQX3=.?4TMU7B_C6G\,LIO"N2O$^VCU0=8:I<;+EV[,J"_6%:U%_M@Z=ECYV: M36'RKFSED[IO<_FE4P%>!.SA#\+#T@?,;&>7)"Q@99;+3UE3K*LOX9FBP?;# M*"4XS=1&M8'#)47^=4L=&VP\B$ASC5),IA/=.]YX@NG%6G\467;_GNJWCT3& M;U8=>=!5MYSQ*56ZGSF1Y:8KO+\5RL=/=TCIS1(*8YF0&X(S/Y9=0*AG"Y51 M3P(QBN)E!P99>U_1SH)T8\&UYA%\=:+QLQ]EW&LI"D!H)*(@Z0:2R!^3H4,, ME(BOQU5N#O'/`W MN.@4#DYZVA!2=VI%?P`^91(1`G8=-'PMA!CU:TC(T&3E2H8938X M1UDKNHONX290>@,I?[CPT&X6#5N&GO"E7^`QC7_H!@@',+Y(E(%9E/:K6L10 M!<&MO&!K-J[HWV/SJ6SOD/ZP=?8JTW@KPR>Z\9.](P14.1R`]+TP+WI#R7&L MDP>]5N_5PK6;#$WS\472'8$%4FCTNN9%NV]V>F>9B=5K'!E/[;24S5/09^>, MP6@)*)"JAQQ0>W?[;1/\0/R7&]O;\/"A)`J3JJ1( M*D.N;6JKHP1XTC38<<=0Q7R-RQM0&F3;4Z_"]VC``4Z_^O!@*_N1^SQ@TZ"8 MC%\RS\!FQ-YO,PS,!_+&%/<5)-?E0]`"7G5QC-]:QC=_-`+*!!-6$0Z=7_BR M9\0'!TQ".C?+Z@L:--D*D[:5&&[:7;4,`;9PDTAFD>H(N[AI'4+:E:\01L.7 MLMOO@HH<=LQ^]V+)A;;,=;UVJ]W1'+\37$`ZF4Y6KTTZY$N5)ZNN]%TZ9&BU MAR:W*[.498-0TOMGF%G6UMKV*7'Y.J.D\[@V0^_@,6&+0Q^HZ97"R:,OJ>'' MTI7,A_SRO?1# M#J*@AX8$^IZ_>=TR/N,)W7OU0#(`V%I^?'.[<'P&/$=\E$X>6`ZY>B\[K8NT M-Y3LK,4;PP:09^;%H&OVSL\>!_"2S>F8'9B]BS888,/'1YLGM MP2T5,H/$IERVWT[:EGUQPQWSK',!2JM7RGY[W9YYWK[89+<5FOP@HC^*44#@ MNU#@NP1N&!-'?`:1Q4W%,L):]7].=X0`F=N%+NKF1BPDX\Y`O*&8ZZ^!EC5E MUC)6Z9CK8+8:&94%6?7R[AK,8LDYMJ/,7U_T%[!]$6HZW'2Z)C=\X$Y[`PV8/MJN3Z%(,BI7+[O MEL[WW4)\#["4)GC#]X?&]QSWV83Q^:[[^M;-"L8_[Z]4]NM3U^.D(1W&>G-] MMD,>9YT$8H9GLK@?.RT\@;&`(+QU9@G'S[L^V$L9HS'88D\V9J;X34[="AT8 M;X\C$4;E2@\.NV==TS5L^?S#S0OR=]:OB?#]TZIH8`.U)<<4'F9=)K)'Q8ZK M`>5NF6/KZQL[$DF;[7J+E@'KD\,E'[(<`_8/@\E7[&8[3'Y19D>#RP:7!P>O M`Y?C>VL.LSY-X062O!4F-^>/RN62/W$P+,N<%XU<&F(IB&:=Z^B4#9U! MN_7(]XCPJ92\W]; M8V-+^S\[?74F=$G3EV2J-?,?U/P5&L#;]"C<.,ZE=W?A1*N\U/O\ZOA5R?E2 MNG"N#Y.7&YZ:E`";LO40YL+MS1G:8K.U*>A^X&O'31N-_&_ M/++IFQ?]OCGH[=^&KB%T^A>MBX:?; M'W#00:ZPP?Z$?>6QXY)VVD2"#R><=PAKW(AHDB(0>S?6&K04 M1TL3"3Z8Z9^F6?34YW\Z9F&87\2E,0OWK4H:L_!IKW'#DVA9(^CPS,(R^A,= M#8*>A(%8;NF")G&@66FSTJ>8.)#<+EL[F'FTM\LV+A92NDI-JT#4Z1BO21I8 M>?H[;)WM\4"@OH`Y[YJ#8<_LK.^1/27H#+JMWD4#F!QC?S`TS[H]$#EUB@Z]9:;/2@[7V>V3LKQVB/EIC?]\F_B/T6&9+XB.T\/<#GD,P\?<#F8.Q M\?<#GD,P\O<#FZ3QJG+JN55VI`O;4J!;9,#6B%WPM;Z-6A= MEU47$=,8!?X/X0$]W'M+>T)\?O\)F\'*'A-A;N?$XVH`<7Y>BAN[/&9_L@"JU^_]6 M;6J[[^H(C\?'+QL@7;"3S\[@W^,Y)@T\RI`$N^+[M'=:22R_,0)W5MIU([BD M7;O7A<9VZS]T>'6Z9N?BS.ROP`M#,`,3W`%ST"]6@+".IL/G^=[UB8.& M+IG>\UZ9%WIO[6V$S?-G96J0Q^,)^112F9(I329MOJ5CA&K?')X!9(?;2JX& MJOH=J*%Y!O\>#:3N+!RV4:#IDV=@B`6EE-[S%Z-.G0%5C#WK#6$PW5>R[BS' MI0`0BCL5>JJR0>IE3L#*S(2YL#'J&/OQ6C9VA7Y`JFV?9'3:/M>ZUN,"(%_GD'-E7%*1.RM[X(L M#.?(RO%L-R:T:8S`39YTU.WBOW>4ZV6G<"!@;@6+9-',3VEQ72"O\5 M.]&#,7;"*'!&L8KNO^RVV@8@R"4@I"";![J2(]2RVD(C-!:+[]_?.B"![@6L M5[C.U/&LB#JP$[#1Q"9@5]PP?@,2^R5PQC?"^.3=">#U=2E+)Z&!V3[OF%W4 M%:524$X[[W5HJ7W!X@H0I1$4KEY8@>N0\?[6.'%>&YS5DHVW)7ZQJ^T[%*KPQM)7/'@8E*OE`J1&KF/#M!/!W==U MR;ELJT19"F=Y?,R[Q*<6>$`R`#Y@&:X?A@@!L)!@\M@);^G.(RQB+$81T`/Z M,#::6$2^""AKBN,QS9]?)`W:-V*:P5![OWY,\P==!<4=+-;A,\B0I`7"+@&$ M_VEYL14\&!VV.]HY[#4PAYV^V3T_6]*-/JOO=3;:$_/@UL?21E+VW%H,9+VF M[R9@01@G@]?&`_P*+WKP.0@12M*H^"`'_Z0&E]_+=0';C5XO('RT%5*-10+: M;L!B0L%FR-C`>9+=+0!3,"6;RHF(M.@*\GW@1!$HL7D!`32!L(IX%K!A49,Q MTX-]%N47B:P9R.*$L:X%6#`@">&12SM:+?"6B+)6SO)V+!+FB@8MR(*/8A20 M,&`#II,C"T`IGJ,\RH)$%C2PX%EG079`%UV(6L07:[2V5!MT^W8)N9$$C M"QI9L&M9\)!,-=>F-Z[@M% M.[^#Q_2+"Q__]OS9O_TE#D]O+&OV]GV"JQ`>?P\S`V:$9\,V/C@AXC8.1/(J M$0!\^"8F?WWQGO_^9^_WJW_V.J>_6\$I1B]?_&V](-E&X.ZT6X:V9!ESU!:] M`K_%8G@;+4];VMM5I%9E./$W`6(WS%E-I0'#[W.)FPX@+XQ'X/\[*$1=7*1A MBR"R0,S`2_'$LJ,8Q81IN-;(![G@!_PJR`]4"?"`XQ*_,:^YO$^@`Q%8+DDP M_\X921':'[X"47>`P"B"0?B-% MI28P<^;/FW1AP@QHD'D1O`&`Z!X#.0B@$`]"J@Q1?.0\WZGC.=-XBHO!SMZ` M$>;H`$5AD!0[]7SOU,;M\C$-[LM";E=[.J$(C0I-`7@#@3!*GC!`($Y#U%WB MIRU"@I+O,7I?&PCGDS'F\`8A1XLXM!.^?FN\[+;36)$V+#S&AS0OP1U*'^"O M>X25E]VSL_E?^IL:>N6>*CC[%P6_"->_!R.,=#[0)+)QDK/.M@8A`\AS'-N1 MBLV!D``=)UD^3[H>:5+W1C`^^9!'U(\>DN^^'E`'AP,``R1AHN'2H;?3P]]O M`P'6%SQU&QI7($C&JY1Q54E^QPKMY/3ZT(%<9AK[=BEK`QUOO1WA#=78NBC; M=>[?TP-]3LI2R=RR;1IA`97.=[O-]$BIF*JIQ=WNC79>;0>QY?(UU/O43^)(]ZZ-YG)>7[M* M]F8TM&"H!\N-*`=HT&HG-ZI"RX6YDLPE M/'16AUF@[?%$T/:#F2]/,C]]??[,&.-)LS_#PULM*P8'FU]7R_C$LZ@AG5`[ M,(+T,WE%KQS\%#,3[Z[0&KUH&U4613Z`G MC.>D83SZ4]@R6<>V9IBS`@_A*N_A'X&7+OG0NVJUQB3VQ@`+RZ&%J+_:_8.\"W5\3TU=JY#?=NB:'2;C MP#_/E[<$0LS-">+T\@!L9(S$.M:2^G%26"/``Y\&(Q99`)`'*JTO(D3A%&2Q)=^@XN2WX0)5W!JD,,' MR:YE,T*3__#PF1.AXI;$'K+^#_^/0`$.-#9,0O3[J-"V\.LB*TV M=UR<5Y*JNYK.7)]26]*+.'O7>WHR%MZ/%NDBK721E%FC4K+X$4'4845);E6( MY$SH4`D\9O(*YR:EWP-ZA8OI.X`MO)V'(H*O2(J7@&W,GH*MCL7$\;2K8;.9Z]B4+9+N M/)^4S:696S,?UDWY1U/K)R4U<5`KE64L\W"+"1CQHEKV9O3+LWXG2=;8<[;0 M-\E%:4+COFGV2WI?K7NNWU?[Y(51$#/)9C+9+0_P&(HHO0J'U':-VB*]$T=$ M?A5X0(_&QY;Q,79=:VK"H';+-+X*S&'G[UB2.19(2?D%3F%3LAI+3*1=RCJR M;H2!24?DPBMU-(&MY$\$=&G,@$H$9T5/49J&MC][((X)0S]P*'F/^97&>>^" M(@.Z^FH%/TP0QT2Q,RN(E&:DA86J&$+0RF[E3Y]X8!YZ2)'&5ZF2KDG57WDW M#BX,^"IR7.UF0*^M1#E(`[X'B5@S;H5*P+=(;,=NA$H?E>_<=&SVS:]!W1-` M@]"^A;F#!TRTO(,?5?XG[H\\.;II$(<,?M[:FX7QY'8\6!)`21:(P/Q04UD8 M=/\3R0"'`6T8(*0$)@UE)8"\U,WU!*OD],4>T=_&1>;777:17NGR`EE<^ M!6J&6**F!XDQ]FN`5V$93P@K@65[,'=^)FQGXM@*VXH$L4R#'.SG#!7K@NZT M4K8`6GC)&W[92U,952HMFT)3SJ_*`17K?:8/O3+#UE)MPZQL+4$\IQKL=J/O M5U#_)FZ`+O8LF_\AYFU+EY8%E&>#>P&P1[/`M9PIF^5:(J>4'5:`!H!4RGX` MKZ"@MWUP&HB]1G$(LB`$&OZ'D'8B$2/>!D?R!REI.T3+Q,D\O9SQ'JM.A#', MHIX.R/(>L=J']=B6Q[ZG%8)L&($N1O,$U?*8W))0SHEGQ/BR-4:P86F3,*DY M`_,Y'BQIRAH?A*"/@$HKS,!J,^:(3'5M&8S"B9`K@Z^#&V9*Q:<6V>0/]#.X M6%A`8[F!\)`@(H$L-B6=+GX(?0OKO6(O.05ZY!7V/7@&A&=V-2,TTU69R M=&,&7W\`+IW"F/?6!+T"X"R8!LRL_U%FN2^S/BBX(<#T`I\3="5>RL+W?=?" MD^EQC*57<'%9(T^.3R.@M`@O$4YWE(O\M+ST,1CD4M7\H'6C4[[]+^,D\_@81K= MUQD4&0*KDI"@T1F#:,;22?.^\P8SB>>K*B#+EK'`=-C6R' M6)GOON%?9)%8808#B*W8BT,D!$>*+FD?,=S32V(4(%_8R,)"OZD;-AB/Q1%7 M+9HN6_ETQ=?EJTY\G93HULJ&X01=,462T\P17>RFW+R2AV/!8S MD$;R\@]=3,,-\04VC78?H;!#N^QS5G81U]I>]MDBE;Y`#7\IX%?9?574P*YN MM+TU73SPT>H,MW+7UJWQV@Y0Q+Q7)U'KRIAM,\M6J8@C%>.:>=Y(\CJLKM1J?`X<;&QP[#[_:SU?G%U=FSP MK#5Y]8:[K3M\``<.UX)NXIBJK14WP1YC\R3NE75=4S M5MT/Q]N[AV&+'D^DJ=G[@>Z]GM'5E>F]3Q:%M9/&6\59\ZHV'(;8WG&TL#\L MZ-HU\<(=8J/;(*,^R.CUVH>%C2;X^Y3(\[QH8\+]D.=!!)'9SSM!1^^U+*YT M_-&#^M@4=6EXU6"U1-ND0>H!(+6PC5,_K#91\)SP;=6IL\"ZO%Z%/UTHBMHS!SM..6J" M&0TM%J7*@=F_*#WI]=!B&.^MF8/*EI+=Q@[U"FALP$VA66+#[N?/]@V\@\?& M4>;T-%AI,N".%B]U0O2^%@K2?X,F_KD)/@T M37V:Q1_WWK>4IIJK=UA=K+NX#8'6 MX*U&1\O[3\5JR.$XR6'3/5=(#V6#O:&'AIL/5"E7Z<%O!(2/,3GK@=Z(1F]` M4]#H/.;$JB;/K,D%/7R:VC87=$LG_=C`66OJVC&+'D#L9$<-UO;OWM7'C*JD M`LVQ`N_\B&!W\,@X9/?^0$8\6+S4"=$;`;'?J5K4U,[7W5VOH>,T'P>'4NMH MQQ>J+@X$#*5`<7!M1[,NA6T'ETH]TT!?DW!MU)9W#P6*U5Q+@F>&UB MT&4PQUE3F'^'_GX3#=K`BCE.,!0W+O:M=(X:&X6-@GUCXRE$T#?S.A^QZKN# MTIOZ'2+%=RX*-C`ZOM#&YKUS&I.Q"E9]C)'W<#O@B/#6[S:9;?7!QE:(1VW+>UN`\$"`>7 ML%1K:%;5Q^(IA``.B":;FV*[==!W::P&U9P<'RP`QY[_[": MNJ%1@0_CD5D.6YH^!-#T5NW+:L&J\^==T8HC][QR/VML0C2F0;1`^MU=-%> MB^1JU>NHE,I(:Y2SOWBEE0,>+@73:$L:Q3*ZO_M41O<**_,LPFKT.*^5C/J2 M'9JZ`#LI4'R\,-Y;!>P"5;C:G9R,G7P$E+6Q*F3)]F7CJP!]SKE.];2_6<39 M#V9^8$6";G'[J*6-$W5[^S4H'-N?BK>'$=O9LJ92C19_&*^7'XXJG;RW.K$] M\%C61@"K;9E)S7?-\19JXFL^'?26O;"3"B)%=4QIKY?$N[;`S71@3#0&1L(3 M$Z=HUEUA3GC^["".=DK*ASOI#4K/K*\RAWE;M.SP_;VBM3,L_4"Y5N+J0$RV M7RW',WS/`)_1N:-25$W2H9I2\.&;F/SUQ7O^^Y^]WZ_^V>N<_FX%IWA:^>)ON(BE MR2G;GGU^N)\0X;!F8*>3! MA(83&C/K@9)XXADYY[@BDX*,N$)5=,R@S@LWR[&3_.@ MP27"`#.?S@C/'H3V$3#BQL_N0`58QI=Q/C/V-X MNL>TT&T9?W@@]FC,[#"+>()Q`P"'@UN!@6]]=TS[@;=&EFMY-KW]LFU,`"2] M-C(A[IP*)EVRMM,R+'.#10-C^C>?@JP;\,$[0QVEK`M$R M1GM[3(2'KA(M9.)X0+LX`A`.B,ID+;A>9.$QTA>G)BPNFCD"5[-\?GXWNK6` MZT.>!8\W7/]^&27N2!=<@@!SC4Z7&",4+^`S"^'?E!F`C.RQC%#:!WZD0@G(AUA0W;=&R`YG?XTP.SX^;! M!#%BJT2/\7[VW%=[7K(G*8H5K5IC']0F*`E-DH81,#=*/93RLUG@`RWS>+F[ MSFR:)=D5T$I$/R#-@M3["F+3.,$AZ'?\^!I$,NF\LW;;1`LTO+5`.Y$E`9`& MXKK&=;#61/42QC#\3-.ZUCWL#I0&J8RQ)@63.5AM)!^!'^Y$$&8!@)J'E/.? M?H"+]N\]R;7.V*%3.M:@@9B`"(8=A4S2!"D1W#DVZDO_SAG3T'YF]!.-)4B3 MP@YG$LP(RAM!R::R-.AKU>K!?>#IELZ!8TM,\@P(YXC7&AJN#VQJT3YQH"D& MZ[/[FP>,$Y)U0,T58?A`S%P+YM2V\A^A`%Q<@0L5/I9/]R00@O,@<(6UX3"9C;S`P^X,+9@X)@I!PBMH>!2TBAW)8 M:'3U"V%J!)ODGZ35-;/`IIN;#>!.I#PW!>!.HH/RN,D:@#?1&B/,9Z<.A&M% ME#&.SR&E\!+(QI3Z81)'4EN0*X@33ZT?PIABM?7LY-:=Y;AD4:(.DB_2*L/] MB+>A0BQSS9^Q1SJ4F0LW%\8A!IL(UFQG_N[8@8_/NZA:V:9"#17+-X%1;H7+ MUK8`8Q4H(4*.`>S/W)@L8X>[K\'3P+-+!;OFWBTSF3*&%2(^$+>XVCOQB>+D MGT7T9?+=^KF&:=5Y`1+/X2?^N/[P`LQ]VYE:;OC7%Z>]%W_K7(`KT4Z7M&*R M$A?57;VH4[RCL,FJ?K%")_PRN;1MM'[)"=JS[0D>!2T*J>PKW\M@#MR+^?F) M.=N?.9ZD?/C%NB&18>I2)CEK'+X+"QF*H(]<5%SHSEEC7#1];QKWMPXV+`S( M+++`A`RF;*2"\$1$>18*#3SV`=496L$#B1+P*"TG2"=0PA`@&;LP'3Y#@E($ MC@]*7EY](=_=L(`,@C$Y8L3W?P#)P2_7.!@AY'(*K]F6\6NB3H%R,#XP-C02 M^@KKLYV9"^^<_-&Z;AF_7EY^?9U(;^DSHU^H['3?^`C;,SKMT_^+Z[@,(L<& MV=AIJ^5?X[9)$1M7/UG!L]T8AC3"R?75^]?&-W$3NTPMUZ?_CW6QVCB*]K0% MA@(#N>[.-`<<%KF%40)>H!!X>@R[EZIM`:23&%!(;FB%$OR]%*J.-T$"2=3D MQ/@ M7B4SGVVD4(!`L]#^9RY9FU]"T/XN>C\`?VN\5%WEL:4VW1K>&T(O3-3]/,3R MQK]D*'+P$96:(NK_2F@$R<-@=B#^EF8P<()(`[-(6I5+(0Y"* MVH2W0D1H&*,M.+\M%&+T9H3>\I\M3&:$VWG;(5X33B31ZBVFJ]BG2J5[7>.L3P">\F)"9%R MU&[.^Y;.YSUXV^[#Z9SK^;`8FE0O_/W3E9D:MZQ!U*!.F,1P4=MR>JF-XZGI MX6VF2E(KDG\4E^3$IU#'"->9PC8EY]DZ/K+32T.!%^'`=W:BW`5[B&&J)-&K MYTE1-Q#4[@2;%HK!8;&R\^&88DX`Y9GEC$\=[U0%PA/P*GH?.VZLXE/@JSBG MZ1<3F@8A'82WSBP-BJ?35:D7Y^.&H.!11*!B1P5IN0]H8Z:A#8)&:L),_;'@ MQI!C`?L`#*$#?PM.G^;Y``(9Y5\\H5!A`P)`[E@$,O4NCGA_*TA4P?044WA( MWL<_]"<=B51Z2J-&DP.@C&M82>"$/UH@7)0]2C\#`4E%-;?:L4\&0,3*.3L* M&F"3&.]/I182'>4@2CWP`(P9C$U[U)IFMXR/<8![RAC"M(IYH/&AP@KNT38I M@X,!-RF3ZEXQ??)<1HCGVW@K-/7CRF4_I/H?84J;`/X$C&N!#DC.CE%_\8-H ML-)AE4Z#Z%+DA85,8D;RV)(_^>HQ=CBNM(20MF+\L6PN@]H85H"7^> M^B%N_,9S8&48:U$"2D9&$A!+/E2'/9JHS3#6#084/3ZNDG)E6;A)GQ6]XC`1 MK5,+*(;.S)(@W9VOG0*,<$">.,L=,FRH>#I=V>(2W@'P[H$G`E/:/UG]O]Q' M7!$67S4?AZ7"1/2'UA0V2A97J)_%21>*EI3&D>>C-R:?HU&$.$M+'*YR0A9# M+H:AH-E0=W_8.GME&OU!JPO_&[0ZK^BY=FOP*E$N$FZ+0#55`!PL7O>A-0<-TC1W M#)+DE)L$?CA#21B06AS+V`8Q'8(&`=(RKAWD5<]7:BL)*+@D/3'BBE*!E"P) MCE$<$3-8QDW@Q[.L=E"&UN+KD@IH#'HGC>@^D%\GY;G^Y@-/(95,R&((W5T` M`IZ*^WC[46AAAZQ]9Z[02BTZ]J2<@9O;!!RT?@E<.N="G(Q(T2FAL<@$^I&R M3OJ)KGO(90+A*N$[UD^94AYE\\1V0,HIZP*//WPT86+!<5?Q`_`1P@)#>)E2 M'C".B!!'`R4=RP\H)(,N-;V4?5:%<%7(Q,6EH:\["U#AHIF2;@/%**V=A<88 MWIVSI-42:6`Z.A)"'M+2SO%_J2(W\40A`,$NM.!;(NHQQ$[=O%\F2U1DM M\D;(!GC69D5DX*L!A1`?_PT<[,&ZWW>XL&DRD MJBC1P`IN>`6)O8@\!#$FEBT=)]L)['B*)&[C09F&I!%X-Z`#F_!IQB@T M5]N35=INUVR>F!1$3"NB>6FEMF9DRVB]AZ M"M)?Y.EHCFA\G3V-NU2)V<\^^,'^8F=)\BOT4VS=(LMWQ%7F%OIZ6:NB92R?!DTRVP7D@'&+ M^CG4\P="#81JUN)9*BPOEKP@+YBD)PE)E:ST!4]$ZCE4)R,_&WU-+%IOV2[E M"BS75H%[A*(5H+M"3KNT3=%:MRB,[.F36E$4.&!OD#N331'8D%9*BK)]$PIU MMO1&]QQ;^Y1(S#P>G`'6;65Y\\(?D.$!IQ2Q?CPJQX8'NG;TI\QHH)=GVBF> MB=$-:S:#Z1!G+3PKPB0L.GY)37'KCJR#P@_=^@+88HK1&^7K='&H?E3/VJG/7 M[4;^#)\RIX:^!W_;$K'[.N[5TYUEEJCQ,:%X;;W7:-)3HA0[?2:T$ M_DWL\-&82DS1C[(QD50_H)?B#(4A)>O*5Y/0,#/N7)H0IQ/129/,5UD<,7&W M\$??D_%S]LSU$V(M98J5"6WQDGGM?H9)A53 M ML]=`FEHEC6MQ[U`1]0(!A(3Z.P?P0EET*H\[A[:U-`8R"Y@6:*>HRW5!S5[& M"J(`=&O86*#=>S*\I:^F*'P1@XL/K.*90*3'H5I\CV*&=*^$MQGI`-).'9E0 ML[Z83`?-OB-3V?&[?\5@LHL@]PR11TJPKZ*7*+G2H9QQ&K[$"`0=0KAS8=@# M,K_YDO,LJQ-28YJD,LA;,\W7L^+H%L,NG)^10]/L$'%NH4JY2[D5MXW.%G[I MT(`(S]14H9E44@A>O%3Q#?#Z]!"TM$)SC:0YX_]1&Z60%4+VR_\Z/34^JM2/ M:W[$.#VEW\#R_O%6Y87\!A^,G_056E=_?0'#$/&]D-^"J0[?WD;1[.V;-_?W M]ZV?H\!M^<'-FVZ[W7N#/[_!!U_0V&\6!L^84Y]%Q$EHO_EA>*D9[=]]<(`T MS^"3BL"L85+]\UI!EC-DWR<,?OG3"?^9/_#O)%L?R:;K9%/\"J]^!WO_^-^T M=U`.E*.XN[T/>^>[VOPZ&UN]NF[O_&SYZK:;^1&0?L.RT)X87TGG=!U@;KK< MLJBD9J@NQK^;`'PA#W8>X']Y@V+,>8O_A8__'U!+`P04````"``*1ZI`"=ZG ML.X&``!.4```%0`<`&UK='DM,C`Q,C`S,S%?8V%L+GAM;%54"0`#\[JK3_.Z MJT]U>`L``00E#@``!#D!``#=7%M3VSH0?NZ9.?_!)WVM24Q:2C-P.N'6R0R4 M#)=.WSK"WA!-;2E'DG/IKS^28P>2V+)"`,O,E!+,KG;W^W19K60.ODZCT!D# MXYB2PX:WTVHX0'P:8')_V+B].7/W&U___?NO@W]<]^?1U;ES0OTX`B*<"RDS MP!`X$RR&SND?]P>&"3#GQ[PM1S:UT][9<^3'ZY@$:/;!N4`SI[7WP=EM>;M. MJ]W9W>]\^NST+QS7?1D3'SNMO8ZWO8G/RL0%?63B\T,4WD?Y[V5-['H=;^]E M3;0_=3YM'T7"Q4T,_,'&?F9CO].2-O8?;(28_+Y#'!S9!0D_;`R%&'6:SE).Y/UFC\OSJ_](43(Q80+1/P'+=5, MGI[WY.3Z.F$F@>2T:!<`CD M!TY#'"`!P1$*5>S70P#!;PF*`RR?-E(S0P:#PT;T6\QPNKRMMGC$79?W<04G_):*AHHVPYTM1FPLT`\;N$ MH)B[]PB-)%&>UX10\.R)PL1S6U[*T_OT\:\NY]*!XY@Q.2`R`R&Z@S`Q^RM? MKOGJ?AXC/NR20'T[_2_&8Q1*/WA7'"/&9G)>_X'"^F^FG<3WJ`%VV'")B M?F9%?EQC?WFDI!)-'D=1TIHK28XR_0&CD0[DS"Y]2B0.90&PP\:N7/MB+IVD M(^4`"AO.!/#]4,AUL0(:N[Y/8^GN%?@@7;\+X3L(@]ZG4ZL#:?JX4ZX^VL55 MCXRE=Y3-I*L:;I;$ZL#%EJ8^=O!0N+[D M0FW9XI\WO+]3XC]I7GND:#4S94';N?;W&1T!$[.^W*4(.9Y5ICE2>V9]+J!5 MLYHF?LYG1I)@C7!N*\@(MW].Y M=BRL/>*'L3H_ZE.68"P$PW>Q4)6<&ZKR.4J$!$ZZ>@ MN7+[XR4OM%P+^;\J,O++P>4(6&)TRYLM96V^WA67,D]>?UN'0N!IS]#7L5/>O+K+%8]_0HXR.C4M9H3 MZ4A(D\I_ZE,.ZL:J=C-@CH"=26*^T^DAM+;PJ=-[AEZE-<#GB!=U*R/=BON5 M$?!+OF/+I M^]@B[[D)(736JR"3N5%G]$QEG$3S8G).>&Q2)@.W?+WQ`FRK]+ M<@(,CV5<8^@1+ECRMHC*2_L,!)IJ"#-NHO9TFH-5OF!4KJZ$P`G,O_?(^ELR&A:- MU&O/J1E(&<.:A*J2H;GN??;RC3YSU^N]05*78,G8?+Z,J:`0LNY'_HL#)F+7M+;=WSE8/2C8A= MU7V#Q*[!LZA8V$[L^AV%30?MJOH;I#&KA(%O6PG-:Z2"2BB: M)26C&]KUY6:30>&[6+I*J7DC=O9G#:%KE=0-`"NOM%:2:4B/?8"`GTEX2TR,#$R,#,S,5]D968N>&UL550) M``/SNJM/\[JK3W5X"P`!!"4.```$.0$``.U=;7/;-A+^W)NY_Z!SOU:6)<>) MXTFNH_@EX[DXUMA.V_O$@4A(PI4B5!"TK?[Z6Y"B)$HD"%*D`'HTTS:J@I=] M]@&7NXL%].G7UZG;>L;,)]3[?-0]/CEJ8<^F#O'&GX]^/-VTSX]^_?<___'I M7^WV'U\>OK6NJ!U,L<=;=]!F1+#3>B%\TKK^N_T;P2^8M7Z+QFK!4,>GQ^]; M\/$Q\!PT_Z5UA^:MD_>_M'HGW5[KY/2B=WYQ]J$UN&NUV_5,\>[BY/U%]WSG M*3Z(*>[HVA0?5BBZ[^"?>J?H=2^Z[^N=XO3LXFQW%"$73P'V5W.7E^/7(7./*1MW>B#Y'GKWJ)89)Z]?]^/%C)_Q;:.J3"S_L_XW: MB(OOK.4"]HX?#G-^@!GG>@OCT!=/WU" MS&;4Q0]XU%I\_/%PN]V/>+SCD&EGT::#7!>F$D)<\/D,?S[RR73FXOB["<.C M3(RQ`$+T,R'TSV*TSB[BP&?LB273=O`(!2ZO4+CML:L2E4X1\>J1-!IZ-T'# M,=I3/!UB5J64B7%W$G$"TC`[&.+V$GJ%@J:-OI.X'N7]2I^;Q8"14+%$>:-/ M_^3SMK">)Z>1S?@YML=]S[GV..'S6V]$V32T5$>M37A"K"FV)QS^/;;IM!-B MDXZ1+Z#:))?PG@$BL`,??.H2!W'L?$&NL,B/$XRY_\-#@4/@VSS,18;2(/X` M,5#F!'-B([="+,EQ:P7VR.&_8DGX]Z-[>)+"I;`C07EC[@W0(Z?VGQ/J.N"I M7/\5P'J_PB-B$UX=/H4I=GWPE]/=CRZ1/[EQZ8M_ZSF$89NKJDHZ1B0@O#>) M1P15WT":A)SXE6/0PU);8LA=+(V8[Z=/+K43L[C"[:(LUL*'5C65=$=IG2:GA51>/MWCK%?(E1XQ.%5063TESQ&U1 M!D_/YR/H$?@@"9T)F4.#&KY)+VSJ<5B"UV[8#1X;/!8?5G_O4GA"/Q]Q%F"= M1#W:V$.,T/XK45I?Z^VM7CVT29PO"8U+:G(HW$"0R:0&4A:2_?#\&;;#^/4J MX6>S%)1(^U MWM6D]DN0G"$7/#7\^A\\E^I]HZUUUB#%;\L>:[ZW=\U?!DQ$7S?$A^#KOQBQ M:\^Y`C`9RL]J;KUOA/XEXL<4G&I:_#?$Q>P29!E3)E_ZB9;6AT8H/EWR6.?O M]J[S)X;$SL_C?#JD;H:V$VVL\T;H>5/F6,-GNDPZG4ZI%Z8-'B>(8?\^X&*W M0@@IM^^2CM;'1G"A!"0FZ/W>"8IS%D\P;`85ZTVL[DDCM+XI$CK6\;FV13S`$%$X5,W\$U:+DC2VNK6E6VH1_\IXJ_")LT41&M#G82U]E:W&9&K%,"2 MB(P`]E,GF?6O82.@R!;>85_@L"_P=O8%^KX/J[L_%!DEFTN(2C:L:R>@0KN3 M*7CU^;+RZA?[G'W/$7^(C=EGY(H=VSZ_1(S-(=3X#;F![/%1ZE_;SH`:6=L$ MI!.EBL6@O8&^;=,`A'S`-@:!P21\QWR1K9(]2Y)NFG/1JF3E0##I&;OUGD$H MRN8@H824]6::\]*J)&R(7'TZNKS2K_`(PV)PGM!KA$;IP9#TTIRJ5J5$CJ#Z M;'5YA@8,SQ!QKE]GPO,%PWO/)YA%0N,PD, M>C/ARN^5#9FKSX17:].^4\\N9=96'37GQ7>Q;`D0U>?$=S%N=(89GP\@A`_+ M^\"AG(F`0>X#R+KISJ2KVS,YANHSZ[M:LEP3ICO#7LQXU9-:+Z_D;P0-B0LZ MPSXLA^U:8(7@7W6()J3ERV`RR;..(Z\!FHNP2SW:3';0G<$OI'YY#+H-S*P4 M`0NPLP97B;'T/KKS_=60EHW-I+1![.\\8`BR`X7G++V#U=6;2ZB`LFQ@)MG% M0D]8VO+3&ZY6P%,Z*),B5U%50WAX*DED>JG'B3?&G@T2RY+)9H0C=TUJF7^8V]GJZ:Y)*T&9&BR3?,0'S$$;V+E&S`.K[8-S M&TP#5U2/+$[82EC,[VSU=(?3)5A4@V62Y_C$,/(#-E47\F$F%/7;U8M<_(*GT-A\Z&P^>T4-A\N/#E<>'*X\,0` MD@X7GNP[OPNO]7L6HG7"R'Z`67B&62WEF]6[`9>D%$-C4B)QZ[AY/^`3"#7_ M7KE^S7@9A4U%"8E"K-:N'H/,0=+ZAH!.YV%^427VEU/'EY>9IS1MTLC9#_&K\ MJNTKAL4WUDT@K-(#]C$`$\=%KV!^EX8%[@M14A2NVE7S25D5Y1>`8I+KM+Y6 MU!\*L:":$W9L2VZ2B[1X^WKC2^J'I6:+$V\JA_]S^S8HW%#!8M*.JQ#S?A3: MUT?JRH.-1$O-08:2GK-BCDT@!B5:TJUN?'PT_UE2ZJ\Y'-F!.U5XM7H)4B'\ MZ.V9Y2:H]-5\F%99QRFN@R*\2AZX4NS\\$8[\!/WUGRHMCZ&U@":E,"4"EW6 M&NH^O-$-^D/]Z`HS\APN(!DODEZZ M#_,6X2<'ADEG9KY3CR974[X9S.RC^^QN$8ZD($PJ>%T]XS<`.#H\%X#0JZV& M+WA$&8[:/:%7[&_6\((13XX2%?/=83ZACKAARX\.YTDXWZ,4NH\3%UE%>U:+ M286TWS%?R;UCS77AL:QN<[:72X&K_O+LBIA695'W8?/2#*T?**_PXNR=2C)F M#$]$#=CSPI"`P/LS9#!R+M8>Z]$Q<H97\!A[@6K^Z*K+JM7\92$S:0]T0,??Y M2FU?WP9;<0N8I?.,X"@+CD$/5%44F6?_JN'*1".8GD>\2\2(Z1LYF=UT%R9D M/RJ9^SE2+`:QE3C=DDM22FO-E3]%J4E'8-)K:?-"KUQ2TCMHKIDKRDLF").* M=C)NS,ME2-I/<^UI4:+RL)A4B+-VF#*7HZVVFNNYB_*2)K]9=?5;FR,#S]/N'X$;-G8N/H5[D? ML$W'$1UY-^'6/7632MWVH0N3G*?P+1+9HZN`B7='*'8HZP.\'QBQP[UF:-5_ M0F+?^LYA&&;'\K"#F5A;Z@L3/Q&.RSQ`://!!Z2+_,?(,VMMSQ) MV+8[N_8+HSV;N#CA!CW1ZA[/.J;3?$=5E:ND)O689`)6!Y!71X]O/1`U"&$#U@'# M7'I^2'4(S=M"=9&9OG0**,4@\W.%9^#1DC`7!Y]=''+D.?VIV`WY._Q>LA)4 MNFO>N-WO*E!4B)D&(;J1`/0`R/E\X**H+FZV<%;SS8%L`,UU%;J,08Y*3-K* MBL_D)3/T>?N)6QTT5SKME^A,%9BT2Q:G6JYP].<:UL7FC(+GJ#Z(YA+$_2Z` M0FHQ:0]K6_"^;=,`M`8ZP^#`R),V*MUUUPD7XT:5WW2VNHN^NLNZZC6Y:R#-]J^N\`C#$G2R[^17[JN[ M5JP>1E-`&N\BNN[ZKMB)*=KETUV/M-QHJ MII<&+(OHDKV*-D$E@S6I.JL<.I-<,/`CXF)5^Z^`,)S(SXD+_Q72GNJ#Z"[` M*DE8QD9J(=@&A<4@IXVQ$]ZCF9*5565=?13=U5G5TEX,MTD;'.IZJ,2DZ[[> MK5+:B\$VR<9G2'Y#/`0N4#4O=,E@5D]OOFP?JR`'?C4A>D8V;=L>/09#GS@$ ML7ETL`],TN^(,3!.V2?CR@YE]?1FTDH2DI)2*PG>H/>ZNBXJ><"MGI%%<<6H M+P?;I)>Z$!M6IOA#+--G6+HB01B>$]E,2TAX+S*,U6O.J5 MRM@<%F7>R4RE_E:O.<@L5`+;'=O&E+/9+:L??7'U_TUA))D7HITGOW83'9I(JJ MA_U4L?A6_/$_'^XVZ!ZG&4GBGYX=OSQZAG`<)A&);W]Z]O/-AX,?GOWGG_[E MGW_\UX.#O[[[\A&=)^'N#LA='P>,"?0H>T=%W"_3JZ/@5.GI]\NJ'DS??HZM/Z.!@GD_\\>3H MNY/C'T9_XGOVB4])XQ/?URB._WAR_&;>3[PZ/CG^;MY/O'YS\N:/T_P6-SN< MU=_XH?S&#R=']!N-'V-#XM^60881I6"<_?1LG>?;D\/#;]^^O7Q8IIN727I[ M^.KHZ/5A*?A,2)X\9&1/^MOK4O;X\*^?/EZ':WP7')`XRX,XK+58,S*]X[=O MWQ[R?Z6B&3G)N/[')`QR[A2]=B&E!/M_!Z78`?NK@^-7!Z^/7SYDT3/:!__T M8YIL\!>\0OS[)_GC%O_T+"-WVPVSF__=.L4KN1&;-#UD^H9#F(^QNZ(-9?I/DP6:0 MS0U-,&L_XV']6^G!]2L-UGA8O]::DUJ;=RVU[LR]7N11["/]_IYE^"''<<1" MH?A;IJD)["(>L@&!M4D;3<*]YC9L;$C2?:1WO^6/!VRH.WI=Q%_V-[^6(^AI M3$-`3O+'BWB5I'=\;#E=9GD:A'G9$#>>-_^KN>YA82/3W;,RQ5FR2T-L!5KT M_;XYP=+"'#;:4DV6/N+XX.?K9W^J4I;(=BL)T!)W9Y?WP%/Z="*+^@? M,Q.NUL)N^-HT5L,#)H:XG`_$G<)H)PSN4$/)XBXO;)FL9]9$TV%S0**J>#$7<\]V:4H_^8%D8;#Y;QRD[^/HG,9[!7F5XF#\U1C<)D,ABH0L M8L)T7A0A)NZ&QK,9#\7F/KHT"=W+E7FC\0>RP>D9_=YMDNIC\;XD<"1NFZF( M:%P,E7(N@_!$!L/&7RD9NM%7SH2Y>'J3!FS#]OKQ;IET^KPP?U\&C)MMT]H_ M-8&Z$8*/V9F]R3_\8SYZK)W5T27^=)^-OU.J"_T.4N9QNOS!!] MXJI3A,YB]2!4R2'70EQM@80B:F@ZS7"!$`%GOP9DDZ3")DR;RTO*A><;VJS" M'_9$P)C?,DRY"<#^W0V3QUD(Q4S9#]SDH/37G8MMI_1+$?O:ATV@"K_[,F!\ M:YO6_CFK?T=,P`WCQMH(Q3GIS]PDG?PWGCO&52==-!-_N2QXU&N;J@PN0M#Q M=']ZJZ&CHY0:LC`IY\7C>LEE!&S6L97QR<1KA< M?2!Q$(>$6I1DI.=,G96ZFQ,+>D#JXP"7*U0IHE+3ZELBFDSL8N5>!'=/D? M&JH+=)JC4AMQ=7?D'X-N!JNW/+[>XU_FMY[_-B'[`ZY59X"4-V[+/&D@V\Z% MI7G@'*`EOB5QS+R#9A?BL[/AJ:^-S84&TY]'@P-R%+$*S^W!Q2XV`R9$89CL MJ"5?<(BI5U_`)1C04J=!RF4@.1I)6\ M^S'%2PQ&@\@2,;+M1%(ZPCG-.5YAZK#13?`@)K!&X[=."]2E M].9WUIH+:43%D9#W9?0>"(3$87*'41X\8`HEEH4-2,(;L*G-?Q,JP;G#58JW M`8G>/VQQG&&:<5_F:YP*P_K=PD0;U#W,X+3956BA0HW/<;EBY3/.W64<,"S4 M,HXLX4Y:J_F5EIK! M>0*9:9=<)LFIA%F0^6FRQ6G^>$4[G1=L^7U'MFR?7+_FH54#SDBU`+JIC1!? M(*X@RNZ4*H[7209#V590<`U%ZB%06>?$0$[<[H!-SK$%>E?MBKT+-JQTILL] ML1GPO>*8&+N8!R$N`Z]U@1-\),&2;$A.<$8]DM\Q7">;"*<9\\[\T>`8G7$3H(YD`:Q-FH9J%8?S M1R^.XDV(JJG\AP*C6Q>QY6+;B:R)"'\$XRIX9%NPYH2 M/BQ56=N^%9*NSR8,[^P%XJ.='T<4Y$17'4Y0L!S4/],=CAH1Q,A%%3K07JHT M7<(=)HL:PG[XJC6"32WLT&,GZ7A?_%;O`!+7[6$__*+T%WR/XYW!Z*I0<+(( MW3%:N5I;2'K@L?:VIT+2E:^.[VPOO%1/=-7"N(+E3B:9_;[I>CPUBN=^#:!& M)N]O>'YT/WY.;;6CJ6J/$WHQ0+(*4B2_X]<1XN@LB7,2W^(XI$9I/%&G!7O# M3&M^YU9)+2VNES7E'5XDFPX$>OXYR3$Z/GKA^+9,/ZTZ=V0,.`5Y$7_`>JWBI5?+ ME8V*@[T7DMNBX"-#RU!9)*UK0G*I!;K(,CIY=3L8F-F=";NW08KNF23Z]Z.7 M1\?LLB3*6#'(!0IV^3I)R=_II.7[-XNCHR/VO_]`WRU>O7F[>/O]&T0X6$1B MM$SRM7C.DHTI[,=W=I]WU`^GG(R--M[F#N]("%X=5Q@+QJ>S":KH) MD!A'[X.4D2D[#A:D*(A)2KK--C^RW"^9S<\BR:SPO5IV!N'OW:P=PB],$%\YL4!]DN M?31:0Y`(@P9KJ;'=5U2$T-X$R%TH-K*YN8;`DIJ\4%J@($=ADN4+=+PX.GJS M.'K[2BPG9'XM$T"@/)H3I458'\Y"SX+V&"!](7DXBK<"18QO663T@7CSN-<^ MSINGX&60XZQZ8&J/JYI1R>4.E=7.E.L=J5$[43YM/RF/)GRZN1`^46U`88'I M>33?=,UH[)P`A-L!<1HZY=7&IE>#Y-3@?)K+J(-6_ZZG@QC[B<1)2C]]$>>8 M_N:Z9::.*&A\E1@Z)+JRR_%)G--/;AAERM;_0:">Z`..T^>!G6(R*%1-HZ)M_X>)V?I'),%F%V)=Y>Y/$>JH7'\BP!X, M0O#8W";[8T)Y_P1A5!SWI[""9NSJ5?6JD(*$E_(""E[NS?[FU[,DCEA]4W9W(4LV)&*K[$4@ MOEYCS"ZSLP69-;^YO0Z MPC]^!T3%LY@!&TH]Z8&7;J+/%.Y=1J1)?-O)?0]JTF7*7W:,^)[7%4ZOV6:> M)E\QT79U*T0#1W^^G2JBRQ0)5;$[S9Z]15S;BXLC]M`Z=TF>DQA%-%4.TJR^ M4>+!I4)#+FH.]/<2T8ES<1.RT^K"CIE3=;1<.9/$?+T3"054:WCA..8P"H[1N/@^+3IK#&9[4''EL."_E")'N3@J?N;&'"H""'2@/XW4B5V=V7#_FC M&Y6H%P4W9C(?]B%'+7&Z;SKJ60-X&"+8X*PHTO;G)(DR_3LA4G'8@PIR@SO' M#IA874B/2SI^#L30\JLTB79A[KIJX536@FX':\CJ2C[911F-(F MIJB!R9&G/DE$1GL^PT`5_X)87$`K/4*7VSP6$6)O2\<:Y+Y.EE^N M>"9_G6ST^SG[DL#[.&TSNUL(68XN5V+*BIB0RUT;(VN3%=KZ,6N=TͧDI M>;N[,7+F0M;)DF6?Y;/K_:.4F3YPM2PS2-U\43'%+52]&+$F`5>Z2G.&Z,D0 M9L7';O$B&S*.6!/2?B@3\SK5HI"1+MRJD"$46V?)D%!UM"XT$)5L&47B+*Z6 M40:BNEEC%-S>IKR(2Y&U$O&D>21=5Y%`=KF^8N-M>PLL5JXV6SCX.5Z-"`B5 MMB\AH0''/BB4REZ&!0VR\I],G"6N"B*=!IHUY.U/8_D:]=E"QB'N= MB.+);&/H+,.CV<6`F.CI5$*S`&PXD7!7EA<8EC?3HT'3(A<[3)C?I_XSCG$: M;*A5I]$=B0F;GN7D'O>'`\,&8/>C3$%U#K8(Q04J5#D#]Y7=QXKQZ&X;Z()] M=*XCAB-PH#MF5B[7V4BS\S<'^VOB_-W')-.=(9=)N]E#VS-7O<%4G(Y\S@0= M%NJW-7M#!5SY\C2V.MFTZW)8N4TG(3"3#I#4B'N<%2R@7"9KW'*UG^X[45*]F*!XEE. MAAD-5/;F5W870!3F0[IPKP>T';B?_M!W@U@X^4"!B=>#=]2N8I1-XNP=7B4I M%G(WP0/.VL4N:2J\WXHH#?0)Y^N$_@L-2^)U8DU`@+3"P1TFJ.Y57"PJ1FZF MBVH34&T#$D:4A2Q%TZC1]J(,>=S"!9V*TUE/DD8D#M)'=)'C.W8-Q;?JEGYT M_H9W_E+T8]`W\E#C1>RJ_9P09+P'P2Y[5I M(TL6V[<%FW\.@-K)2W&^OT+BL.@P;=@@8YT(-`NK*"CT<<1+BI]=.,S$)\!U MM=EE)TB!#F*DL'O1R2/(H/G^T`C5F0<,#D^.PK%IJ'481@>%R-D>1[*/B`K[ MRUF[2";WO>33C2]ASQOCS18?#$PO;"X0&)CN+!`9!1DWENTC!O235`?K MY1Z<_Y1O$)?E-M\%&0G9(1:R89VL\:$^35`_ZH?1)EGUU'15(W:!N)8X1";T MW'F,/:#&>()+;%6)V,IORO>1V`."SSMX7YP85YB%&42'=4.%O^@/ZV[PLLZN MH:NVXXVIGXXXF_\73&[7M*V`DCNXQ?'N;HG39"5*W"W9]VCG1N)[R2[/\H#7 M6Y,$EU'-P9W>'PZX3=>!+3DZVS\];E0T5=8L;6@I'5.(SA&3C,[+3]<)_`!] M@5\TPR[9ECV1HEU,\K*,*^^&9N_DZR!'+*;M6'5^VBUAL`EW&[&%O*QZKC`$ MO;^Z=GG2?F2(V#MZ/S8^0+Z:5Q2KNUQU'S1YO:BY:,;+[MI<-'1VXF;"$S;"2F&TPG3X0W:JB7L^- M6RD@*!FW*!E6JU"R424?W&A.,$Z\1D6DB/\GS(9,_0)92]95X?[* M5%W5>/15B#FFB;*'-17B6]T+1X=3FB*Q-#?87`4DNHC/@BVA,_)>:NCU0&G2 M!Z%-F5H>,86#BQ@5*AH"005-6S#F""!=P(A5;7EK[L(,S:LA/B?1R1*L&?0-#!T!R"4-VE,V# M\&@/Y.!,AN3YY[.+%YZX@PF[)%<;^JD%N.Y@]A::NP?0>A[>*E[[<_W,68^5 MY5NS\R[]6SR;Y)&]!B\C36$MZ%J+P0MKCI]5.XW^9U<<8;])%),7;N(RX(\) MW['K5WQ/Z0O^?4"G_[5#O[GOG3P!/XV3NR MNP90?9*=C&HM":!Z0EV\#G;P+A"O7]??7J#JZZCX/!+?1PT#7*XD@/>JR+-Y M>RAL-.CJW(AC8N5=8I$.L98#B>7%DYA0(;"[5`04_R!WKZCOB+'L?)?2O%98 MQLWY0M/;E(0YCKC4Z;<@C?AIP0])NL(DWZ7:@A"CFP;>`QO=$?*X)-I$HM'2 MHWBSS./*AHO%`MYT=9RVT;S+_;3).X:UQO.^^L#)`2O05O8%?Z74]:;;-'[1 MW9>;R"F92HGXB5QXFG$"9&=8U1G/!H\CB5HQ@& MC0%>`AR+^*0K2MC=B.[PL-^7$UT,&\#-`K80#-)L+*R\Z0GFQ-WK;'VC/7R;G0LR!; M?]@DWTR>*].JN3H%*@.@/?S)%!#7\.W,IQV4Q!B*HP.>2FIISG6J>05Z*9R9 M<94F]R3"T;O'G^E4_B*N*C.>ACFYIU-VHR?^!C0&?;W<'JSLTA/G8MD,>O>( MGK.6Z.CT`M6E..O6O/"]2<#+T#F_.3V0P)+KU4/9"^>OU+H5R7LJ.#2$0/UK MS[C>V@T\"=SL^`6;JR3EV9#G%6]Z`>[51W#GZ[UVNBQI;->)O"HD&__SX,%= M?1RC#M6;"AD4NU&B'>PD(<+1GB[;%8A#LL%[Y2UNDNG2DED^YV[O=KH.Z]FO MK3Z$NG5WZ#\_Q23(04?2"7Y:=61<5L=B);'HGT/6A]NR#Y>T#XL;IB]07:,X MJ#[I^#'+.?U6N_DXM=.Z*"Y?U_:^B*DY_.YS1O%8#TU MZ&M]U&B`[PHND&C$AYKTPV#V%:B'2;G\16&7ALV-P\US`6:10?UV@&%8@`MZ MYWA+ASS"CX+0/V\P^P-[9N>.3?/^+JWXT.@9(W708&<(J,VYIMH"58KB1:R& MJKOP-@$P5S%M`M/%^U;:'P(R(MBX33L:6/F,N[=U:+)&T[/\\8K^)ORN-G^Z MSRCYT3;@],4=)2C#QW=*?<0;0%4+/F0]0Q"R499DVR0+-FPU!,^!9VC>,"\> ME\\-Z5VK[^6A'K\"ON?SKGV@5+=1*U>`O_LC,UIZ"TARS-WQA2`CTST[=CZ# MX>!7;Y0\EU["49,<])$A?K+C'(O_-M9;BA/A!@NR%HU`/_%C#D[R2(PXT?2\ M5'_!;KC42Z%5\0@/UD%'(3U;T_^'V?OSS47*+,.Y>`AG0X(EV?BP8&G/5LD+ M+;94=>F,IV&8[.CL_PL.,;EGNZA6;BA1=^R`4D"&KE?JHEK9)X\S@E9A2&?! M8)=&SXG!;5A0^TU_0-`XCAV5. MHTV?B_/!Y+$1:831;D.0Q%_[8X_,64<4%^]^X"K%VX!$Q:NFIW'$WVX]VZ7L M5/XIS_DDT65$8W"%Q8>"5<:ALB$6A8JF4-$6HHTA\>QMT1P2[3DJ+CX5]A)F M\92OR/\3CC,L<`:3XS0+$;[@!"O[/O)S*>& M8COM*31]RH+Z0576;V>S?F`ZY-;VJ69J8ZSW8X[6\FWS"5K;L5T&JG.\PC1X M1E\P3>"T58CZ=1T'JBX4PT!5*J)"TZ=`U0^JLCY56>_6710,ZW<7%;TF79=FAOJ[L?W;N`S`=XIHL:RCZYCA&T$L-F5@S#1_J)$#@?,15>8S1H MJES&Q]NIFG!@T8BGMU$E[!MP"_4I7#U5(+6\)N'P&6+'./V\>:N*.@,\TWGL M82NNV50WXW6-^1"+]&`M8U+5F&^7PB8!+T/GI7\:$-C03TW8"W@S/G@L2U6& MO^](BO>.-)[&DK5F>.%.'2\X`O:'IP\'@>4 M&K4.V/+\7,>.K>ZY3P9E6_U86WY"G/U6'IRJ]ORWV@=SX_5/!EH^P**=X/!-%B9"Z", M8?7G]L8`EDI*>%A3U,?ITR33)E^G2]-,DY["W$BWI%$^FTXJ;-XNULR*S,_I MW_AIGS_QY0.)@SB<:'E&UY@/\48/UC+N5(T]D>49._`R=%[ZIP&!#?W4A+TC MSHIVTX_KW3(C$0G2Q^*5^CCZ2Y"F-!=1O]LVN"FXXRL2S&CNNL7\KL9.YL$=)R$ND2"\6SPG>"CB*Q-L(K,?$ M^W,.CY:.\/6]@Z5C'-W'U&*2E,+75&*:%.(IY`VFN[&K"I^WTY?9T?F9(HU/ MC1S$&689C7?L/RSXW=.`R$ZI\F#?/I"CB316S8#&&DN`G7OFC*%L:.1_:+2P M*-\5DQR0YS`A(]`0%VW'H$'^"1>% M+M/;("XJA)TE<99L2!04U<.N*(O*3/ER543-8%.]86&RMC)-^Z!Q:ZHNZ;R> MT&AW@?9:YMQOMLU?.BM;1W7S7BS)>-%!R8`.@HP=DSI6.ZA,ZU6`7YD+,76LQ]/4&/^3H'07SF\N54PO[$PO[0><` M2L)T?J<8^`'@QQ,\.`O6_;2ZCN-=M^-CGU").A3JOFVB=T45O.)B\&IOF1 M./:,WF'$B%6@)2B2.WP3/%B.%FHMZ((3&O,E>S+L:3\J[M]P,2\.X/H,?922 ME&7HY9-3GS`;+S1JKKU"'V6E=/)DP)@=BF/?,!@Q#'@%^'`)>V9BG6PBG&;B M+!N;%!D,&CV*L`^9](&0/JY1*)1'6)F*%Z/'*#1_,(8#^FR($846S$ M:7#Y%VK/?/]0//7.3G4&%.KEBJL4ASUODE^"E+#5@O*)]_=Q+HZ#QQ M/-3^?\?/U?%&)_"=]_S-&B-J)*N6$=5]O4I2E#5_D^((/ZY^`U+^!NRH/Y-< MU&?[\P3=E[\"*7\%S`T3MZZY`DJX<2\=GOAW$\_W+@LX"N9CRN=+#?Z+.Z$QE5"$NT\:XTTZ,SJ1.;=NZBRW1)NDO#*0P:Z'2@5V MOT-M>&S[S49!BT;,@_/]6-(>;<]6*@]`6O M=][:.Y0.9#&QWQ_C>H-_'&SC.U^4!SM:TJS$;A-ZG:9*>)6F* M0UX0PR#F6S4#ZAV6`!7/6[-)?*$OGKE@+:!&$UX,'#Y@A?2Z(>1MN^(@YOKE MGR8CE5T[WGFH;E0PIZT7PYTG<'WST]XQ>!;FW*3NW>)"KD%*B5I MU*2RKOFBZ_+N749=?P/RI/C\SW&VQ2%9$1R=)W^:-WT_08<[O?T/.A],=^PQ@N(6.\[.=C3]U;Y*JM:!GN6$,@;]FCZ1` MGG],LNR%!@_PR0H]HR2'*'1T*M!\I*I_HG^F_UD&&:;_\K]02P,$%`````@` M"D>J0#1A67F,$P``0C$!`!4`'`!M:W1Y+3(P,3(P,S,Q7W!R92YX;6Q55`D` M`_.ZJT_SNJM/=7@+``$$)0X```0Y`0``[5U9<^.X$7Y.JO(?%.=U/;;D.5TS M2?G<$A-^_NMUY+6>J9",^]_VVN\.]UK4=WF?^4_?]K[W+O<_[_WKGW_[Z]>_[^__ MY_3^NG7.W7!$_:!U`VT&C/9;+RP8MB[^V/_!Z`L5K1]Q7RWHZMW1NX\M^/,A M]/MD\DOKADQ:AQ]_:74.VYW6X=%QY_/QAT^MNYO6_OYF/O'^^/#C^++[A,?_G(Y&T!4/0E]_VAD$P/CXX>'EY>??Z*+QW7#P==`X/CPYF#??B MEL>ODB5:OQS-VK8/_G-S_>`.Z8CL,U\&Q'<75*J;-+KVER]?#J+_%YI*=BPC M^FONDB`RBDR^6MH6ZK_V9\WVU4_[[<[^4?O=J^SO@0S^\E5PC][302OZ_G$P M&=-O>Y*-QI[B._IM*.C@V][H9S#95X(\/(K)_S%3S8G?O_`#%DRN_`$7HXCI MO9;J]_O]58+[$76'`?SOGV? M$D\IYV%(:2"_^R3L,_@U"W.>KA#8OR,"A#FD`7.)5R&69+\;!?80P#_5D)#= M07=,13042BHHJ\^M`7H(N/MSR+T^3%H7OXRX9IYF'^N M.S@C9H&Y@*RIC'V49/*?2%6RLM-P=G(:2^51*ZRDIE;@L2Z=$ M,M#.G:`20.>:(]-(R[)SXKH\A/%R3UW*GLFC_1A/H2S+S)7_#,"X8-1:2>6M:-5A[&UJC+"T+*4,U_T_GD=^($`24#0F8#?,%=Q:8'G[+0ODDC#Q@W@AO:%$AB*::FR93:4MK6;ZI/HIL$=*H2S+ MS!D?C5@0K1B@`EA*`CANP;$KAP6:NBC+WC7,N;`N"`KKE2T_"9JR#-S2%Q+/ M%JCR\=(VBG#$R+NVZ=/:BNB MSAA?U!FC_3%B=?KS-7FD7CJ;RP>6+XF^8J*M\7A'!>-P#"G&[`KUEKF&[90( M2O"]1+\USGL\(%XAGI/NXFO>,H]PT765*U^<4S=GSS* M0!!U<(H[\A3,J'O'FM8YC.5BR>54%)&8!T0^1K(.Y?X3(6.0>;M]0+U`SGY1 M>-K[A^VIU^@?TY^=^0FN%Q\?UMA/;^BT9[PN*_%$)/DFPIWU"'^N:3#IY)JV M.!A'7HI]=\B\N?('@H_R2W/&"\]`TN("-M_?]H`BE,`BC_:QRO4"X`94B.DB M9F`^XOR9BD>>,#T<53ZXU">P'IR\,FFCT>7V3@=)L7KM9&AQA?NJE.EA:7$* MY[LOQ]2-G.7G?$28;]*DCL8YJHLV5[6D4:H!R,XK=B8*=<:Y@C^M;'/>V'E? M%U7:&N8RZS/EM6LQQTKJOGOBSP=]RF+]P1^K:H.?G'AQN:=/3*TI?G!+1FE+ MI*ZI\Z$N*DNH(JDV`_-:B]N.W,^`<4&\*]@%OOZ;3HR"7VGK?-PIR:]SK[>7 M3>+" M//P3+9W/.R+Z=-YG4C_:NM1[@JB`E8?)Z)%[&GDGVCA?=D32JUS/9/P>:VKG MHQ'WHTN#AR$@E=TP4&$6BDGS/&\@=-J'.Z(..RPS)7W8NI)FY^L>=*M1QW(3 MIXWE#<@K^%6N9R+^N'41GP`;?<7*I4=T0S[1QFG7YF2>(>0UMF=2_H0VD.=N M?<-.)K6MTZ[-"=IR:*^Q/Y/^9S3I+_96E_!+VK'7T-IIU^;@:ZF!%``S'7Q! MUD$\..RUL-3>:>_*:=8(87&P2E?%UX/56XF-7%7DB4#$\U1U!Y?,!Y88B)%+ MEG'1D8?\[:ZCR,`W"_3/>MU1T)]:F^U4?G]J=;<4*TWJ'_VY9Y_F4UQYYC25A99P&*O3;'%N%FC'HKQ9V2[]W@HX) MZU^\CM49$I:=;C"D(@:$.)?=I69DI,X]+=X*/J0@F=QZ)8U/A M(#!6IT3SSLE$AG^U9C\3FU'H+X%V2\FQ/#(G7_SKNGS3[O(]W?I-T2Y-N->, M/#(/3DYTGIB8R*ZT\#;9=E'+VT&M(RH/JGK%:Y;W4]R1B3JHVWLHD@3XEY"Y ME&?V6ZQ#:XY32H3`ZD)45OI.I\&_[ZQ&Y7IT3;'QV0;S7J7#AA8VGD[@M+&] M5A4H7`^M*;ZM7-:=-O"Q71L5:#D=5F5>#M3MF[&H@?XR24_EM+$=(!5H/`-? M9:X2]#O]`KMU@T`[V$Z2"E1OAM<4W\E2,'3FQ?%*4Z>#[2/)4)'>I%=A-&4C MWN^SF/$[POI7_AD9,UA2EA";=N29Q$X'V[=22.%VP)JR*[^G`6$^[5\0X<-: M)>$H$HY"3\4Y3DO9&<9`-K'3P7>]%!@#=L":LE?OB:CTUL1J6E]O['2PO2Z% M=)P.I/S=L[:L$O(6+=?6S.E@NU4*Z30=2#-.7#?,YR(JHA)04(EI7EYMZG0: MX#-)`]64VZIU@5SYKA>J%,,[+B)=!8%@CV&@7,(]KBYFX7`)K`,K3Q8CHIH/ M.!WL`*.-'-2*BN+/<1%7X@+.Z33+BZ<%J4\<*SD2ZI?GE*Q.7KY<6_:G$U_, MJN!6L+NW1"?;HF[%!:R=CQN>^/16YVV7RX&]U7E[J_/V5N>MIG/LDE,65IVN MB,#V(V?.'151N1:[&PH=-7JVDTTV?3X\#5E>U\KRG(3!D`OVQV+C:U;Y*A5Z M-E1!5:?@:*!YQRC5RQ;Y]!M3H"=&E=+M'$,C+QQBC+8W#G%K],2G//I,YW^# M26Z83H.LU[\0\F+5ZT%SMBP"5304;RZ"'/:AE^&?U0M0\)BQ<^?_Z^:5/WD@ M'I734-U?.>]+-1 M5ML4A-T:^@_ MG7$9Q4I/2P/8%)G*I*WC25ZK81LT32F(H2!V!]&2\L`]\SD^T1+]_&ZE)=UQ M?A4*^D):5>AHVDHSJ_&1;<=6].@G_1*:MP6(OR1K=E9&`#+>;^BV5C:TZ#5/ MK#64LMVR!(AN[(5T^]T?E-#NC!J_^LGF%+R,$=^`MS"C%YW)\6NC%!P$UNB: ML25_H%&`XZ_4AP7/`[`G_1'SHZ>F5'G#[%%@UP%^Q962P\$>9E.V[?,M4.S5 MO>;2Y,1,:;U;!5@T`)J11?`K8;Y"U/65:Z$[.*>"/4<#UZ13`Q5^S94\NLT` MTI0$[5ON\^0HSIZ^M33X)5;R:-@(HREIV(N9Z1*$%=<9"`'PXL;UE`ZXH'&[ M'GFE9%Z5:XP*_ZDF<,;EDPE65!H:Y, MMS18("Z9[I2[+Z>-[6',-<<5@5<^6ZD>F:T)\+9C`+^>4&']+M<,JCR_:-OA M?,#M$!9CV&_%``%I=P`3H#FD3T>%7S,HCU8S@!B>O-JMSC1RKX0$;1BX\* M"?'[_1@)-SX*6Z:[.I0,L@R^*(%P/@HV$-9;EU#0];39:1V5>KR?5["@F07] M6]1H$6O+D*C.,]OT&-*W3-)=3CA\RR1M>"9I/$^I;3[WU;)G:Z9I=/4).[4U M5PV*IMR-IYS>;JC:Y.4[NL8T]8E!U6G-^@@[!]20Q78I^\Y&O\FV]8D\S:W7 M-2"5&2[6O*PIY)FI52,=>B1J00UG@6I*:NEJY=%E2S%DU38E$2 MR;29RDUIC1YS6E"SZ5`J"TK!FJ33[ZLR%6LBPX\Z+:CB+%!-B4Y9D4KF*3BU M/7Y8:4$M:]%4%IR"?A"^+I;KC!X96B+9>2G<<]>W4+M2C+:.0:5MO0>L,M!5 M';3'5#"N;FE$@#;4[*KZ),K@U#'>U*#V%=8K.U770'L%(W%JX_NRT=\:[]4E M>\!$@/CTR__":01ACVM\`]'0?231K>Y(A=!&BKJG,'E)%M`'*IZ9JRK+P3B\ MIRY_\J->LAZ0V/2G:QDJJA]@VQ!'4P[_T1H:SZ7GH5`K9P0YPGD/JZ-@;A1W M`*U.7HCH1^%5EUP,*`M"TU\;1F7N?98NO,H\)ZEYL-?4#Y*!\O51E?Y/?(:_\/%>B2O@?ZG!JYY% M_2]+[W:6SJ1)T]V6HJV7PF3/B!Q>>OQ%7OE])J@;H(91S[G)%SV]1O86-%TL M:#I-D%E7&$V-E2YX!U6;R>U/7&\7S@)J)-\)_LQ@9CR=?)>T?^7/ZW*37@&>KRZF6$3GT,/[*YRC&U(0$W)"%C4$EI4$;KR`688B0SD="=H M8,QMM^T"/:Y\4T,A?>#E$$OIJ:\>12W.*;#KLDBM\+='(_WZ_9.1LQ#LTH5R4B#+-?@&@%ZD/UVAXE6"$T)O)A=NYS3^-]+OR$$0.`J>P[3.[86W(\9,$-_UK3XV0H;&A`I.!N]KQ0A,,_((_.B/7G>26*%'#_'8'/S1`K4!@7D M6I[9*KE0QL\)V.XQ-I]D*AM4V%7+TS#'%=HKBE4P=%;+]("\P0H9^)KBHH>] MURS-R_T]9((FO,GJ94$+-[U])_@)``75K0EXR`6\(9X0P.A2VH\>@$BY@;`= M,_:]X*<'5#MH\B%ORDQC+\-*%B/\1(!*!TT^X,UX_$^#^9+Y!+:,U6QC#)WA M)Q5L8P1E"`#?(:/QW*[/H@_AHV1]1L1D6IO;[_]&A(`I59],4K0KIX/MM2VH MSA3O;4'X#8GOM)=C)9.+T\%VYE8R<(H!KVPK@_MB$``&BU#_4N;Q#":CG-A1 MZM6J\\HP9O)TXW2P/;ZYWA3*B:P9NY5TU"=@'T),P!2R2M!8T3L=;!]O^8&0 M`JFR748-"E!M:1Q@>W$W,`XJK-Z"F`A[3J4K6,1W=W`:2A"/E-O/@.V*)^)/ M0XH7#R#%X<9W2Y"[@^EB3;S%VT@6YZE*^D?)J;TEJJA+=[!X^-2TLUMKC)Y; M6Y7D=5NZ-,2;V^QOR2K50W=2>=H6W;[99'UL:41(^J-]VK9-M\@TP#MO MD"EAM0CO,LR^;6-=*:U1;.6:$U_>\H#*GB#]>7#=$GOG3+H>ES"-]T`SI\#+ M3P.N0OVAVURZ-C065!3BSEO9/'SE;T9#6P%9.,M;9B1+3S MMK)>MPZCQM1._ M)$Q$MS(WT0-_D:=J^RO\G(O%;&SCJ#&1H6R+TQBRV1<;Z=!7VPPQ:W;&69AV MWG0>Z).REBM_P,4(Z:)ARL,]':NZ0OZ3S:980X)3]G:%F7S'20MJ=.,QB%MC M.':H=MY\U*O?+,X.4R$#/+KPH+Z+XL$T,)/+3Y.K'Q2+L^+0QOCR=81NAWDU MHXMPR8MZY^T4^H!]\AGPR1!VAN?T,D$**:69,7&IC04Z,:C%:K&2O0X M=MX<;ND+F=_/CP7WX4\WON#?OG4L(@7.A@3F(34G70C!Q1D7ZCT&Y9ZQJ46< MHQL42[)AT,:^/K@>)0O;X*__%_4$L#!!0````(``I' MJD`*J1$N,0@``-L\```1`!P`;6MT>2TR,#$R,#,S,2YXX_\/SE=H'*LN,F38RDBZ1- M#@;J)$C2;H'%84%+8YNH3+HDE=CWZV](299L4XH-3W<7WF'CUW?_^.GXGY[WY>SF(_D@ M@G@"7),^R@P9A.2!Z3$Y_Z_WF<$#2/(YT4505;/3/"#8O(UY2.>O29_.2>O@ M-=EKM?=(J]/=.^SNOR77?>)YW\?$FV[KH-O>WL1;8Z(O"B;>YE&TW^"?[VMB MK]UM'WQ?$YW][O[V4=A[$FM-IB.VCHR/? MCF:B'$940UBJ_,B7(@(_%YK9;ATU`$,@;DQ..`0AUDP M=LN;$0>`\7M0V@U)QAP@3EF@W!@[Y(`H%K@!..#.CIY/03E38T=<-O14EAC! M$0=`PK!THAWX.)IG82HA>&1B4AG8N3FD@?9@-HTHIUK(^04^+Y@3G,<3MY)0 M2]^$YJ.0AU(@69`O"_WXDLBM/&XB58_[X*MCRKG05.,V^NZ83J>,#X7I?_7J MV*S,KM%^AR!B&I]N>N6;FO4CV[)/>7C.-=/S'NJ3$ZN_01@R6"F16$Y-AS!D MG%G/<#,D7O[SH-"D/"2)'E)0=.RO:B@JCA6$5_R=;6-J%>JQ*+/+I5\Z_Q?C#"F\.+&!ZTQ374%2>\?VG9+QH\5\DL4E^ M3JW^\C(+\EFPX.UJ^)ZJ\44D'E2/APS/CCI);Z5$>=X.GI(W8X!8"R\Y*AQ/ M006238VMJ^%9K!@'I=)SJ7.H/"MOS2F4J2`2*I:`#Y=4F\;2+KGK?)]1Q7#; MNBX$E[#M&BCG^G"5:PLW5!<5[#K9IX%]!:%N(`!V3P<1)%P[^LNI/EJE.D.3 M'+[K1/?X/08E)(-T[RAVE%+;;JU26X"]4(I-N*.SG-*\HYS2]CJE!D8L;M0M?YRAO=6&78="'>=Z9Y2L;G_I@?TWZB4%+?,4Q[:YRM[JE!G\[YF M?19(D4[Q35'E6>JLK8-4]^((_YID^NTK,]M'4A-D,"?]NQZQ5G8]EQ>4R<\T MBJ$/U)!I3M1)OIPCY3EYLYH3@R=6`2EHV'6^;V%D:%A[3^SH+^=Z?VV72M`O M[X2+;RDF$Z;M!1&W&+PZ:L9'P(/%*:9*H)SZ@U7J"VKL5K.D:->3@`9POW\O M`>_C">M+/>4TKUTW#]"URUWF]A`>:7%1PJDVEX-@,DK/TL*MKU)-S&`P7?8@P,[G/FUWK+Z5Z[?.984;-S` MD-A:B*[Y1'O24&PR-1?XI&]L/U:;HA(OJQWY`P-LSB91)F*45U1EV`2M:;+ M:^]YG79SIL+$MTT<6$2UH0,9;D,'W$5@-4UG`&-SOXZUREJL$J/6H!/H0Z15 MUN/EJFK'75'<5.6,`Y:VMW'"53!6QXLB+GO8R@]7`5HM1XK`Q=,VKJS5J=5Q M8P&RK6W,K]>OU;&?HY+F-AZL%L35L9]A3&,KVZMU?9 MZNTN]N'UM:=A8NXC#4)3J9.&EK$Y!5HI/'9D88JG>&]WB=VE+-F"/B)VOX<4BXB#&$\`8O9+A>QYBZ#W@] MCL34B-R8FW(,A8!K21>#FPC97X%K$#&DS4LK7AQW$5X7WM`R3_ M]_BUA"EE89I33/05;ECRO3U'ZU.E('N%9CEX(KYZ?E2'4_TET)#_G[T M?!9$L9GF[@_)=^(SEJ0&8E*UG&50``K;@#`!$`&````````0```*2!```` M`&UK='DM,C`Q,C`S,S$N>&UL550%``/SNJM/=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`"D>J0`G>I[#N!@``3E```!4`&````````0```*2!$58``&UK M='DM,C`Q,C`S,S%?8V%L+GAM;%54!0`#\[JK3W5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(``I'JD"OT#K;R@X``&_:```5`!@```````$```"D@4Y=``!M M:W1Y+3(P,3(P,S,Q7V1E9BYX;6Q55`4``_.ZJT]U>`L``00E#@``!#D!``!0 M2P$"'@,4````"``*1ZI`B/U:W*(A``#L^`$`%0`8```````!````I(%G;``` M;6MT>2TR,#$R,#,S,5]L86(N>&UL550%``/SNJM/=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`"D>J0#1A67F,$P``0C$!`!4`&````````0```*2!6(X` M`&UK='DM,C`Q,C`S,S%?<')E+GAM;%54!0`#\[JK3W5X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(``I'JD`*J1$N,0@``-L\```1`!@```````$```"D@3.B M``!M:W1Y+3(P,3(P,S,Q+GAS9%54!0`#\[JK3W5X"P`!!"4.```$.0$``%!+ 4!08`````!@`&`!H"``"OJ@`````` ` end XML 17 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Basis of Presentation
3 Months Ended
Mar. 31, 2012
Organization, Consolidation and Presentation Of Financial Statements [Abstract]  
Basis of Accounting [Text Block]

2. Basis of Presentation

In the opinion of management, the Company’s condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the periods presented in accordance with United States of America Generally Accepted Accounting Principles (U.S. GAAP) and with the instructions to Form 10-Q in Article 10 of the Securities Exchange Commissions (SEC) Regulation S-X. The results of operations for the interim periods presented are not necessarily indicative of results for the full year.

Certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.

The information presented in the accompanying condensed consolidated balance sheet as of December 31, 2011 has been derived from the Company’s audited consolidated financial statements. All other information has been derived from the Company’s unaudited condensed consolidated financial statements for the three months ended March 31, 2012 and March 31, 2011.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, MTI Instruments and its VIE, MTI Micro. The Company is the primary beneficiary of the VIE. All intercompany balances and transactions are eliminated in consolidation. The Company reflects the impact of the equity securities issuances in its investment in the VIE and additional paid-in-capital accounts for the dilution or anti-dilution of its ownership interest in the VIE.

The Company has performed an analysis under the VIE accounting model and determined that MTI Micro is a VIE. One of the criteria for determining whether an entity is a VIE is determining if the entity, MTI Micro, has equity at risk. Management has concluded that MTI Micro does not have equity at risk to fund operations into its next phase of development. Further, the Company has determined that it is the primary beneficiary of MTI Micro, and therefore should include MTI Micro’s results of operations in the Company’s consolidated financial statements.

The Company's analysis to determine the primary beneficiary of MTI Micro focused primarily on determining which variable interest holder has the power to direct the activities that would have the most significant impact on the financial performance of MTI Micro. MTI Micro is governed by its own Board of Directors and significant decisions are made by a majority vote of this board. MTI does not have control of the MTI Micro Board of Directors; however, as of March 31, 2012, the Company’s Board of Directors and the MTI Micro Board of Directors consist of the same members. Under the Articles of Incorporation of MTI Micro, each share of MTI Micro stock is entitled to a vote, and further, holders of a majority of the shares of MTI Micro's common stock have the ability to reconstitute the board. As of March 31, 2012, MTI, Counter Point Ventures Fund II, LP (Counter Point), Dr. Walter L. Robb, a member of the Company’s and MTI Micro’s Board of Directors, and Peng Lim, CEO and board member own 47.6%, 45.2%, 5.1% and 0.5% of the common shares of MTI Micro, respectively. Counter Point is a venture capital fund sponsored and managed by Dr. Robb. Since no entity of the related parties has power but, as a group, the Company and its related parties have the power, then the party within the related party group that is most closely associated with the VIE, MTI Micro, is the primary beneficiary. Even though Dr. Robb and Counterpoint combined control a majority of the outstanding common stock, and they have the ability to elect the directors of MTI Micro and decide whether to continue to seek business opportunities for MTI Micro or instead seek opportunities to sell the intellectual property, they have not elected to do so. The Company continues to oversee the day to day operations, exercise management decision making, seek opportunities to sell intellectual property, and has a vested interest in the commercialization of MTI Micro’s fuel cell technology. Since inception in 2001, the Company has made the largest investment and been the principal funder of MTI Micro. The Company has also been exposed to losses and has the ability to benefit from MTI Micro. Considering the facts and circumstances, management believes the Company is most closely associated with the VIE, MTI Micro, and therefore, it is the primary beneficiary.

Should there be a change in the facts and circumstances (such as undertaking additional activities, a change in governance or a change to the related party group) in the future, management will reassess whether the Company remains the primary beneficiary and should continue to include MTI Micro in the Company’s condensed consolidated financial statements.

Non-controlling interests in subsidiaries consist of equity securities issued by a VIE of the Company. Non-controlling interests are classified as stockholders’ equity in the condensed consolidated financial statements. The condensed consolidated income statement presents condensed net income for both the Company and the non-controlling interests. The calculation of earnings per share is based on net income attributable to the Company.

Reclassifications

It is the Company’s policy to reclassify prior year consolidated financial statements to conform to current year presentation, if applicable. Prior period amounts related to prototype evaluation agreements have been reclassified.

XML 18 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (Unaudited) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2012
Dec. 31, 2011
Assets    
Cash $ 1,978 $ 1,669
Accounts receivable 661 1,881
Inventories 1,007 957
Deferred income taxes, net 20 20
Prepaid expenses and other current assets 87 102
Total Current Assets 3,753 4,629
Deferred income taxes, net 1,515 1,515
Property, plant and equipment, net 223 258
Total Assets 5,491 6,402
Liabilities and Stockholders' Equity    
Accounts payable 177 191
Accrued liabilities 1,119 1,238
Deferred revenue 58 58
Total Current Liabilities 1,354 1,487
Commitments and Contingencies (Note 10)      
Stockholders' Equity:    
Common stock, par value $0.01 per share, authorized 75,000,000; 6,259,975 issued in both 2012 and 2011 63 63
Paid-in-capital 135,447 135,389
Accumulated deficit (120,919) (120,097)
Common stock in treasury, at cost, 1,005,092 shares in both 2012 and 2011 (13,754) (13,754)
Total MTI stockholders' equity 837 1,601
Non-controlling interest 3,300 3,314
Total Stockholders' Equity 4,137 4,915
Total Liabilities and Stockholders' Equity $ 5,491 $ 6,402
XML 19 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Operating Activities    
Net loss $ (836) $ (62)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Gain on derivatives 0 (44)
Depreciation 38 99
Gain on disposal of equipment (5) 0
Stock based compensation 58 102
Changes in operating assets and liabilities:    
Accounts receivable 1,220 (572)
Inventories (50) (10)
Prepaid expenses and other current assets 18 8
Accounts payable (14) 177
Deferred revenue 0 (8)
Accrued liabilities (119) 50
Net cash provided by (used in) operating activities 310 (260)
Investing Activities    
Purchases of equipment (3) (13)
Proceeds from sale of equipment 2 0
Net cash used in investing activities (1) (13)
Financing Activities    
Proceeds from the sale of subsidiary equity and warrants issued 0 203
Net cash provided by financing activities 0 203
Increase (decrease) in cash and cash equivalents 309 (70)
Cash - beginning of period 1,669 1,118
Cash - end of period $ 1,978 $ 1,048
XML 20 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 21 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Nature of Operations
3 Months Ended
Mar. 31, 2012
Organization, Consolidation and Presentation Of Financial Statements [Abstract]  
Nature of Operations [Text Block]

1. Nature of Operations

Description of Business

Mechanical Technology, Incorporated (MTI or the Company), a New York corporation, was incorporated in 1961. MTI operates in two segments, the Test and Measurement Instrumentation segment, which is conducted through MTI Instruments, Incorporated. (MTI Instruments), a wholly-owned subsidiary, and the New Energy segment, which is conducted through MTI MicroFuel Cells Incorporated. (MTI Micro), a variable interest entity (VIE) that is included in these condensed consolidated financial statements and described further below in Note 2.

MTI Instruments was incorporated in New York on March 8, 2000 and is a worldwide supplier of precision non-contact physical measurement solutions, portable balancing equipment and wafer inspection tools. MTI Instruments’ products use a comprehensive array of technologies to solve complex, real world applications in numerous industries including manufacturing, semiconductor, solar, commercial and military aviation, automotive and data storage. MTI Instruments’ products consist of electronic gauging instruments for position, displacement and vibration application within the design, manufacturing/production, test and research market; wafer characterization of semi-insulating and semi-conducting wafers within both the semiconductor and solar industries; tensile stage systems for materials testing at academic and industrial settings; and engine vibration analysis systems for both military and commercial aircraft.

MTI Micro was incorporated in Delaware on March 26, 2001, and has been developing Mobion®, a handheld energy-generating device to replace current lithium-ion and similar rechargeable battery systems in many handheld electronic devices for the military and consumer markets. Mobion® handheld generators are based on direct methanol fuel cell (DFMC) technology, which has been recognized as an enabling technology for advanced portable power sources by the scientific community and industry analysts. As the need for advancements in portable power increases, MTI Micro has been developing Mobion® as a solution for advancing current and future electronic device power needs of the portable electronics market. As of March 31, 2012, the Company owned approximately 47.6% of MTI Micro’s outstanding common stock. Although MTI Micro continues to believe in the potential of its Mobion® based power solutions, it has suspended its MTI Micro operations until such time as market demand and other deciding factors, including obtaining additional external financing, the successful completion of customer trials, a new development program with a government agency, and/or a customer order, come to fruition. MTI Micro will continue to seek additional capital from external sources to resume operations and fund future development, if any. If MTI Micro is unable to secure additional financing, a new development program or customer order, the MTI Micro Board of Directors will assess other options for MTI Micro, including the sale of its intellectual property portfolio and other assets.

Liquidity

The Company has historically incurred significant losses, the majority stemming from the direct methanol fuel cell product development and commercialization programs of MTI Micro, and had a consolidated accumulated deficit of $120.9 million as of March 31, 2012. During the first quarter of 2012, the Company generated a net loss attributed to MTI of $822 thousand and had working capital at March 31, 2012 of $2.4 million, a $743 thousand decrease from $3.1 million at December 31, 2011. The Company generated positive operating cash flows of $310 thousand for the three months ended March 31, 2012 and currently has no debt outstanding. While it cannot be assured, management believes that the Company will continue to generate positive cash flows in 2012 and be able to fund the Company’s operations for the foreseeable future.

As of March 31, 2012, the Company had approximately $2.0 million of cash available to fund future operations. During the three months ended March 31, 2012, the Company’s results of operations resulted in a net loss attributed to MTI of $822 thousand and cash provided by operating activities totaling $310 thousand. The Company expects to continue funding its operations from current cash, its projected 2012 cash flow pursuant to management’s current plan, and possible draw downs from its existing line of credit, if necessary. The Company may also seek to supplement its resources through the sales of assets (including its investment in MTI Micro). Besides the line of credit at MTI Instruments, the Company has no other commitments for funding future needs of the organization at this time and such additional financing during 2012 may not be available to the Company on acceptable terms, if at all.

XML 22 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (Unaudited) [Parenthetical] (USD $)
Mar. 31, 2012
Dec. 31, 2011
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 75,000,000 75,000,000
Common stock, shares issued 6,259,975 6,259,975
Treasury stock, shares 1,005,092 1,005,092
XML 23 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Line of Credit
3 Months Ended
Mar. 31, 2012
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]

11. Line of Credit

On September 20, 2011, MTI Instruments entered into a working capital line of credit with First Niagara Bank, N.A. Pursuant to the Demand Grid Note, MTI Instruments may borrow from time to time up to $400 thousand to support its working capital needs. The note is payable upon demand, and the interest rate on the note is equal to the prime rate with a floor of 4.0% per annum. The note is secured by a lien on all of the assets of MTI Instruments and is guaranteed by the Company. The line of credit is subject to a review date of June 30, 2012. Under the line of credit, MTI Instruments is required to hold a line balance of $0 for 30 consecutive days out during each consecutive year. As of March 31, 2012 and December 31, 2011, there were no amounts outstanding under the line of credit.

XML 24 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
3 Months Ended
Mar. 31, 2012
May 04, 2012
Entity Registrant Name MECHANICAL TECHNOLOGY INC  
Entity Central Index Key 0000064463  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol mkty  
Entity Common Stock, Shares Outstanding   5,256,883
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2012  
Document Fiscal Year Focus 2012  
Document Fiscal Period Focus Q1  
XML 25 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
New Accounting Pronouncements
3 Months Ended
Mar. 31, 2012
Accounting Changes and Error Corrections [Abstract]  
Accounting Changes and Error Corrections [Text Block]

12. New Accounting Pronouncements

In September 2011, the Financial Accounting Standards Board (FASB) issued guidance on the presentation of comprehensive income. This guidance eliminates the current option to report other comprehensive income and its components in the statement of changes in equity. The guidance allows two presentation alternatives: (1) present items of net income and other comprehensive income in one continuous statement, referred to as the statement of comprehensive income; or (2) in two separate, but consecutive, statements of net income and other comprehensive income. This guidance is effective as of the beginning of a fiscal year that begins after December 15, 2011. Early adoption is permitted, but full retrospective application is required under both sets of accounting standards. The guidance also previously required the presentation of adjustments for items that are reclassified from other comprehensive income to net income in the statement where the components of net income and the components of other comprehensive income are presented; however, this portion of the guidance has been deferred. The Company adopted the guidance during the quarter ended March 31, 2012. The adoption of this new guidance did not have a material impact on the Company’s condensed consolidated financial statements.

Other pronouncements issued by the FASB, or other authoritative accounting standard groups with future effective dates, are either not applicable, or are not expected to be significant to the financial statements of the Company.

XML 26 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Product revenue $ 1,204 $ 2,539
Funded research and development revenue 0 13
Total revenue 1,204 2,552
Operating costs and expenses:    
Cost of product revenue 578 939
Research and product development expenses:    
Funded research and product development 0 25
Unfunded research and product development 373 385
Total research and product development expenses 373 410
Selling, general and administrative expenses 1,092 1,307
Operating loss (839) (104)
Gain on derivatives 0 44
Other income (expense), net 3 (2)
Loss before non-controlling interest (836) (62)
Plus: Net loss attributed to non-controlling interest 14 256
Net (loss) income attributed to MTI (822) 194
Comprehensive (loss) income attributed to MTI $ (822) $ 194
Net (loss) earnings per share attributable to MTI (Basic and Diluted): (in dollars per share) $ (0.16) $ 0.04
Weighted average shares outstanding (Basic and Diluted) (in shares) 5,254,883 4,771,658
XML 27 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity
3 Months Ended
Mar. 31, 2012
Stockholders Equity Note [Abstract]  
Stockholders Equity Note Disclosure Excluding Issuance Of Stock Warrant To Variable Interest Entity and Stock Option [Text Block]

6. Stockholders’ Equity

Common Stock

The Company has one class of common stock, par value $.01. Each share of the Company’s common stock is entitled to one vote on all matters submitted to stockholders. As of March 31, 2012 and December 31, 2011, there were 5,254,883 shares of common stock issued and outstanding.

Changes in common shares issued and treasury stock outstanding are as follows:

Three Months Ended Year Ended
      March 31, 2012       December 31, 2011
Common Shares  
Balance, beginning 6,259,975 5,776,750
Issuance of shares for restricted stock grants   483,225
Balance, ending 6,259,975 6,259,975
  
Treasury Stock
Balance, beginning 1,005,092 1,005,092
Balance, ending 1,005,092 1,005,092
 

Warrants Issued

On December 20, 2006, the Company issued warrants to investors to purchase 378,472 shares of the Company’s common stock at an exercise price of $18.16 per share. These warrants were fair valued by the Company until their expiration on December 19, 2011.

The Company recognized these derivatives as liabilities in the statement of financial position and measured these instruments at fair value. The fair value of the derivative was recorded in the “Derivative liability” line on the financial statements, and was valued quarterly using the Black-Scholes Option Pricing Model. As of March 31, 2012 and December 31, 2011, the fair value of the warrants was $0. Gains and losses on derivatives are included in “Gain / Loss on derivatives” in the Condensed Consolidated Statement of Operations. During the three month periods ended March 31, 2012 and 2011, the Company recognized a gain on derivatives of $0 and $44 thousand, respectively.

Reservation of Shares

The Company has reserved common shares for future issuance as of March 31, 2012 as follows:

Stock options outstanding       778,046
Shares available for issuance 270,616
Number of common shares reserved 1,048,662
 

Earnings (Loss) per Share

The Company computes basic income (loss) per common share by dividing net income (loss) by the weighted average number of common shares outstanding during the reporting period. Diluted income (loss) per share reflects the potential dilution, if any, computed by dividing income (loss) by the combination of dilutive common share equivalents, comprised of shares issuable under outstanding investment rights, warrants and the Company’s share-based compensation plans, and the weighted average number of common shares outstanding during the reporting period. Dilutive common share equivalents include the dilutive effect of in-the-money stock options, which are calculated based on the average share price for each period using the treasury stock method. Under the treasury stock method, the exercise price of a stock option, the amount of compensation cost, if any, for future service that the Company has not yet recognized, and the amount of windfall tax benefits that would be recorded in additional paid-in capital, if any, when the stock option is exercised are assumed to be used to repurchase shares in the current period.

Not included in the computation of earnings per share, assuming dilution, for the three months ended March 31, 2012, were options to purchase 778,046 shares of the Company’s common stock. These potentially dilutive items were excluded because the Company incurred a loss for this period and their inclusion would be anti-dilutive.

Not included in the computation of earnings per share, assuming dilution, for the three months ended March 31, 2011, were options to purchase 878,591 shares of the Company’s common stock and warrants to purchase 378,472 shares of the Company’s common stock. These potentially dilutive items were excluded because the average market price of the common stock exceeded the exercise prices of the options and warrants for this period.

XML 28 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes
3 Months Ended
Mar. 31, 2012
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]

5. Income Taxes

During the quarter ended March 31, 2012, the Company’s effective income tax rate was 0%. The projected annual effective tax rate is less than the Federal statutory rate of 35%, primarily due to the Company’s expected level of earnings for the year ended December 31, 2012, and the permanent difference related to the stock-based compensation expense for employees of MTI Micro who transferred to MTI. For the quarter ended March 31, 2011, the Company’s effective income tax rate was also 0%. The difference between the annual effective tax rate and the Federal statutory rate was the result of the change in the valuation allowance and the gain on derivative.

The Company provides for recognition of deferred tax assets if the realization of such assets is more likely than not to occur in accordance with accounting standards that address income taxes. Significant management judgment is required in determining the period in which the reversal of a valuation allowance should occur. The Company has considered all available evidence, both positive and negative, such as historical levels of income and future forecasts of taxable income amongst other items, in determining whether a full or partial release of our valuation allowance is required. In addition, the Company’s assessment requires us to schedule future taxable income in accordance with accounting standards that address income taxes to assess the appropriateness of a valuation allowance which further requires the exercise of significant management judgment.

As a result of our analyses in 2011, the Company released a portion of our valuation allowance against its deferred tax assets. The partial release of the valuation allowance caused an incremental tax benefit of $1.5 million to be recognized in the fourth quarter of 2011. The release of a portion of the valuation allowance was based upon a recent cumulative income history for MTI and its subsidiary exclusive of MTI Micro (MTI Micro files separate federal and state tax returns) causing the Company to evaluate what portion of the Company's deferred tax assets it believes are more likely than not to be realized. The Company has determined that it expects to generate sufficient levels of pre-tax earnings in the future to realize the net deferred tax assets recorded on the balance sheet at March 31, 2012. The Company has projected such pre-tax earnings utilizing a combination of historical and projected results, taking into consideration existing levels of permanent differences, non-deductible expense and the reversal of significant temporary differences. The Company needs to generate approximately $225 thousand of taxable income in each year over the next twenty years to ensure the realizability of the approximately $1.5 million of deferred tax assets recorded on the condensed consolidated balance sheet at March 31, 2012.

The Company believes that the accounting estimate for the valuation of deferred tax assets is a critical accounting estimate because judgment is required in assessing the likely future tax consequences of events that have been recognized in our financial statements or tax returns. The Company based the estimate of deferred tax assets and liabilities on current tax laws and rates and, in certain cases, business plans and other expectations about future outcomes. In the event that actual results differ from these estimates or the Company adjusts these estimates in future periods, the Company may need to adjust the recorded valuation allowance, which could materially impact our financial position and results of operations. The valuation allowance at March 31, 2012 and December 31, 2011 was approximately $20 million for both periods. The Company will continue to evaluate the ability to realize its deferred tax assets and related valuation allowances on a quarterly basis.

XML 29 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Events
3 Months Ended
Mar. 31, 2012
Subsequent Events [Abstract]  
Subsequent Events [Text Block]

13. Subsequent Events

The Company has evaluated subsequent events and transactions through the date of this filing for potential recognition or disclosure in the condensed consolidated financial statements and has noted no other subsequent events requiring recognition or disclosure other than as stated below.

On April 12, 2012, Kevin G. Lynch was appointed to the Board of Directors and the Audit Committee of Mechanical Technology, Incorporated.

On April 14, 2012, the Board of Directors of the Company adopted, subject to stockholder approval, the Mechanical Technology Incorporated 2012 Equity Incentive Plan (the 2012 Plan). Up to 600,000 shares of Common Stock may be issued pursuant to awards granted under the 2012 Plan. The 2012 Plan covers the Company and its majority owned subsidiaries, and references below to service providers to the Company (other than with respect to changes in control) generally refer to service providers to any of the other entities, as long as they remain majority owned. The 2012 Plan is intended to replace the Company's current option plan - the 2006 Equity Incentive Plan.

On April 14, 2012, the Board of Directors and executive officers of the Company surrendered 355,459 stock options without consideration and without any obligation on the part of the Company to grant stock options in replacement thereof or other consideration relating thereto at any time in the future in order to make more stock options available for future grants.

On April 17, 2012, in conjunction with the suspension of MTI Micro in late 2011, an auction was held to sell certain surplus equipment on hand.

XML 30 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information
3 Months Ended
Mar. 31, 2012
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]

9. Segment Information

The Company operates in two business segments, Test and Measurement Instrumentation and New Energy. The Test and Measurement Instrumentation segment designs, manufactures, markets and services high performance test and measurement instruments and systems, wafer characterization tools for the semiconductor and solar industries, tensile stage systems for materials testing at academic and industrial settings, and computer-based balancing systems for aircraft engines. The New Energy segment is focused on commercializing direct methanol fuel cells. The Company’s principal operations are located in North America.

The accounting policies of the Test and Measurement Instrumentation and New Energy segments are similar to those described in the summary of significant accounting policies in the Company’s Annual Report on Form 10-K (Note 2). The Company evaluates performance based on profit or loss from operations before income taxes. Inter-segment sales and expenses are not significant.

Summarized financial information concerning the Company’s reportable segments is shown in the following table. The “Other” column includes corporate related items and items such as income taxes or unusual items, which are not allocated to reportable segments. The “Reconciling Items” column includes non-controlling interests in a consolidated entity. In addition, segments’ non-cash items include any depreciation in reported profit or loss.

(Dollars in thousands) Test and Condensed
Measurement Reconciling Consolidated
      Instrumentation       New Energy       Other       Items       Totals
Three months ended March 31, 2012
Product revenue $            1,204 $           — $ $             — $ 1,204
Research and product development expenses
       (income) 374 (1 ) 373
Selling, general and administrative expenses 518 37 537 1,092
Segment loss from operations before non-  
       controlling interest (478 ) (28 ) (330 ) (836 )
Segment (loss) profit (478 ) (28 ) (330 ) 14 (822 )
Total assets 1,833 85       3,573        5,491
Capital expenditures 3 3
Depreciation 25 13 38
 
(Dollars in thousands) Test and Condensed
Measurement Reconciling Consolidated
Instrumentation New Energy Other Items Totals
Three months ended March 31, 2011
Product revenue       $ 2,539       $       $       $       $ 2,539
Funded research and development revenue 13 13
Research and product development expenses 330 80 410
Selling, general and administrative expenses 533 393 381 1,307
Segment profit (loss) from operations before non-    
       controlling interest 622       (527 ) (157 ) (62 )
Segment profit (loss) 622 (527 ) (157 )           256 194
Total assets              2,539 420        1,061        4,020
Capital expenditures 8 5 13
Depreciation 19 77 3 99
 

The following table presents the details of “Other” segment loss:

(Dollars in thousands)       Three Months Ended
March 31,
2012       2011
Corporate and other (expenses) income:
       Depreciation $ $ (3 )
       Salaries and benefits         (352 )         (175 )
       Gain on derivatives 43
       Other income (expense), net 22 (22 )
Total expense $ (330 ) $ (157 )
XML 31 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Issuance of Stock, Warrants and Stock Options by MTI Micro
3 Months Ended
Mar. 31, 2012
Issuance Of Stock Warrants To Variable Interest Entity And Stock Option [Abstract]  
Issuance Of Stock Warrants To Variable Interest Entity and Stock Option [Text Block]

7. Issuance of Common Stock, Warrants and Stock Options by MTI Micro

As of March 31, 2012, the Company owned approximately 47.6% of MTI Micro’s outstanding common stock, or 75,049,937 shares, and 53.3% of common stock and warrants issued, which includes 32,904,136 outstanding warrants. The number of shares of MTI Micro common stock authorized for issuance is 240,000,000 as of March 31, 2012.

Common Stock Issued – MTI Micro

On January 11, 2010, MTI Micro entered into a Purchase Agreement with Counter Point. Counter Point is a venture capital fund sponsored and managed by Dr. Walter L. Robb, a member of the Board of Directors of the Company and MTI Micro, and a current stockholder of MTI Micro. Pursuant to the Purchase Agreement, MTI Micro issued and sold to Counter Point 28,571,429 shares of common stock, par value $0.01 per share (the MTI Micro Common Stock), at a purchase price per share of $0.07, over a period of twelve months, and warrants (MTI Micro Warrants) to purchase shares of MTI Micro Common Stock equal to 20% of the shares of MTI Micro Common Stock purchased under the Purchase Agreement at an exercise price of $0.07 per share. The sale and issuance of the MTI Micro Common Stock and MTI Micro Warrants occurred over multiple closings (each, a Closing). Nine Closings occurred through December 31, 2010, with MTI Micro raising $1.9 million from the sale of 26,952,386 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 5,390,477 shares of MTI Micro Common Stock to Counter Point. The final Closing occurred on January 5, 2011, with MTI Micro raising $113 thousand from the sale of 1,619,043 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 323,809 shares of MTI Micro Common Stock to Counter Point.

On February 9, 2011, Amendment No. 1 was entered into between MTI Micro and Counter Point. Pursuant to Amendment No. 1, MTI Micro issued and sold to Counter Point 6,428,574 shares of MTI Micro Common Stock at a purchase price per share of $0.07, through December 31, 2011, and MTI Micro Warrants to purchase shares of MTI Micro Common Stock equal to 20% of the shares of MTI Micro Common Stock purchased under Amendment No. 2 at an exercise price of $0.07 per share. The sale and issuance of the MTI Micro Common Stock and MTI Micro Warrants occurred over multiple closings (each, a Closing) occurring over four one-month closing periods (each, a Closing Period). Four Closings occurred through September 30, 2011, with MTI Micro raising $450 thousand from the sale of 6,428,574 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 1,285,715 shares of MTI Micro Common Stock to Counter Point.

On September 23, 2011, Amendment No. 2 was entered into between MTI Micro and Counter Point. Pursuant to Amendment No. 2, MTI Micro issued and sold to Counter Point 1,200,000 shares of MTI Micro Common Stock at a purchase price per share of $0.07, through December 31, 2011, and MTI Micro Warrants to purchase shares of MTI Micro Common Stock equal to 20% of the shares of MTI Micro Common Stock purchased under Amendment No. 2 at an exercise price of $0.07 per share. The sale and issuance of the MTI Micro Common Stock and MTI Micro Warrants occurred over multiple closings (each, a Closing) occurring over three one-month closing periods (each, a Closing Period). Three Closings occurred through December 31, 2011, with MTI Micro raising $84 thousand from the sale of 1,200,000 shares of MTI Micro Common Stock and MTI Micro Warrants to purchase 240,000 shares of MTI Micro Common Stock to Counter Point.

The following table represents changes in ownership between the Company and non-controlling interests in common shares of MTI Micro:

            MTI       Non Controlling Interest
Average       Ownership       Ownership      
Price Shares % Shares % Total Shares
 
Balance at 12/31/10 75,049,937 50.6 73,325,490 49.4 148,375,427
 
      Stock issued under Purchase Agreement, 2011 $      0.07 1,619,043 1,619,043
 
Balance after Purchase Agreement 75,049,937 50.04 74,944,533 49.97 149,994,470
 
      Stock issued under Amendment No. 1 $ 0.07 6,428,574 6,428,574
 
      Stock issues under Amendment No. 2 $ 0.07 1,200,000   1,200,000
 
Balance at 12/31/11   75,049,937 47.61 82,573,107 52.39 157,623,044
 
Balance at 3/31/12 75,049,937 47.61 82,573,107 52.39 157,623,044
 

Reservation of Shares

MTI Micro has reserved common shares for future issuance, broken down between the Company and NCI, as follows as of March 31, 2012:

      MTI       NCI       Total
Stock options outstanding 22,566,560 22,566,560
Warrants outstanding 32,904,136 12,196,411 45,100,547
Number of shares reserved for outstanding options and warrants 32,904,136 34,762,971 67,667,107
 

In addition, MTI Micro has 15,375,637 stock options available for issuance.

As of March 31, 2012, the Company owned an aggregate of approximately 47.6% of the outstanding shares of MTI Micro or 53.3% of the outstanding common stock and warrants issued of MTI Micro, and Dr. Robb and Counter Point owned approximately 45.2% and 5.1%, respectively of the outstanding shares of MTI Micro or 40.3% and 4.3%, respectively of the outstanding common stock and warrants issued of MTI Micro.

Warrants Issued – MTI Micro

On December 9, 2009, MTI Micro issued warrants to the then current shareholders of MTI Micro, including the Company, without consideration, to purchase 32,779,310 shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The warrants became exercisable on December 9, 2010 and expire on December 8, 2017. The warrants have been accounted for as an equity distribution of $2.0 million, including warrants to the Company with a value of $2.0 million, which were eliminated in consolidation.

On December 9, 2009, MTI Micro issued warrants to the Bridge Investors of MTI Micro, including the Company, to purchase 5,081,237 shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on December 9, 2009 and will expire on the earlier of: (i) April 15, 2014; (ii) immediately prior to a change in control; or (iii) immediately prior to an initial public offering of MTI Micro. The MTI Micro Warrants were issued without consideration and were accounted for as equity and a loss on extinguishment of debt was recorded in the amount of $289 thousand, including warrants to the Company with a value of $57 thousand, which were eliminated in consolidation.

Under the Purchase Agreement entered into on January 11, 2010, MTI Micro issued 5,714,286 MTI Micro Warrants to Counter Point to purchase shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on the date of issuance and will expire on the earlier of: (a) the five (5) year anniversary of the Date of Issuance of the Warrant; (b) immediately prior to a change in control; or (c) the closing of a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act. The MTI Micro Warrants were accounted for as equity.

Under Amendment No. 1 entered into on February 9, 2011, MTI Micro issued 1,285,715 MTI Micro Warrants to Counter Point to purchase shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on the date of issuance and will expire on the earlier of: (a) the five (5) year anniversary of the Date of Issuance of the Warrant; (b) immediately prior to a change in control; or (c) the closing of a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act. The MTI Micro Warrants were accounted for as equity.

Under Amendment No. 2 entered into on September 23, 2011, MTI Micro issued 240,000 MTI Micro Warrants to Counter Point to purchase shares of MTI Micro Common Stock at an exercise price of $0.07 per share. The MTI Micro Warrants became exercisable on the date of issuance and will expire on the earlier of: (a) the five (5) year anniversary of the Date of Issuance of the Warrant; (b) immediately prior to a change in control; or (c) the closing of a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act. The MTI Micro Warrants were accounted for as equity.

XML 32 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurement
3 Months Ended
Mar. 31, 2012
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]

8. Fair Value Measurement

The Company performs a detailed analysis of financial assets and liabilities in determining the appropriate levels of classification. At each reporting period, all assets and liabilities for which the fair value measurements are based upon significant unobservable inputs are classified as Level 3. The derivative liability was valued using the Black-Sholes Option Pricing Model, which is based upon unobservable inputs. The derivative liability was $0 as of March 31, 2012 and December 31, 2011. The Company had no Level 1 and no Level 2 assets and liabilities as of March 31, 2012 and December 31, 2011.

The following is a rollforward of Level 3 fair value instruments for the twelve months ended December 31, 2011:

(Dollars in thousands)

      Beginning       Total (Gains) /             Ending
Balance as of Losses Purchases, Balance as of
  January 1, Realized and Issuances, Sales December 31,
Instrument 2011 Unrealized and Settlements 2011
       Derivative liability $                    73 $                  (73 ) $                        — $                        —
Total Level 3 instruments $ 73 $ (73 ) $ $
XML 33 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies
3 Months Ended
Mar. 31, 2012
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]

10. Commitments and Contingencies

Commitments:

Leases

The Company and its subsidiary lease certain manufacturing, laboratory and office facilities. The leases generally provide for the Company to pay either an increase over a base year level for taxes, maintenance, insurance and other costs of the leased properties or the Company’s allocated share of insurance, taxes, maintenance and other costs of leased properties. The leases contain renewal provisions.

Future minimum rental payments required under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) are (dollars in thousands): $209 thousand remaining in 2012, $285 thousand in 2013 and $266 thousand in 2014.

Warranties

Below is a reconciliation of changes in product warranty liabilities:

(Dollars in thousands) Three Months Ended
March 31,
      2012       2011
Balance, January 1 $ 26 $ 36
Accruals for warranties issued 3 12
Settlements made (in cash or in kind) (3 )          (3 )
Balance, end of period $          26 $ 45
 

Licenses

Under a 2002 NYSERDA contract, MTI Micro agreed to pay NYSERDA a royalty of 5.0% of the sales price of any product sold incorporating IP developed pursuant to the NYSERDA contract. If the product is manufactured by a New York State manufacturer, this royalty is reduced to 1.5%. Total royalties are subject to a cap equal to two times the total contract funds paid by NYSERDA to MTI Micro, and may be reduced to reflect any New York State jobs created by MTI Micro. As of March 31, 2012 and December 31, 2011, there are no amounts accrued in the condensed consolidated balance sheets related to this royalty provision.

Under the 2010 NYSERDA contract, MTI Micro agreed to pay NYSERDA a royalty of 5.0% of the sales price of any product sold incorporating IP developed pursuant to the NYSERDA contract. The obligation commences on the first date of the first sale of these products and is in place for fifteen years. Total royalties are subject to a cap equal to three times the total contract funds paid by NYSERDA to MTI Micro. However, if the product is manufactured by a New York State manufacturer, this royalty is reduced to 1.5% and total royalties are subject to a cap equal to one times the total contract funds paid by NYSERDA to MTI Micro. As of March 31, 2012 and December 31, 2011, there are no amounts accrued in the condensed consolidated balance sheets related to this royalty provision.

Employment Agreements

The Company has employment agreements with certain employees that provide severance payments, certain other payments, accelerated vesting and exercise extension periods of certain options upon termination of employment under certain circumstances, as defined in the applicable agreements. As of March 31, 2012, the Company’s potential maximum cash obligation to these employees was approximately $641 thousand.

Royalty Commitment

On January 28, 2010, MTI Instruments entered into an Asset Purchase and Sale Agreement with Ernest F. Fullam, Inc., Peter Fullam and Diane Fullam to acquire the tensile stage line of products from Ernest F. Fullam, Inc, a pioneering microscopy accessories company from Clifton Park, NY. As part of the acquisition, Mr. Peter Fullam joined MTI Instruments as a Product Sales Engineer until September 30, 2011, at which time he became a consultant for MTI Instruments, and MTI Instruments purchased machinery, inventory and the rights to use the Fullam/MTI Instruments product name. Additionally, commencing with the quarter ended March 31, 2010 and ending at the close of the quarter ending December 31, 2012, MTI Instruments will pay Ernest F. Fullam, Inc. a royalty equal to 5% of the Gross Sales achieved on specific Fullam products. Royalty expense related to this agreement was $0 and $3 thousand for the three months ended March 31, 2012 and 2011, respectively.

Contingencies:

Legal

We are subject to legal proceedings, claims and liabilities which arise in the ordinary course of business. We accrue for losses associated with legal claims when such losses are probable and can be reasonably estimated. These accruals are adjusted as additional information becomes available or circumstances change. Legal fees are charged to expense as they are incurred.

XML 34 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (USD $)
In Thousands, except Share data
Common Stock [Member]
Paid-In Capital [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Non-Controlling Interest (NCI) [Member]
Total
Balance at Dec. 31, 2010 $ 58 $ 134,733 $ (122,483) $ (13,754) $ 3,405 $ 1,959
Balance (in shares) at Dec. 31, 2010 5,776,750     1,005,092    
Net income (loss) attributed to MTI 0 0 2,386 0 0 2,386
Stock based compensation 0 656 0 0 0 656
Issuance of shares - restricted stock 5 0 0 0 0 5
Issuance of shares - restricted stock (in shares) 483,225          
Net loss attributed to NCI 0 0 0 0 (738) (738)
Equity contribution to NCI 0 0 0 0 647 647
Balance at Dec. 31, 2011 63 135,389 (120,097) (13,754) 3,314 4,915
Balance (in shares) at Dec. 31, 2011 6,259,975     1,005,092    
Net income (loss) attributed to MTI 0 0 (822) 0 0 (822)
Stock based compensation 0 58 0 0 0 58
Net loss attributed to NCI 0 0 0 0 (14) (14)
Balance at Mar. 31, 2012 $ 63 $ 135,447 $ (120,919) $ (13,754) $ 3,300 $ 4,137
Balance (in shares) at Mar. 31, 2012 6,259,975     1,005,092    
XML 35 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Inventories
3 Months Ended
Mar. 31, 2012
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]

4. Inventories

Inventories consist of the following at:

(Dollars in thousands)
      March 31, 2012       December 31, 2011
Finished goods $ 390   $ 310
Work in process     253   211
Raw materials 364 436
$                      1,007 $                             957
 

As of March 31, 2012 and December 31, 2011, the Company had an inventory reserve of $220 thousand and $243 thousand, respectively.

XML 36 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 33 90 1 false 5 0 false 3 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.mechtech.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.mechtech.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) [Parenthetical] Sheet http://www.mechtech.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) [Parenthetical] false false R4.htm 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.mechtech.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) false false R5.htm 005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) Sheet http://www.mechtech.com/role/CondensedConsolidatedStatementsOfStockholdersEquityDeficitUnaudited Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) false false R6.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.mechtech.com/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 007 - Disclosure - Nature of Operations Sheet http://www.mechtech.com/role/DescriptionOfBusiness Nature of Operations false false R8.htm 008 - Disclosure - Basis of Presentation Sheet http://www.mechtech.com/role/BasisOfPresentation Basis of Presentation false false R9.htm 009 - Disclosure - Accounts Receivable Sheet http://www.mechtech.com/role/AccountsReceivable Accounts Receivable false false R10.htm 010 - Disclosure - Inventories Sheet http://www.mechtech.com/role/Inventories Inventories false false R11.htm 011 - Disclosure - Income Taxes Sheet http://www.mechtech.com/role/IncomeTaxes Income Taxes false false R12.htm 012 - Disclosure - Stockholders' Equity Sheet http://www.mechtech.com/role/StockholdersEquity Stockholders' Equity false false R13.htm 013 - Disclosure - Issuance of Stock, Warrants and Stock Options by MTI Micro Sheet http://www.mechtech.com/role/IssuanceOfStockWarrantsAndStockOptionsByMtiMicro Issuance of Stock, Warrants and Stock Options by MTI Micro false false R14.htm 014 - Disclosure - Fair Value Measurement Sheet http://www.mechtech.com/role/FairValueMeasurement Fair Value Measurement false false R15.htm 015 - Disclosure - Segment Information Sheet http://www.mechtech.com/role/SegmentInformation Segment Information false false R16.htm 016 - Disclosure - Commitments and Contingencies Sheet http://www.mechtech.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R17.htm 017 - Disclosure - Line of Credit Sheet http://www.mechtech.com/role/LineOfCredit Line of Credit false false R18.htm 018 - Disclosure - New Accounting Pronouncements Sheet http://www.mechtech.com/role/Newaccountingpronouncements New Accounting Pronouncements false false R19.htm 019 - Disclosure - Subsequent Events Sheet http://www.mechtech.com/role/Subsequentevents Subsequent Events false false All Reports Book All Reports Process Flow-Through: 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) [Parenthetical] Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011' Process Flow-Through: 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) mkty-20120331.xml mkty-20120331.xsd mkty-20120331_cal.xml mkty-20120331_def.xml mkty-20120331_lab.xml mkty-20120331_pre.xml true true